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Primary tooth pulp cells have a unique character that can be attributed to their 
neural crest origin. The long-term aim of this research is to utilise these cells to 
regenerate dentine–pulp complexes in damaged immature permanent teeth. In the first 
instance, it is necessary to successfully culture and characterise progenitor cells isolated 
from primary dental pulp and assess their ability to differentiate into cells of different 
origins. Future research can proceed to treatment-based clinical trials using ‘progenitor 
cells’ from primary teeth to treat future problems or diseases that may arise in the 
same patient by regenerating the pulp–dentine complex, leading to root maturation; 
and potentially regenerating damaged heart muscle or nerves. 
Objectives 
To characterise primary pulp cells from three defined stages of root resorption by in 
vitro immunocytochemistry and immunohistochemistry experiments. The expression of 
markers for embryonic, neural and mesenchymal stem cells were studied. The 
differentiation potential of primary pulp cells into the three germ layer lineages, 
specialised mesoderm (cardiomyocyte progenitor cells) and specialised ectoderm 
(neural progenitor cells) was assessed. 
Methods 
Caries-free primary canines at three defined stages of physiological root resorption 
were included in this study (n = 9). In vitro cultures were established in xeno-free, 
serum-free Essential 8 (E8) medium on a human truncated vitronectin matrix (VTN-N). 
An embryonic stem cell line (GENEA002) grown in stem cell media (M2) was used as a 
positive control in immunocytochemistry and multilineage differentiation experiments. 
The expression of  embryonic stem cell proteins (Oct4A, Nanog and Sox2), neural stem 
cell proteins (nestin and distal-less homeobox 2 [Dlx2]) and mesenchymal stem cell 
surface markers (cluster of differentiation markers CD90, CD73 & CD105) was 
investigated. Flow cytometry analyses were also performed based on criteria proposed 
by the International Society for Cellular Therapy. 
The differentiation potential of primary pulp cells into ectoderm, mesoderm and 




Most primary tooth pulp cells in culture and in tissue sections expressed the early 
neural progenitor markers nestin and Dlx2; a few isolated cells expressed the  
embryonic stem cell transcription factors Oct4A, Nanog and Sox2; and the majority 
expressed the mesenchymal stem cell markers CD90, CD105 and CD73. Flow cytometry 
for mesenchymal stem cell markers did not detect differences according to resorption 
stage. 
Differentiated cells showed positive immunofluorescence for orthodenticle 
homeobox-2 (Otx2) (ectoderm), Brachyury (mesoderm) and Sox17 (endoderm) proteins 
of the three germ layers as well as expression of cardiomyocyte progenitor markers 
TNNT2 and Nkx2.5 and neural progenitor markers nestin, Sox1, Sox2 and Pax6. 
Conclusions 
The present study identified cells that variably express marker proteins belonging to  
embryonic stem cells, neural stem cells and mesenchymal stem cells. The in vitro ability 
of the cells to differentiate into the three germ layers cells, as well as cardiomyocyte 
and neural progenitor cells, was detected. The root resorption stage was not a 
significant factor in relation to mesenchymal stem cell marker expression. 
This research provides an insight into the unique type of progenitor cells present in 
the dental pulp of primary teeth and their differentiation capabilities that can be 
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In permanent immature teeth where there is loss of pulp vitality, clinicians face a 
challenge. Roots have thin dentine walls liable to fracture under physiological forces 
and wide, open apices that are time consuming and technically difficult to treat. The 
aims of current treatments for these teeth are to produce a barrier, against which a 
root canal filling material can be placed, thereby preventing the extrusion of material 
into the surrounding tissues and providing a restoration that reinforces or strengthens 
the weak immature dentinal root walls in an attempt to improve their function. 
Traditionally, multiple-visit apexification with calcium hydroxide or a single visit apical 
plug technique were the treatments of choice in the management of necrotic 
permanent immature teeth, aiming at the formation of a hard tissue apical barrier (Al 
Ansary et al., 2009). 
Research in the field of regenerative dental procedures has attempted to explore, 
with some success, how to trigger dental pulp cells to differentiate, lay down dental 
tissue and continue root growth in permanent immature non-vital teeth with the aim of 
inducing complete regeneration. The concept of pulp tissue regeneration and root 
maturation was developed in the 1960s when Ostby (1961) reported an experimental 
histological study in monkeys utilising a blood clot in endodontic therapy. Coviello and 
Brilliant (1979) suggested that over-instrumentation of immature root canals during 
root canal treatment will induce bleeding into the root canals. The resulting blood clot 
stimulates the formation of new healthy vascularised tissue in the root canal, which can 
induce an apical closure. Vojinovic and Srnie (1975) suggested that the remnants of the 
Hertwig epithelial root sheath around the apex of an immature tooth may activate the 
apical mesodermal tissue to form root components. 
New regenerative procedures for dental pulp are being widely investigated for the 
management of permanent non-vital immature teeth. Banchs and Trope (2004) 
reported a protocol for the revascularisation of immature permanent teeth based on 
reactivating stem cells in the apical papillae of traumatised teeth. This old/new concept 
has become the most widely used protocol in regenerative endodontics. This technique 
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has shown some success and it is now internationally recommended that pulpal 
revascularisation should be attempted in permanent non-vital immature teeth. 
In recent years, researchers have attempted to trigger stem cells to differentiate and 
regenerate pulp tissue or produce a functional tooth replacement. The first 
bioengineered tooth germs in mice have now been reported by Ikeda et al. (2009). 
However, the use of tissue regenerative procedures targeting the dental pulp in the 
management of dental injuries is still largely experimental and our understanding of the 
most successful ways to grow new tissues is limited. 
The current study investigated ‘stem-like cells’ from deciduous tooth pulp at stages 
prior to and up to exfoliation. The donated teeth used in this study were extracted as 
part of participants’ dental treatment plans. The aim was to investigate the expression 
of specific stem cell markers in decalcified sections of primary teeth as well as in 
cultured primary pulp cells at different stages of root resorption using 
immunohistochemistry (IHC) and immunofluorescence (IF) techniques, respectively. The 
multilineage differentiation potential of cultured cells from primary tooth pulp at three 
defined stages of root resorption has also been assessed. 
This study provides evidence that primary tooth pulp cells comprise a heterogeneous 
population of cells that retain the unique characteristics of neural crest cells. Most cells 
were found to express the neural stem cell (NSC) markers nestin and distal-less 
homeobox 2 (Dlx2); a few isolated cells were detected that expressed the embryonic 
stem cell (ESC) transcription factors Oct3/4, Nanog and Sox2; and the majority 
expressed the mesenchymal stem cell (MSC) surface cluster of differentiation (CD) 
markers CD90, CD105 and CD73. Cells were also assessed using flow cytometry for the 
quantitative measurement of MSC markers according to the International Society for 
Cellular Therapy (ISCT) criteria (Dominici et al., 2006). 
Cultured primary tooth pulp cells were challenged with differentiation into multiple 
in vitro pathways. Cells showed positive IF for orthodenticle homeobox-2 (Otx2), 
Brachyury and Sox17 proteins, indicating de-differentiation capability into cells from the 
three germ layers (ectoderm, mesoderm and endoderm, respectively). In addition, cells 
were able to differentiate into cardiomyocyte progenitor cells expressing the specific 
protein markers TNNT2 and Nkx2.5 as well as expressing the NSC markers nestin, Sox1, 
Sox2 and Pax6 following neural induction. Primary pulp cells showed evidence for 
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multilineage differentiation in vitro , fulfilling another criterion proposed by ISCT for 
them to be considered stem cells (Dominici et al., 2006). 
Flow cytometry analyses was performed on three cultured cell lines, one from each 
resorption group, according to the criteria proposed by ISCT (Dominici et al., 2006). 
Based on these minimal criteria, it is recommended that 95% or more of the cells 
should at least express the following markers: CD105, CD73 & CD90. ISCT also 
recommended that the lack of expression of haematopoietic antigens in 2% or less of a 
cell population be used as an additional criterion to exclude the cells most likely to be 
found in MSC cultures. 
Quantitative analyses of MSC marker CD105, CD73 and CD90 expression in three cell 
lines showed positivity in more than 99% of cells from each group. Haematopoietic 




Chapter 1: Literature Review 
A systematic literature review and a comprehensive search were developed to 
ensure that as many studies as possible were identified through a structured electronic 
search and hand search. This was followed by critical appraisal of identified studies with 
a focus on the study questions. 
1.1 Electronic search 
A search for relevant studies using PubMed electronic databases 
(http://www.ncbi.nlm.nih.gov/pubmed) was initially performed on 15 October 2012 and 
was updated regularly until 15 September 2015. This used a structured search strategy 
to determine an article’s relevance to this literature review based on its title and 
abstract. The subject search used the combination of MeSH terms listed in Table 1. 
There were no restrictions on the year or language of publication. However, results 
were filtered for “Human”. 
1.2 Subject search strategy for MEDLINE 
All reports identified by the search strategy were scanned based on the title, 
keywords and abstract to exclude reports that are non-relevant to the study questions. 
Table 1: MeSH terms used for Medline search 
"dentition"[MeSH Major Topic] AND (((((((("physiological phenomena"[MeSH Major Topic] OR 
"genetic phenomena"[MeSH Major Topic]) OR "cell physiological phenomena"[MeSH Major 
Topic]) OR "immunologic techniques"[MeSH Major Topic]) OR "genetic techniques"[MeSH 
Terms]) OR "cytological techniques"[MeSH Major Topic]) OR "culture techniques"[MeSH Major 
Topic] AND "humans"[MeSH Terms]) AND (((((((((("embryonic structures"[MeSH Major Topic] 
OR "amelogenesis"[MeSH Major Topic]) OR "amelogenesis"[MeSH Major Topic]) OR 
"ameloblasts"[MeSH Major Topic]) OR "dental enamel"[MeSH Major Topic]) OR "tooth 
root"[MeSH Major Topic]) OR "dentin"[MeSH Major Topic]) OR "dental pulp"[MeSH Major 
Topic]) OR "tooth germ"[MeSH Major Topic]) OR "odontogenesis"[MeSH Major Topic]) OR 
"tooth"[MeSH Major Topic])) AND "stem cells"[MeSH Major Topic]) 
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1.3 Hand search 
The University of Otago Library databases Medline (Ovid), PubMed, ScienceDirect 
and Scopus were searched for papers that cited a seminal article, to aid in the 
identification of authors or institutions working on this particular topic and papers 
originating from these sources. 
The search also involved checking the references at the end of the relevant identified 
articles and manually searching through printed indexes, bibliographies and special 
issues of relevant journals. 
1.4 Systematic literature review 
MSCs were initially identified in the early 1970s as a sub-population of bone marrow 
cells with osteogenic potential. These early reports confirmed the presence of clonal, 
plastic-adherent bone marrow-derived non-haematopoietic cells following heterotropic 
transplantation in mice and guinea pigs (Friedenstein et al., 1968; 1974; 1982). The role 
of stromal cells in mediating tissue regeneration led to the proposal by Caplan (1991) 
that these cells were MSCs capable of differentiation to all cells of mesoderm lineage 
and stimulated further investigation into the role of these cells in mediating tissue 
regeneration. 
Few cell types have captivated so many biomedical researchers over the last 10 years 
as have stem cells. PubMed identified over 17,000 references for MSCs and more than 
4,500 for mesenchymal stromal cells in 2012 alone (Keating, 2012). The MeSH term 
"Stem Cells"[MeSH] via PubMed in 2015 revealed 147,774 references with at least 
53,725 of these published in the previous 5 years (Figure 1). 
 
Figure 1: Results of MeSH term "Stem Cells"[MeSH] search via PubMed 




















Stem cells can be found quiescent within all adult tissues and classified as ESCs, adult 
stem cells and induced pluripotent stem cells (iPSCs). In response to injury, these cells 
initiate their differentiation and proliferation capabilities as part of the process of tissue 
healing. 
ESCs are primitive (undifferentiated) cells that are derived from a pre-implantation 
embryo. They are capable of dividing without differentiating for a prolonged period in 
culture and are known to develop into cells and tissues of the three primary germ layers 
(ectoderm, mesoderm and endoderm). Adult stem cells are undifferentiated cells found 
in many organs and have limited capacity for both self-renewal and differentiation. The 
third category, iPSCs, are adult cells that have been genetically reprogrammed to an 
ESC-like state by transfection with genes important for maintaining the defining 
properties of ESCs. Yamanaka, the Nobel Prize winner in 2012, used Oct4A and Sox2 to 
successfully transform human fibroblasts into pluripotent stem cells (PSCs) (Takahashi 
and Yamanaka, 2006). In addition to the transcription factors Oct4A and Sox2, the 
importance of the transcription factor Nanog to reprogramme human somatic cells into 
PSCs was emphasised by Yu et al. (2007). This highlights the importance of these factors 
in the regulation and maintenance of the pluripotent state. 
1.5 The dental pulp 
 The dental pulp is a loose connective tissue consisting of cells embedded within a 
collagenous extracellular matrix. It is composed of 75% water and 25% organic matrix. 
The connective tissue of the central pulp chamber is enclosed by hard dentine and 
considered embryonically and functionally united with dentine, as demonstrated by the 
dental pulp’s formative, nutritive, protective and reparative functions (Nanci, 2008). 
Within the pulp, four distinct regions can be observed (Figure 2). At the periphery of 
the pulp, adjacent to and in contact with the predentine, are the characteristic 
odontoblast cells. Beneath these cells is the cell-free zone of Weil, which contains an 
extensive nerve plexus and capillary network. Adjacent to this cell-free zone is a cell-rich 
zone, an area with high cell-density and a rich capillary plexus. The cell-rich zone is 
thought to contain both pulpal fibroblasts and a population of undifferentiated 
mesenchymal cells, which are identified as polyhedral in shape with a large nucleus. 
Beyond this is the central core of the pulp (Sloan, 2015). 
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The central core of the pulp is composed of fibroblasts and undifferentiated 
mesenchymal cell populations. The cell-rich area contains a network of capillaries that 
are vital for nutrient transportation, especially during dentinogenesis. 
Following dentinogenesis and after ceasation of active dentine formation these 
vessels disappear from the odontoblast layer because nutrient demand is reduced. This 
supports suggestions that dental pulp progenitor cells may originate from the 
perivascular tissues (Shi and Gronthos, 2003). 
 
Figure 2: Haematoxylin and eosin (H&E)-stained decalcified section in a resorbing primary canine 
from a collected sample. The dentine–pulp complex comprises mineralised dentine, the odontoblast 
cell layer and the central core of the pulp. Reparative dentine shows as a dysplastic, irregular 
structure produced by a new generation of odontoblast-like cells 
During tooth development, the formative role of the dental pulp cells is to synthesise 
and secrete dentine, which surrounds and protects the developing pulpal tissue. One of 
the important postnatal biological functions of the dental pulp is a nutritional one: the 
pulp keeps the organic components of the surrounding mineralised tissue supplied with 
nutrients. The pulp also has a sensory function through its nerve plexus. Extremes in 
temperature, pressure or trauma to the dentine–pulp complex will be perceived as 
pain. In addition to these functions, the pulp has a protective role through the sensing 
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of noxious stimuli and formation of tertiary (reactionary or reparative) dentine (Shi and 
Gronthos, 2003; Sloan, 2015). 
1.5.1 Extracellular matrix 
The extracellular matrix (ECM) is a dynamic, heterogeneous, three-dimensional (3D) 
structure that anchors and surrounds cellular compartments in tissues. The ECM is 
essentially composed of four components—collagens, elastin, glycoproteins and 
proteoglycans—that undergo tissue-specific modifications and cell-mediated ordered 
assembly to generate structures that range from a translucent hydrogel to hard 
mineralised tissue (Kaur and Reinhardt, 2015; Lu et al., 2011). 
The principal collagen fibril present within the tooth pulp is type I collagen, present 
as fibres of varying size with an irregular arrangement within the pulp. Type III collagen 
is also present in large amounts, along with a smaller amount of type V fibres. The 
collagen fibril orientation, along with the presence of proteoglycans, forms a scaffold on 
which hydroxyapatite mineral can be deposited. Mineral crystal deposition occurs at the 
gap zone within collagen fibrils of mineralised dentine (Ricard-Blum, 2011). 
The non-collagenous protein content is characterised by the presence of 
proteoglycans including decorin, biglycan, versican, syndecan, tenascin and fibronectin, 
as well as glycosaminoglycans of all four species: chondroitin sulphate, dermatan 
sulphate, heparan sulphate and hyaluronan (Sloan, 2015). It is this matrix, along with 
the water content, that gives the pulp its unique gel-like properties. Glycoproteins such 
as fibronectin and laminins polymerise and provide connections between cells and the 
ECM through their interactions with other structures, growth factors, cytokines and cell-
surface receptors (Kaur and Reinhardt, 2015). 
In addition to collagens, glycoproteins and proteoglycans, mesenchymal cells 
synthesise vast quantities of ECM-associated proteins (Lu et al., 2011). These include 
growth factors and enzymes involved in proteolytic cleavage and protein modification 
(e.g., cross-linking enzymes). Growth factors and cytokines in the ECM include bone 
morphogenetic proteins (BMPs), transforming growth factors (TGF-α, -β), fibroblast 
growth factors (FGFs), Wnt and many more representing the core matrisome proteins 
(Hynes and Naba, 2012; Naba et al., 2012). 
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The differences in the expression of ECM proteins such as type I collagen, fibronectin 
and tenascin have been assessed using IF techniques in cultured dental pulp stem cells 
(DPSCs). In a study by Harumi Miyagi et al. (2010) on one permanent and two deciduous 
tooth pulp cell lines there was a difference in the distribution and expression of ECM 
genes and proteins based on the type of dentition (deciduous versus permanent) and 
teeth functional status (un-erupted versus erupted). Type I collagen was detected in all 
cell lines but was expressed at lower levels in the cell line derived from the deciduous 
un-erupted tooth. 
ECM proteins serve as biological modulators that interact with cell-surface receptors, 
release soluble extracellular factors such as growth factors (cytokines), proteases, 
calcium and hormones; they also direct intracellular signalling, resulting in the 
activation of transcription factors and other signalling cascades (Alford and Hankenson, 
2006; Bornstein and Sage, 2002). 
Studies on the interactions of ECM proteins with dental pulp show that the 
properties of ECM proteins are complex. They interact with the network of collagen 
fibrils and participate in the 3D structure of the complex scaffold of connective tissues 
(Alford and Hankenson, 2006; Bornstein and Sage, 2002). The ability of cells within the 
dental pulp to produce ECM proteins and the properties of these proteins may also vary 
according to modulating factors, such as the type of dentition, developmental stage of 
teeth, functional status and the degree of root reabsorption of deciduous teeth (Harumi 
Miyagi et al., 2010). 
1.5.2 Odontoblasts 
These distinctive cells of the dental pulp align in a layer underlying the periphery of 
the dental pulp while extending their processes into the dentine. In the crown of a fully 
developed tooth the odontoblast’s cell body is columnar and measures approximately 
50 µm in height whereas in the middle portion of the tooth the cells are cuboidal and 
become flattened in the apical region (Nanci, 2008). 
The morphology of the odontoblast reflects its activity. Three stages of odontoblast 
can be identified by electron microscopy. The first is active phase odontoblasts that are 
in a synthesising and secretory state with an elongated body, basal nucleus, basophilic 
cytoplasm and a prominent Golgi apparatus. The second is quiescent or resting phase 
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aged cells that are broad with little cytoplasm and large autophagic vacuoles (Couve and 
Schmachtenberg, 2011). The last is transitional phase odontoblasts, which are 
intermediate between the secretory and the resting states (Nanci, 2008). 
Origin of odontoblasts 
The life cycle of an odontoblast follows several successive steps. Initially, neural crest 
cells from the midbrain and rostral hindbrain migrate towards the first visceral arch and 
become pre-odontoblasts along with the mesenchymal pulp cells. Pre-odontoblasts 
generate functional odontoblasts, then secretory odontoblasts and finally aged 
odontoblasts. Differentiation is initiated at each cusp tip and is carried out according to 
a specific spatiotemporal pattern. The differentiation process gradually extends to the 
apical area and leads to the formation of a gradient of differentiation (Ruch et al., 
1995). 
Following the migration of neural crest cells to provide dental papilla cells, at the late 
bell stage of tooth development, these small centrally nucleated ectomesenchymal cells 
start to differentiate into pre-odontoblasts after a specific number of cell divisions. Only 
cells of the dental papilla in contact with the basement membrane at the interface with 
the inner dental epithelium undergo terminal differentiation. Other daughter cells (not 
in contact with the basement membrane), become part of the sub-odontoblastic cell-
rich layer, or Höhl’s cell layer (Bleicher et al., 2015). To differentiate into functional 
odontoblasts, pre-odontoblasts must become polarised. Their nuclei move away from 
the basement membrane, while their granular endoplasmic reticulum and Golgi 
complexes become aggregated into a supra-nuclear position. Mitochondria are 
dispersed throughout the cell, denoting increased energy production. The part of the 
cell that contains the nucleus is termed the basal pole and the opposite region, close to 
the basement membrane, is the apical (secretory) pole. At this stage, cytoskeleton 
components such as microtubules, microfilaments and intermediate filaments 
accumulate at the apical pole of the odontoblasts (Bleicher et al., 2015; Ruch, 1998). 
Odontoblasts persist throughout the whole life of the tooth, and they can be 
reactivated by pathological stimulation such as dental caries or during cavity 
preparation to synthesise a new layer of dentine or dentine-like tissue to preserve pulp 
vitality. 
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Sensory function of odontoblasts 
Dentine sensation has been traditionally explained via theories that yet have to be 
proven. The most widely accepted has been the hydrodynamic theory, which suggests 
that nociceptive pain responses may result from the activation of nerve endings in the 
dentinal tubules due to an increase in pressure caused by dentinal fluid movements 
(Brännström and Astrom, 1972; Brännström et al., 1967). Several reports have raised 
the possibility that odontoblasts possess sensory transduction ability and can sense 
mechanical stress caused by dentinal fluid movements, although this remains to be 
demonstrated (Allard et al., 2006; Magloire et al., 2009; Tokuda et al., 2015). 
Interestingly, it has been suggested that odontoblasts can act as a sensory functional 
network if subjected to various stimuli. The idea that odontoblasts may sense external 
stimuli and transmit the signal to nearby nerve cells is supported by the close 
approximation of the odontoblasts to the nerve terminals in dentine (Ibuki et al., 1996; 
Magloire et al., 2009). Further support for the sensory function of odontoblasts was 
provided by Khatibi Shahidi et al. (2015), who traced labelled individual mouse incisor 
odontoblasts using 3D IF images. They showed that odontoblasts have slender oblong 
cell bodies, which in the terminal region taper off into a bottleneck-like constriction. 
The bottleneck bends at an almost 90-degree angle, widens again and forms a foot-like 
structure that they termed an “odontopode”, from which the main process protrudes. 
This bottleneck constriction represents an adaptation to provide space for an organised 
blood vessel network supplying the long odontoblastic processes with oxygen and 
metabolites. They also found protrusions directed towards the pulp, which could 
function as sensing elements in interactions with the sub-odontoblastic cell layer or as 
transport routes for nutrients from the microvessel-enriched pulp. 
The numerous specialised cell junctions among odontoblasts and between the 
odontoblasts and sub-odontoblastic layer cells allow for direct intercellular 
communication (Ruch, 1998) between these compartments forming a sophisticated 
neurosensory structure that is positioned in close proximity to the microvasculature 
with properties similar to the blood–brain barrier (Farahani et al., 2011). In addition, 
odontoblasts express several classes of ion channels, which are associated with pain 
sensation and signal propagation, including L-type Ca2+ channels, mechano-sensitive K+ 
channels and voltage-gated Na+ channels (Magloire et al., 2009). Ca2+ levels within the 
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odontoblast have also been found to increase upon mechanical stimulation (Chung et 
al., 2013; Tokuda et al., 2015). There is growing evidence for the ‘‘odontoblast receptor 
theory’’—the basis for the sensory transduction mechanism of dentine sensation. This 
theory suggests that odontoblasts are sensory receptor cells able to detect the 
force/pressure inside dentinal tubules via specific mechanosensitive channels, and 
release adenosine triphosphate (ATP) as neurotransmitter to activate ATP (P2X) 
receptors on neurons in dental pulp, driving the sensory transduction sequences. 
1.5.3 Fibroblasts 
Fibroblasts are the most abundant cells in the dental pulp, particularly in the coronal 
part where they form the cell-rich zone. These plastic-adherent cells play a significant 
role during tissue development, maintenance and repair (Flavell et al., 2008; Nanci, 
2008). The histological appearance of these cells reflects their functional role. In young 
pulp, they have a plump cytoplasm and a large number of organelles responsible for 
matrix synthesis and secretion. Aging fibroblasts appear as flattened spindle-shaped 
cells with electron-dense nuclei. Desmosome junctions are often present connecting 
the fibroblasts, which suggest a network of communicating cells (Nanci, 2008). 
Distinguishing between fibroblasts and MSCs is a difficult task. Alt et al. (2011) found 
no significant differences in the proliferation capability between human skin-derived 
fibroblasts (hSDFs), human adipose tissue-derived stem cells (hASCs) and embryonic 
lung fibroblasts (WI38). All in vitro cultured cell lines showed a similar spindle-like 
morphology. Experimental evidence presented by Alt et al. (2011) suggests also that 
hSDFs contain a heterogeneous cell population, including stem cells with various levels 
of differentiation potential and fibroblasts with no capacity to convert to other cell 
types. In their conclusions, Alt et al. (2011) suggested that commonly used parameters 
such as spindle-like morphology, plastic adherence or presence of cell-surface markers 
such as CD14, CD31, CD44, CD45, CD73 and CD105 are not capable of discriminating 
between stem cells and fibroblasts. It is thus important to assess not only morphological 
markers but also colony-forming capacity and the differentiation potential of cells to 
distinguish between stem cells and fibroblasts. 
An interesting model illustrating the possibility of a myriad of variations among cells 
with hard tissue phenotype found in fibro-osseous lesions (Figure 3) was reported by 
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Kardos and Kieser (2000b) and may explain the variety of cellular phenotypes seen 
within the dental pulp. This model is defined by the space within a regular pyramid. 
Fully committed fibroblasts occupy the apex of the pyramid. The base of the pyramid 
relates to ectomesenchymal-derived cells expressing hard tissue phenotypes (i.e., 
osteoblast, cementoblasts, chondrocytes and odontoblasts). Cells within the pyramid 
express phenotypes that do not correspond with only one of the phenotypes at the 
base, but a proportion of each depending on their proximity to a corner. Traditionally, 
differentiation capacity has been used as a line of demarcation to distinguish fibroblasts 
from MSCs. Therefore, fibroblasts are routinely used as a negative control for the 
evaluation of cell differentiation capacity in many studies. 
 
Figure 3: A model illustrating the possibility of cell phenotype variations as defined by the space within a 
pyramid. The space betweenthe top and the base of the pyramid  is occupied by cells with variable levels 
of commitment to a certain fate ( Adopted from Kardos and Kieser, 2000b)Several reports have 
shown that fibroblasts can differentiate into various lineages: for example, human 
foreskin dermal fibroblasts can give rise to adipocytes, osteocytes and chondrocytes 
(Chen et al., 2007); and fibroblasts isolated from human bronchial and uterine tissues 
have differentiated into adipocytes and osteocytes (Kim et al., 2008). The fact that 
fibroblasts are phenotypically heterogeneous and share tissue localisation, morphology 
and key molecular markers with stem cells (Häkkinen et al., 2015) complicates being 
able to distinguish them from stem cells. In addition, the fact that cells within a 
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specialised tissue are heterogeneous populations demonstrating variable levels of 
commitment to a cell fate (Alt et al., 2011; Kardos and Kieser, 2000b) casts doubt on 
assumptions that fibroblasts are a homogeneous cell population within a tissue and can 
differentiate into multiple lineages (Chen et al., 2007; Kim et al., 2008). 
1.5.4 Immune cells 
Immune cells identified in the pulp include macrophages, neutrophils, T-lymphocytes 
and B-lymphocytes. These cells are essential for homeostasis within the pulp and play a 
major role in the host defence against dental caries or oral infections (Sloan, 2015). 
Macrophages are located throughout the centre of the dental pulp. They are large oval 
or spindle-shaped cells with dark stained nuclei as shown under light microscopy. Pulp 
macrophages are involved in the elimination of dead dental pulp cells and their 
presence indicates the turnover of pulp cells. T-lymphocytes are also found in normal 
pulps but B-lymphocytes are scarce (Nanci, 2008). Bone marrow-derived dendritic cells 
are found beneath the odontoblast layer in erupted teeth. They account for 
approximately 8% of the total pulp cell population and have a close relationship to 
vascular and neural elements of the dental pulp (Nanci, 2008). Dendritic cells increase 
during a carious challenge as they identify foreign bodies for the immune cells (Keller et 
al., 2010), an action resembling Langerhans cells found in epithelium (Nanci, 2008). 
In the event of pulp irritation, the odontoblasts degenerate and form dead tracts. In 
response to further irritation, the secretory activity of the remaining vital odontoblasts 
is stimulated to elaborate reactionary dentine reducing the pulp volume, and the aging 
process of the pulp is accelerated. 
The pulp does not become inflamed until large areas of dentinal tubules are 
decalcified. When caries progresses more rapidly than the production of reactionary 
dentine, the blood vessels of the pulp dilate and scattered inflammatory cells become 
evident in the pulp. Interestingly, immune cells are up-regulated by immunocompetent 
odontoblasts following stimulation by bacterial products such as lipopolysaccharides 
and flagellin, and by pro-inflammatory cytokines that are released following bacterial 
acid attack in the dentine matrix. 
Pulp healing involves inflammatory cells that are important inducers and modifiers of 
the healing response. Their function, abundance and phenotype can be variable and 
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depend on local factors, including the presence or absence of microbial infection. The 
nature of the inflammatory response is a key factor that may determine the wound 
healing outcome (Häkkinen et al., 2015). The inflammatory process induced 
immediately after dental pulp wounding can result in the initiation of angiogenesis. This 
is regulated by a complex interplay between pro- and anti-angiogenic factors that are 
tightly controlled during wound healing (Häkkinen et al., 2015). In the initial stage, 
hypoxia, inflammatory mediators and growth factors released by platelets and 
polymorphonucleocytes activate endothelial cells in the blood vessels adjacent to the 
wound (Eming et al., 2007). Endothelial cells loosen their intercellular junctions and 
move into the formed fibrin clot in concert with fibroblasts and macrophages. At this 
stage, angiogenesis is primarily promoted by factors released by macrophages and 
fibroblasts (Siekmann et al., 2013). 
1.5.5 Pulp vascular system 
Changes to vascularisation can be detected from the cap stage through to 
amelogenesis. In the mouse at the cap stage, the initial vascular network grows to 
occupy the mandibular portion of the dental mesenchyme. Meanwhile, other capillaries 
develop around the dental epithelium. At the bell stage, blood vessels start to enter the 
dental pulp. At the late bell stage, blood vessels cross the basement membrane and 
enter the enamel organ 24 h before amelogenesis is initiated (Nait Lechguer et al., 
2008). To facilitate a rapid and sufficient supply of raw materials from the bloodstream 
to the calcifying front, peripheral capillaries first approach the odontoblasts and invade 
the odontoblast layer close to the predentine with an increase in density. Finally, the 
endothelium changes from continuous to fenestrated in accordance with the nutritional 
requirements of the odontoblasts that lay down dentine. When the activity of 
odontoblasts decreases, capillaries change from a fenestrated to a continuous 
endothelium type, then retreat from the odontoblast layer and finally locate below the 
odontoblast layer. 
1.5.6 Nerves and neuronal cells 
The dental pulp in both primary and permanent teeth is richly innervated by 
myelinated and unmyelinated axons (Johnsen and Johns, 1978). These sensory nerve 
fibres run from the tooth apex in bundles to the crown, where they branch to innervate 
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the peripheral dental pulp (Monteiro et al., 2009b; Rodd and Boissonade, 2001). At the 
pulp–dentine interface, a dense network of nerve fibres forms the sub-odontoblastic 
plexus of Raschkow, from where branched nerve endings project radially through the 
odontoblastic layer and enter the predentine (Rodd and Boissonade, 2001). These 
sensory nerves mediate nociception and are involved in tooth pain. Their total number 
and density within the pulp suggest that sensory innervation is crucial for tooth 
protection, immune defence and dental pulp repair (Rodd and Boissonade, 2003). 
During physiologic root resorption of primary teeth, progressive denervation of 
dental pulp occurs. The mechanisms reflect a sequence of events that characterise and 
define Wallerian-like degeneration. After nerve fibre injury, axons distal to the lesion 
undergo a temporally degenerative sequence. This occurs initially by the degradation of 
the axonal cytoskeleton and activation of Schwann cells that de-differentiate, remove 
myelin and stimulate macrophage and lymphocyte recruitment (Gaudet et al., 2011; 
Neukomm and Freeman, 2014). After nerve injury, Schwann cells acquire proliferative 
and migratory properties and form bands of Büngner (proliferating spindle-shaped 
Schwann cells resembling fibroblasts) that facilitate peripheral axon regeneration 
(Cheng and Zochodne, 2002; Griffin and Thompson, 2008). 
1.5.7 Dental pulp progenitor cells 
Tooth development occurs through reciprocal inductive signalling between 
interacting oral epithelial and ectomesenchymal cells (Peters and Balling, 1999; Thesleff 
and Aberg, 1999) that originate from migrating cranial neural crest cells (Lumsden, 
1988). These interactions result in an outer layer of enamel being formed by the activity 
of cells derived from the oral epithelium known as ameloblasts, while the inner layer of 
mineralised dentine is synthesised by odontoblasts, derived from the dental papilla also 
of cranial neural crest origin (Arthur et al., 2015). The dental pulp is a loose connective 
tissue that originates from cranial neural crest cells. It is populated with fibroblasts, 
odontoblasts, collagen fibres, extracellular glycosaminoglycans, nerves and blood 
vessels (Abe et al., 2012). 
The origin of dental pulp progenitor cells has not yet been clearly defined. These 
cells may originate from the bone marrow and migrate into the dental pulp or they may 
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represent an innate population of cells derived from the neural crest ectomesenchyme 
(Nanci, 2008). 
Cranial neural crest cells have an important role in craniofacial development and 
generate most of the connective tissue of the head. These cells also have been reported 
to contribute to the formation of condensed dental mesenchyme, dental papilla, 
odontoblasts, dentine matrix, pulp, cementum, periodontal ligament, chondrocytes in 
Meckel’s cartilage, mandible, the articulating disc of the temporomandibular joint and 
branchial arch nerve ganglia (Chai et al., 2000). 
It has been reported that the dental pulp contains a cell population that is 
ectomesenchymal in origin (Gronthos et al., 2000; Shi et al., 2001a). Structurally, all 
dental tissues and supporting apparatus are derived directly from the neural crest 
population of cells, with the exception of the enamel and residual clusters of epithelial 
cells (epithelial cell rests of Malassez) from the Hertwig epithelial root sheath that have 
not completely disappeared (Nanci, 2008). 
A small population of pluripotent neural crest stem cells (NCSCs) may persist beyond 
the period of neural crest cell induction and migration and can be isolated from various 
adult tissues. These cells are found to have both self-renewal and multipotent 
differentiation capacities that persist throughout adulthood (Tomita et al., 2005; Wong 
et al., 2006). NCSCs are characterised by neurosphere generation, expression of the NSC 
marker nestin, nerve growth factor receptor and the neural crest-associated marker 
p75. In addition, they can differentiate into both a mesenchymal lineage and neural 
lineage in vitro (Abe et al., 2012). NCSCs represent an accessible and extraordinary 
source of pluripotent cells because they possess the key features of ESCs (d'Aquino et 
al., 2011). As the craniofacial region of the adult body largely originates from these cells 
and there is growing evidence of their persistence during adult life, the present study 
has focused on primary tooth dental pulp cells as a potential source of NCSCs and has 




1.6 Physiological root resorption and changes in pulp tissue 
Physiological root resorption of deciduous teeth has been described as a genetically 
programmed process that leads to the apoptosis of cementoblasts, thus promoting 
osteoclastogenesis (Rolling, 1981; Sahara et al., 1992; 1993; 1996). This physiological 
process is achieved by odontoclasts; which are a class of cells histologically similar to 
osteoclasts but generally smaller, with fewer nuclei and forming smaller resorption 
lacunae (Harokopakis-Hajishengallis, 2007) . 
Less is known about the degradation of the soft tissues of the tooth during primary 
tooth shedding. In the early resorption stage of the root, the coronal pulp appears 
normal and odontoblasts align along the predentine surface. Active odontoclasts 
release hydrolytic enzymes onto the resorption lacunae, degrading the organic 
collagenous and non-organic matrices (Harokopakis-Hajishengallis, 2007). As root 
resorption progresses, odontoblasts start to degenerate and mononuclear cells emerge 
from the pulpal vessels and migrate to the predentine surface, where they fuse and 
form multinuclear odontoclasts with clear attachment zones and ruffled borders 
(Harokopakis-Hajishengallis, 2007) that actively resorb the predentine and dentine 
(Nanci, 2008). By complete root resorption, the pulp shows cellular changes such as the 
absence of odontoblasts and an increase in inflammatory and clast cells, as well as their 
mononuclear precursors (Angelova et al., 2004; Yildirim et al., 2008). The metabolic 
activity of the pulp tissue also increases concurrent with changes in protein turnover, 
cytokine production and ECM remodelling, indicating that the pulp actively contributes 
to the process of resorption (Bernardi et al., 2011). 
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Changes in cellular and stem cell status in deciduous teeth at different root 
resorption stages have been reported by Zhu et al. (2013b). In their study, resorbing 
teeth were divided into four groups according to the stage of root resorption and 
stability in the oral cavity (Table 2). Zhu et al. (2013b) concluded that deciduous tooth 
DPSCs actively contribute to osteoclastogenesis, promoting root resorption in the 
middle stage and suppressing it in the final stage, thereby protecting the tooth from 
excessive resorption. 
Table 2: Deciduous DPSC changes during physiologic root resorption (Zhu et al., 2013b) 
Stable-stage 
group 
Incisors with less than 
1/3 of roots resorbed 
Results 
Middle-stage group cells exhibited a higher 
proliferation rate in vitro than those in the final-
stage group, and much higher proliferation than 
those in the stable-stage group. The final-stage 
group had cells with a similar potential to stem cells 
from human exfoliated deciduous teeth (SHEDs) 
and represents a population of multipotent stem 




Incisors with more 
than 1/3 and less than 
2/3 of roots resorbed 
Final-stage 
group 
Incisors with more 
than 2/3 root 
resorption 
Control group: Premolars 
 
Changes in the innervation of the pulp during root resorption (Table 3) have been 
quantitatively analysed by measuring pulpal innervation density, immune cell 
accumulation and pulpal vascularity in primary molars with variable degrees of root 
resorption (Monteiro et al., 2009b). 
Table 3: Monteiro et al.’s (2009b) results and conclusions 
64 non-carious primary 
molars from 33 patients 
Results 
With the advancement of root resorption there was: 
 decreased innervation 
 increased immune cell accumulation 
 increased vascularity 
Conclusion 
No statistically significant changes in these parameters 
 
There was marked variation in the innervation pattern within the pulp horn region of 
some teeth with advanced root resorption. However, in some specimens, there was a 
reduction in overall innervation density, whereas other samples showed a very dense 
fragmented innervation (Monteiro et al., 2009b). Profound changes in vascular status 
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were noted in some teeth with more than one-third root resorption. Monteiro et al. 
(2009b) identified a trend towards an increased vascularity with progressive root 
resorption, particularly within the pulp horn region. The observed differences were not 
statistically significant and thus it cannot be concluded that the variation is meaningful. 
The presence of a good blood supply may have considerable biological importance in 
relation to the provision of nutrients and removal of metabolic waste products. The 
increased blood supply may also be a consequence of the resorption process itself, 
which presents as a widened periapical area (Monteiro et al., 2009b; Rodd and 
Boissonade, 2005; Sari et al., 1999). The overall distribution of blood vessels showed 
numerous capillaries aligned around the pulp periphery and larger vessels (arterioles 
and venules) within the mid-coronal region (Monteiro et al., 2009b). This may reflect 
the higher metabolic demands of odontoblasts during the active phases of resorption. 
1.7 Classification of root resorption 
Several studies have investigated the histological differences between resorbing and 
non-resorbing deciduous and permanent teeth (Harokopakis-Hajishengallis, 2007; 
Soskolne and Bimstein, 1977; Yildirim et al., 2008; Zhu et al., 2013b). However, the 
classification in these studies was variable. Since there was no existing unified standard 
for classifying the resorption processes, the group sub-division and root resorption 
staging were based on subjective evaluations rather than objective calculations. In the 
present study, an equation developed by Monteiro et al. (2009b) based on the root 
length norms published by Kramer and Ireland (1959) was used to assess the degree of 
root resorption for each extracted tooth. This has been reported to be a reproducible 




In this method, the distance between the cemento–enamel junction (CEJ) and the 
deepest point of root resorption is first measured using a millimetre-precision caliper. 
The resultant measurement is then divided by the expected preresorption total root 
length for that specific tooth type according to the Kramer and Ireland (1959) published 
norms. The overall percentage of root resorption was then calculated for each sample 
using the following equation: 
% 𝒓𝒐𝒐𝒕 𝒓𝒆𝒔𝒐𝒓𝒑𝒕𝒊𝒐𝒏 
= 100 – (
 distance from CEJ to point of greatest resorption in mm ×  100
expected preresorption root length (Kramer and Ireland’s norms)
) 
Cellular, vascular and innervation changes occurring in pulp tissue with the 
advancement of physiologic root resorption affects the characteristics of the pulp tissue 
(Bernardi et al., 2011). The pulp no longer has the same cellular components and 
structure as before. To characterise primary tooth pulp cells, it is important to consider 
the isolation of pulp cells from teeth with different levels of resorption and to classify 
the root resorption staging according to reliable objective methods. 
1.8 Embryonic v. adult stem cells 
Stem cells are characterised by their ability to undergo self-renewal (the ability to 
produce more stem cells), their capacity to proliferate indefinitely and be able to 
produce more than one differentiated cellular lineage (Prochazkova et al., 2015). 
Totipotent is a term given to stem cells that give rise to both the embryo and placenta. 
The physiological totipotent stem cell is a fertilised oocyte (zygote) or first blastomere 
(Ratajczak et al., 2007). PSCs give rise to all three germ layers of the embryo, are 
traditionally derived from the inner cell mass of the blastocyst and are known as ESCs 
(Laslett et al., 2003; Thomson et al., 1998). Conversely, multipotent stem cells only give 
rise to cells from one or two of the germ cell layers (ectoderm, mesoderm or 
endoderm). Monopotent stem cells are tissue-committed stem cells that give rise to 
cells of one lineage; for example, NSCs, liver stem cells or skeletal muscle stem cells 
(Hayashi and Surani, 2009; Ratajczak et al., 2011). 
For many years, it was accepted that adult tissues contain only tissue-committed 
stem cells—such as epidermal stem cells, haematopoietic stem cells or skeletal muscle 
stem cells—that have a limited potential for differentiation (Prochazkova et al., 2015). 
However, some evidence shows that PSCs survive in adult tissues. They act as a backup 
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population that renews the pool of tissue-committed stem cells over time and in 
emergencies when organs are damaged. 
These potential sources of undifferentiated cells can be suitable for many clinical 
applications including transplantation, gene therapies targeting inherited disorders or 
tissue engineering. Some applications are well established, for example bone marrow 
transplantation, but many others are still in the experimental stages in a wide spectrum 
of applications in regenerative medicine (Prochazkova et al., 2015; Ratajczak et al., 
2011). The following section discusses the differences between embryonic and adult 
stem cells in terms of their characteristics and differentiation potential, and highlights 
culture conditions and current applications for regenerative medicine. 
1.8.1 Embryonic stem cells 
ESCs are the ex vivo counterparts of the inner cell mass (ICM) and can give rise to the 
three germ layers of the developing embryo, termed the ectoderm, mesoderm and 
endoderm (Ichinohe et al., 2012). ESCs can be found in situ within an embryo and can 
be used to generate cultured cell lines derived from the ICM of the blastocyst. Under 
appropriate culture conditions, they can be propagated indefinitely in their 
undifferentiated state and are capable of differentiating into all cells of the adult body, 
including germline cells (Bradley et al., 1984; Nichols and Smith, 2009). 
ESCs have traditionally been grown on a layer of mitotically inactivated mouse 
embryonic fibroblast (MEF) feeder cells (Martin and Evans, 1974). Feeder cells provide 
critical nutrients, trophic factor support and removal of harmful components from the 
media, and provide cell-to-cell contact that prevents differentiation and maintains the 
ESCs in an undifferentiated state. In 1998, the derivation of the first three human 
embryonic stem cell (hESC) lines from the ICM of a blastocyst and maintained on mouse 
feeder cells was reported (Thomson et al., 1998). The cells were pluripotent in nature, 
forming teratomas composed of tissues derived from all three germ layers (Amit and 
Itskovitz-Eldor, 2006). 
The unlimited clinical applications of use of these cells in regenerative medicine has 
resulted in the rapid development and refinement of culture systems to ensure reliable, 
reproducible, robust, efficient and safe systems to grow ESCs and clinically utilise their 
potential. Over time, feeder-free techniques have been developed (Xu et al., 2001). 
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The ultimate goal in the clinical setting is the use of a culture system that is free of 
animal products (xeno-free) with a chemically defined culture medium and a defined 
synthetic matrix cell culture substrate (Lyn and Ludmila, 2015). One of the advantages 
of defined xeno-free culture systems is the control of intrinsic batch-to-batch variation 
introduced into the system via the use of biological products such as feeder cells, as 
well as a reduction in the risk of contamination with viruses associated with animal 
products (Lyn and Ludmila, 2015). 
The routine culture of established human cell lines in the laboratory under the basic 
principles of good cell culture practice (GCCP) (Bal-Price and Coecke, 2011; Hartung et 
al., 2001) is regarded as straightforward. However, the culture of undifferentiated hESC 
lines is not as straightforward, as these cells are very sensitive to alterations in their 
culture conditions and respond by changing their growth characteristics and 
morphology. Each cell line responds differently to these alterations (Amit and Itskovitz-
Eldor, 2009; Johkura et al., 2004). 
ESCs are characterised by the expression of specific markers, including transcription 
factors, Oct3/4 (Takahashi and Yamanaka, 2006; Takahashi et al., 2007), Nanog 
(Chambers et al., 2003) and Sox2 (Marson et al., 2008). The precise levels of these 
transcription factors are crucial for maintaining the cells in the undifferentiated stem 
cell state. During differentiation, changes in the levels of expression of these genes will 
drive cells into one particular cell type/germ layer rather than another. These 
transcription factors co-occupy promoter regions of genes involved in maintaining 
pluripotency. In early lineage differentiation, they maintain the pluripotency genes in an 
active state and repress lineage-specific genes (Pera and Tam, 2010). 
The transcription factor Oct3/4 is involved in maintaining the undifferentiated 
pluripotent state and may also prevent expression of genes activated during 
differentiation (Beltrami et al., 2009; Boyer et al., 2005; Nichols et al., 1998; Saxe et al., 
2009). Such stemness properties are attributed to Oct4A; an isoform produced by the 
Oct4 gene that behaves as a nuclear protein. The second isoform, Oct4B, is a 
cytoplasmic protein with largely unknown function (Lee et al., 2006). 
Nanog is a homeobox-containing transcription factor with an essential function in 
maintaining the pluripotent cells of the ICM and in the derivation of ESCs (Mitsui et al., 
2003). Overexpression of Nanog in ESCs maintains their pluripotency and self-renewing 
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characteristics under what normally would be differentiation-inducing culture 
conditions (Rodda et al., 2005). 
Nanog has been considered the master regulator of ESCs. The protein co-occupies 
most sites with Oct4A and Sox2 in the genome of ESCs (Marson et al., 2008). However, 
Nanog’s absence or down-regulation in itself does not allow cells to differentiate. 
Rather, it makes ESCs susceptible to differentiation and lineage selection. Along with 
factors Oct3/4 and Sox2, it promotes the expression of genes necessary to maintain the 
ESC state while repressing differentiation genes, the levels of which becomes 
differentially regulated prior to cell fate selection (Thomson et al., 2011). 
ESCs are a homogeneous group of pluripotent undifferentiated cells that can be 
propagated indefinitely and differentiated into all cells of the adult body (Prochazkova 
et al., 2015). Tissue engineering has tackled the manipulation of ESCs to differentiate 
into a variety of tissues and cell types, including neural, cardiovascular, hepatic, 
pancreatic tissues and almost all craniofacial tissues (Ho et al., 2012). 
1.8.2 Adult stem cells 
Adult stem cells are undifferentiated cells that reside among differentiated cells in a 
tissue or organ. They have the ability to renew themselves and differentiate into 
specialised cell types. This heterogeneous population of cells can be difficult to describe 
using one common definition. There is a large degree of heterogeneity within the pool 
of adult stem cells, ranging from the most developmentally primitive to those that are 
more organ committed or tissue specific (Prochazkova et al., 2015). 
While ESCs can become all cell types, adult stem cells have more limited 
differentiation capability; hence they are referred to as multipotent or unipotent stem 
cells. The primary roles of adult stem cells are to maintain and repair the tissue in which 
they reside. They are rare in number but can be found in various tissues of the adult 
organism (Prochazkova et al., 2015). 
Mesenchymal stem cells 
The bone marrow is a major source of adult stem cells, from which two main 
populations arise: haematopoietic stem cells responsible for the production of the 
blood cell lineages; and MSCs, which provide the bone marrow stromal cell population 
as progenitors for multiple mesodermal cell types. The essential characteristic of MSCs 
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is their multipotent ability, which is usually established in vitro by analysing their ability 
to differentiate into at least three cell types: typically adipocytes, osteocytes and 
chondrocytes (Dominici et al., 2006). MSCs have the potential to produce several cell 
lineages and possess a natural ability to differentiate into mesodermal tissues such as 
muscles and tendons (Pittenger et al., 1999; Sarraf et al., 2011). 
Small cell populations of MSCs can be found in nearly all organs, where they are able 
to produce a healing environment in the case of damage, injury or inflammation (Otto 
and Wright, 2011). They can be found in adipose tissue, intestinal stroma, corneal 
limbal stroma of the eye and trachea. In these tissues, MSCs are mainly localised in 
niches located near the capillary pericytes. Another important medical source of MSCs 
is neonatal tissues such as placenta, cord blood and Wharton’s jelly (Bianco et al., 
2008). The precise mechanism of MSC regulation during the regenerative processes in 
adult tissues is still largely unknown. They may directly differentiate into particular cells 
from damaged tissues and may serve as promoting regulators of the healing process 
(Otto and Wright, 2011). 
Neural stem cells 
NSCs or neural progenitor cells are located in two distinct regions of the brain. One 
population is located in the ventricular–sub-ventricular zone of the lateral ventricles. 
The second population is seated at the interface of the hilus and dentate gyrus of the 
hippocampus (Prochazkova et al., 2015). These NSCs are similar to astrocytes in their 
ultrastructure as well as in their expression of astro-glial markers (Kriegstein and 
Alvarez-Buylla, 2009). Fuentealba et al. (2012) reported that the position of NSCs is 
strictly regulated and specifically organised inside the stem cell niche (SCN). NSCs have 
to respond not only to many factors from the niche, but also to distant diffusible factors 
such as those from cerebrospinal fluid and blood circulation. 
NSC self-renewal or differentiation is regulated by molecular factors from a list that is 
greatly expanding. Sox2 is one of the main regulators and it is a marker of the nervous 
system from early development. Sox2 is expressed in the early embryonic neural 
precursors within the brain’s ventricular zone and in the ependyma in the adult (a 
descendant of the ventricular zone). It is also expressed in the vast majority of dividing 
precursors in the neurogenic regions and in a small proportion of differentiated 
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neurones, particularly in the thalamus, striatum and septum. Sox2 is thus considered 
essential for embryonic development of the brain and is responsible for NSC 
maintenance in the adult brain (Ferri et al., 2004). 
1.8.3 Dental pulp stem cells 
MSC-like cell populations have been isolated from DPSCs from adult third molars and 
from deciduous teeth (stem cells from human exfoliated deciduous teeth [SHEDs]). 
Other MSC-like populations have been identified in human tooth germs at the 
completed crown stage (Takeda et al., 2008), from immature apices as apical pulp-
derived cells (Abe et al., 2008) and stem cells from the apical papilla (SCAP) (Sonoyama 
et al., 2008). 
Numerous studies (Gronthos et al., 2000; 2003; Miura et al., 2003; Shi and Gronthos, 
2003) have demonstrated the ability of in vitro cultured pulp stem cells to generate 
clonogenic adherent cell clusters and produce fibroblast colony-forming units (CFU-Fs) 
when cultured in similar conditions to bone marrow stem cells (BMSCs). Interestingly, 
the frequency of forming CFU-F colonies (aggregates of 50 cells or more) was 20–40 
times higher in dental pulp tissues than in MSCs derived from bone marrow aspirates 
(Gronthos et al., 2000). Cloning studies have shown that individual ex vivo expanded 
DPSCs and SHEDs show considerable variability in their proliferation capacity and 
differentiation potential, irrespective of the tissue source (Gronthos et al., 2002; 
Menicanin et al., 2010). 
Stem cells from human exfoliated deciduous teeth and dental pulp stem cells 
SHEDs are stem cells that exist in the residual living pulp of exfoliated deciduous 
teeth (Miura et al., 2003). They are a heterogeneous population of cells with a 
fibroblastic morphology and the ability to form adherent colony clusters with extensive 
proliferating capacity in vitro. Studies have shown that SHEDs represent a more 
immature cell population compared with stem cells originating from the pulps of adult 
teeth (Miura et al., 2003; Shi et al., 2005). 
Comparisons among SHEDs, DPSCs and BMSCs have revealed the ability of SHEDs to 
grow and proliferate more rapidly with a higher number of population doublings than 
DPSCs (Jo et al., 2007; Miura et al., 2003). 
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Govindasamy et al. (2010) examined the differences in culture characteristics, 
phenotypes, differentiation potential and gene profiles between human DPSCs derived 
from deciduous and permanent teeth (Table 4).  
Table 4: Govindasamy et al.’s (2010) study parameters 
Parameters 
Stem cells from extracted deciduous 
teeth (SCDs) 
Dental pulp stem cells (DPSCs) 
Isolation and culture 
Morphological characteristics: Cells displayed fibroblast-like 
morphology. Both SCDs and DPSCs showed normal karyotypes at 
passage 5 (P5). 
Proliferation rate: 
SCD cultures had 
colony-forming units 
(CFUs) that are higher in 
number and size than 
DPSCs 
The time required for population 
doubling (PD) varied between 27 h 
(P1) and 29 h (P5). Cell cycle 
analysis using flow cytometry 
showed higher percentage 
proliferation rate with 
approximately 85% of cells in phase 
G1/GO. 
The time required for PD 
varied between 28 h (P1) and 
29 h (P5). Cell cycle analysis 
showed Lower percentage 
proliferation rate with 
approximately 90% of the cells 
in phase G1/GO. 
Immunophenotyping 
Cells negative for haematopoietic markers CD34 and CD45 and HLA-
DR, whereas more than 90% of cells positive for MSC markers CD44, 




Osteogenic differentiation confirmed in both SCDs and DPSCs by the 
deposition of a silver-stained mineralised matrix. 
Adipogenic differentiation confirmed in both SCDs and DPSCs by the 
accumulation of neutral lipid vacuoles. 
Chondrogenic differentiation confirmed in both SCDs and DPSCs by 
sphere formation in the micro-mass culture and the secretion of 
cartilage-specific proteoglycans. 
Gene expression profile 
using Human Taqman 
Low Density Array 
41 genes up-regulated, and 12 genes down-regulated, respectively, in 
SCDs and DPSCs, compared with Bone Marrow Stem Cells (BMSCs). 
Pluripotency more highly maintained in SCDs than in DPSCs and 
BMSCs. 
SCDs showed endoderm and 
mesoderm markers such as GATA6, 
GATA4, Sox17, CDH5, FLT1 and DES. 
Endoderm and mesoderm 
markers NOT expressed but 
neuron/ectoderm markers 
more highly expressed. 
Higher mRNA expression of 
osteoblast markers (osteocalcin and 
osterix). 
Oct4A, Sox2 and Nanog significantly 
up-regulated. 




Among other differences, it was observed that the fold expression of several 
pluripotent markers (Oct4A, Sox2, Nanog and Rex1) was higher (>2 folds) in stem cells 
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from extracted deciduous teeth (SCDs) than from DPSCs. However, DPSCs showed a 
higher expression of neuro-ectodermal markers Pax6, Gbx2 and nestin (>100 folds). 
SHEDS also express STRO-1 and CD146 as markers of mesenchymal cells and are 
capable of in vitro differentiation into adipogenic, neurogenic, osteogenic, odontogenic, 
myogenic and chondrogenic lineages (Miura et al., 2003; Morsczeck et al., 2010; 
Yamaza et al., 2010). Phenotype analyses of SHEDs by Suchanek et al. (2010) showed 
that in comparison with DPSCs, SHEDs had significantly higher positivity for CD71, 
CD105, CD117 and CD166 markers. Based on these differences, especially the high 
positivity of SHEDs for CD117 (typical for pluripotent cells) and CD 105 (a component of 
the TGF receptor), they proposed that SHEDs are more undifferentiated than are DPSCs. 
A comparison between the in vitro proliferation and mineralisation ability of CFU-F 
dental pulp cells derived from primary and permanent teeth (Zheng et al., 2011) 
showed that CFU-F-selected pulp cells from primary teeth had higher proliferation and 
mineralisation rates than did pulp cells from permanent teeth. In culture, SHEDs 
appeared as single cells or as small colonies after 24 h of cultivation. After 5 days, cells 
formed colonies and reached 70% confluence and after an average of 98.7 h, they 
reached full confluence. SHEDs had a higher in vitro proliferation rate and 
differentiation capability than DPSCs. (Wang et al., 2012a). 
Results from in vivo transplantation experiments suggest that SHEDs have a higher 
capability of resulting in mineralisation than DPSCs. Yamaza et al. (2010) transplanted 
SHEDs and DPSCs subcutaneously into immune-compromised mice to assess the ability 
of these cells to reconstitute a pulp–dentine complex. Cells were seeded in 
biodegradable scaffolds with the architecture and cellularity resembling dental pulp 
prepared within human tooth slices. It was found that, unlike DPSCs, SHEDs failed to 
reconstitute a complete dentine–pulp-like complex in vivo. In contrast, the results 
obtained by Bakopoulou et al. (2011b) showed an increased potential of SHEDs to 
differentiate into mineralising cells. In addition, in vivo osteo-inductive capability of 
SHEDs was reported by Miura et al. (2003). This capability was not observed in DPSCs, 
highlighting the different behaviour of DPSCs compared with SHEDs in vivo. 
Cultured DPSCs from human pulp tissue can form CFUs, which have diverse 
densities, sizes and morphologies, suggesting that each cell clone has a distinct 
proliferation/differentiation potential (Gronthos et al., 2000; Huang et al., 2006; 
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Suchanek et al., 2007). In addition, some markers of stem cells are not uniformly 
expressed in all cultures of DPSCs, again indicating heterogeneity (Gronthos et al., 2000; 
Huang et al., 2006). DPSCs showed the ability to produce more CFUs than bone marrow 
MSCs. Cells survive for a longer time, replicating with a high proliferation rate (80–100 
times) with no signs of senescence (Gronthos et al., 2000). They also have a greater 
tendency to differentiate into odontogenic/osteogenic lineages (Huang et al., 2009c). 
Cells from sound human deciduous tooth pulps with different levels of resorption 
have been isolated to evaluate stem cell parameters (Bernardi et al., 2011). The sample 
included 30 primary teeth (Figure 4) classified according to how advanced was their 
root resorption. In group I (n = 21), most teeth had a completely resorbed root, with 
four having approximately two-thirds root resorption. Group II (n = 9) represented 
primary teeth with no visible resorption. Despite the presence of colonies and increased 
cultured cell numbers from primary teeth with no visible resorption, cell lines from this 
group failed to reach 50% confluence when maintained in culture for up to 45 days. 
Bernardi et al. (2011) attributed the low cell proliferation from the no-root resorption 
group to in vivo biological conditions in the tissue. They assumed that stem cells in the 
pulps of deciduous teeth are quiescent in the early stages of physiological root 
resorption and that this changed with progression of the resorption process (Bernardi 
et al., 2011). 
  











• 21 teeth had advanced root resorption (group I) 
• 9 teeth had no root resorption (group II) 
Exclusions 
• 5 cultures had no verified cells 
• 8 cultures did not reach 90% confluence 
• 10 cultures were excluded without stating the 
reasons 
• Total exclusions from final analysis, 23 
samples out of 30 (76.7%)  
Conclusion 
• Conclusions were based on characterising 7 
teeth from group I that had variable degrees of 
root resorption (23.3% of the total sample and 
41% of teeth included in group I) 
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Kaukua et al. (2015) addressed the molecular differences between pulp cells from 
deciduous and permanent teeth by comparing key differences related to self-renewal, 
proliferation and differentiation profiles using a microarray chip for stem cells (Table 5). 
Kaukua et al. (2015) investigated HMGA2 as one of the genes that confers self-
renewal and proliferation capacity to stem cells. This gene is strongly expressed by NSCs 
in the sub-ventricular zone of the brain. Expression declines over time with aging. 
HMGA2 was expressed at high levels in cells from deciduous teeth but was not detected 
in cells from permanent tooth pulps. The identified sub-population of HMGA2-positive 
cells constituted approximately 16% of the total number of stromal cells in deciduous 
pulps. The full phenotype of this sub-population remains unclear. However, markers 
involved in cell division and mitosis were up-regulated in deciduous tooth cells 
compared with cells from permanent teeth. Growing evidence suggests that deciduous 
teeth have a population of cells with a higher self-renewal and proliferation capacity 
than those of permanent teeth, making them more suitable for tissue regeneration 
(Kaukua et al., 2015). 
Table 5: Results from the study of Kaukua et al. (2015) 
Deciduous teeth from 3–12-year-old children 
(n = 8) 
Permanent teeth from adults 19–52 years of 
age (n = 8) 
Deciduous and permanent teeth had full-length roots with no visible root resorption. Teeth 
were extracted because of pericoronitis/periodontal problems, caries and orthodontic issues. 
Results 
Genes involved in cell division, mitosis, stemness and aging were more highly 
expressed in pulp cells from deciduous teeth. 
 
1.9 Culture techniques for primary tooth pulp cells 
Pulp cells have been isolated either by the outgrowth method, where cells outgrow 
from pulp tissue explants (About et al., 2000a; Couble et al., 2000; Tsukamoto et al., 
1992), or by enzymatic digestion with collagenase/dispase enzymes (Gronthos et al., 
2000). 
The isolation method and culture conditions can give rise to different populations or 
lineages of pulp cells for in vitro experimentation. Huang et al. (2006) compared pulp 
cell cultures via two approaches and reported morphological differences between pulp 
cells isolated by the digestion and outgrowth methods. They reported that cells 
cultured after enzymatic digestion proliferated at a faster rate than the outgrowth cells. 
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A comparative analysis of the characteristics of deciduous tooth stem cells and their 
differentiation potential using the two isolation methods (outgrowth v. enzymatic 
dissociation) was reported by Bakopoulou et al. (2011b). In their study, the two 
methods of cell isolation yielded different cell populations with respect to their 
morphologic, immune-phenotypic and osteo/odontogenic differentiation 
characteristics. They concluded that different isolation methods and/or culturing 
environments would give rise to population or lineages with different morphologic, 
immune-phenotypic and osteo/odontogenic differentiation characteristics. 
The enzymatic digestion method described by Gronthos et al. (2000) involves 
digesting the minced pulp tissues in a solution of 3 mg/mL collagenase (type I) and 
4 mg/mL dispase for 30–60 min at 37°C. Cell suspensions are then seeded in culture 
flasks (1×105 cells/flask) containing α-minimum essential medium (α-MEM ) 
supplemented with foetal bovine serum (FBS), L-glutamine, L-ascorbic acid-2-
phosphate, penicillin-G, streptomycin and Fungizone. Cultures are incubated in 5% CO2 
at 37°C. The digestion method was reported to release all cells from the tissue and 
resulted in different types of colony formation. However, some degree of cell damage 
and loss did occur (Gronthos et al., 2002). Liu et al. (2006) used a similar enzymatic 
digestion technique: pulp tissue was picked up with sterile tweezers and minced using a 
scalpel blade under moist conditions (using α‐MEM). The minced pulp tissue was 
digested in a solution containing collagenase type I (3 mg/mL) and dispase (4 mg/mL) 
for 30–45 min at 37°C. After digestion and washing with α‐MEM containing 10% foetal 
calf serum (FCS), 100 μM L‐ascorbic acid 2‐phosphate, 2 μM L‐glutamine, penicillin (100 
U/mL) and streptomycin (100 mg/mL), cells were filtered through a 70‐μm pore size 
strainer to obtain single‐cell suspensions. Cells were incubated at 37° with 5% CO2. 
The tissue explant outgrowth method was first described by Park et al. (2004) who 
placed permanent tooth pulp tissue explants (1-mm fragments) into 6-well plates with 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% FBS and 
antibiotics. The outgrown cells were transferred to culture flasks, grown to confluence 
and continuously passaged at 1:3 ratios when confluent. Huang et al. (2006) used the 
same technique but allowed pulp fragments to exhaust the outgrowth of cells by 
consecutively transferring explant fragments to a new well once a week until no further 
outgrowth and no live cells were observed. 
32 
Kerkis et al. (2006) were the first to use an explant culture of primary tooth dental 
pulps to obtain primary tooth pulp stem cells, thereby isolating a non-homogeneous 
relatively pure population of cells that they called “immature dental pulp stem cells” 
(IDPSCs). Their cell isolation method, which was based on tissue explant cultures and a 
non-enzymatic mechanical transfer, has been shown to sustain a long-term culture of 
dental pulp while providing stem cells in substantial quantities without aberrant genetic 
and biologic changes. The technique was then adapted by Lizier et al. (2012) who 
maintained dental pulp in culture for several months. 
Cell morphology, expression of specific MSC phenotypes and ESC proteins, genes, 
karyotype, growth rate and differentiation ability of cultured cells were evaluated after 
cryopreservation and with culturing in three distinct culture media (Figures 5 and 6) by 
Kerkis et al. (2006) and Lizier et al. (2012). All media used were supplemented with 15% 
FBS, 100 U/mL penicillin, 100 mg/mL streptomycin, 2 mM L-glutamine and 2 mM non-
essential amino acids. Cells were seeded at a density of 105 cells/cm2 and were counted 
for at least 15 consecutive days to evaluate the growth rate and the effect of 
cryopreservation. 
 
Figure 5: Study flowchart by Kerkis et al. (2006) and Lizier et al. (2012). Assessment was done directly 
following dental pulp extraction (early population) and after multiple mechanical transfers (late 
population) 
  
10 deciduous teeth from healthy subjects (range 5–10 years), free from caries or restorations  
7 pulps removed and fixed in 10% 
formalin solution for 48 h; specimens 
embedded in paraffin blocks and 
sections of 10 μm obtained 
3 pulps rinsed in PBS and sliced; each slice 
placed in a different culture dish; 5-bromo-
29-deoxyuridine (BrdU) then added directly 
into basal culture medium 
First pulp slice fixed and processed after 6 h of 
treatment with BrdU 
Second culture dish with pulp 
slice, BrdU added after 42 h 
Third culture dish with pulp 
slice, BrdU added after 66 h 
33 
 
Figure 6: Media used by Kerkis et al. (2006) and Lizier et al. (2012) 
DMEM–F12 and α‐MEM were reported as the most appropriate media for the 
isolation and long-term expansion of IDPSCs. DMEM-LG (low glucose) was not efficient 
with this isolation technique, but was able to support long-term expansion of the cells 
after cryopreservation. Data from the study by Lizier et al. (2012) contrasts with 
previous observations by Kerkis et al. (2006), who showed IDPSCs had a noticeably 
reduced growth following multiple passages. Lizier et al. (2012) attributed this 
contradiction to their daily use of enzymatic treatment while counting cells, which 
seems to have hindered the growth of IDPSCs; whereas passages were performed every 
3–4 days by Kerkis et al. (2006). 
The International Stem Cell Initiative consortium assessed eight cell culture methods 
for up to 10 passages. Parameters assessed by phase contrast microscopy were cell 
attachment, cell death and differentiated cell morphology (International Stem Cell 
Initiative et al., 2010). In addition, serial cell counts were used to assess culture growth, 
and the maintenance of stem cell surface marker expression by flow cytometry was 
evaluated. Of the eight culture systems investigated, only the control and two 
commercial media, mTeSR and STEMPRO were able to support and maintain most cell 
lines for 10 passages. Cultures grown in other media failed before this point because of 
lack of cell attachment and cell death, or overt cell differentiation (International Stem 
Cell Initiative et al., 2010). 
A xeno-free and feeder-free medium specially formulated for the growth and 
expansion of human PSCs was developed by Chen et al. (2011a) and published under 
the name of E8. Chen et al. (2011a) demonstrated that subtracting albumin or any of 
the growth factors from mTeSR1 medium led to a dramatic decline in human ESC 
culture performance. They showed that removal of albumin from the medium led to 
frozen–thawed IDPSC  
DMEM–F12 DMEM low-glucose  α‐MEM 
freshly isolated IDPSC  
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toxicity from a secondary component in the media, later identified as β-
mercaptoethanol (BME). They re-optimised the basic components of human ESC and 
iPSC cultures in the absence of albumin and BME and developed a completely defined 
medium containing eight components (E8) that was validated by Cellular Dynamics 
International. They also reported that using vitronectin (VTN)-coated surfaces would 
support established human stem cells and greatly improve the efficiency of obtaining 
human iPSC from dermal biopsy samples. 
1.10 Stem cell characterisation 
MSCs or mesenchymal stromal cells are a diverse population of cells with a wide 
range of potential therapeutic applications. However, there is no consistent 
nomenclature or definition for MSCs (Keating, 2012). Another challenge for stem cell 
characterisation is the absence of a specific marker to define MSCs. Although a large 
number of determinants have been identified, these markers are not exclusive to MSCs 
(Lindner et al., 2010). 
STRO-1 is one of the most predominantly used antibodies for fluorescence-activated 
cell sorting (FACS) and is a specific MSC marker (Lin et al., 2011b). The argument about 
STRO-1 being a specific MSC marker was initiated by Hung et al. (2002). They reported 
on a population of human bone marrow-derived MSCs termed “size-sieved stem cells” 
found to be consistently negative for STRO-1. Ning et al. (2011) indicated that STRO-1 is 
essentially an endothelial antigen and its expression in MSC is probably an induced 
event. The variable endothelial expression patterns found with STRO-1 (Lin et al., 
2011b) highlighted the need to re-examine published data that relied on STRO-1 as an 
MSC marker. 
Which particular phenotype truly describes the heterogeneity in cell populations 
from different tissue origins is another controversial question. Alt et al. (2011), while 
assessing the parameters that distinguish between stem cells and fibroblasts, 
highlighted this controversy. They found that cultured cell lines had a similar spindle-like 
morphology in vitro and there were no significant differences in the proliferation 
capability between hSDFs, hASCs and embryonic lung fibroblasts (WI38). Alt et al. 
(2011) showed that tissues harbour heterogeneous cell populations including stem cells 
with various levels of differentiation potential and fibroblasts with no capacity to 
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convert to other cell types. Their conclusions highlighted that commonly used 
parameters such as spindle-like morphology and plastic adherence, and cell-surface 
markers such as CD14, CD31, CD44, CD45, CD73 and CD105 are not capable of 
discriminating between stem cells and fibroblasts. It was suggested that only colony-
forming capacity and differentiation potential of cells would distinguish stem cells from 
fibroblasts. 
The variability in MSC characteristics according to their tissue of origin was 
highlighted by Keating (2012), who provided the clear example of the heterogeneous 
population of adipose-derived cells that contains a stromal vascular fraction. This 
fraction contains cells that express CD90 but not CD105 until they become plastic 
adherent (Yoshimura et al., 2006). However, these cells are considered MSC-like. 
Despite substantial research over the last decade, MSCs remain a relatively poorly 
understood, heterogeneous mixture of cells with unpredictable properties (Samsonraj 
et al., 2015). 
1.10.1 International Society for Cellular Therapy criteria 
The disagreement around defining MSC populations led to difficulties when 
comparing studies published in the 1990s and 2000s. As a result, the ISCT proposed 
new definitions and criteria (Dominici et al., 2006; Horwitz et al., 2005) as a solution. 
The ISCT position statement by Dominici et al. (2006) suggested a set of minimal criteria 
for cultured cells to be considered multipotent undifferentiated mesenchymal cells. 
These criteria included plastic adherence and in vitro tri-lineage differentiation of 
adipogenic, chondrogenic and osteogenic cells. Additional requirements included cell-
surface expression of CD105 (endoglin), CD73 (ecto-5′-nucleotidase) and CD90 (Thy1) 
and the absence of haematopoietic markers CD45, CD19, CD14, CD79 or CD11b and 
HLA-DR. 
The current standard methods proposed by the ISCT for MSC characterisation 
depend on both their surface marker profile and differentiation potential. These 
minimal criteria remain the baseline for comparative characterisation of progenitor cells 
and are as follows. 
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A. Adherence to plastic 
Plastic adherence is a well-described property of mesenchymal multipotent cells 
(Colter et al., 2000; Jiang et al., 2002). Isolated cells would be expected to demonstrate 
adherence if they are to be considered a population of MSCs (Dominici et al., 2006). 
B. Flow cytometry 
The ISCT position statement (Dominici et al., 2006) proposed that 95% or more of 
the cells should express the following markers at least: 
 CD105, known as endoglin, is a type I membrane glycoprotein located on the cell 
surface of endothelial cells, activated macrophages, fibroblasts and smooth 
muscle cells. It is a major vascular glycoprotein that is restricted to endothelial 
cells in all tissues except bone marrow. It is also found on bone marrow pro-
erythroblasts, activated monocytes and lymphoblasts in childhood leukaemia. 
Endoglin is a component of the TGF-β receptor complex and binds TGF-β1 with 
high affinity (Rius et al., 1998). Anti-CD105 leads to negative or weak staining of 
normal endothelial cells. 
 CD73, known as ecto-5’-nucleotidase, is an enzyme used as a marker of 
lymphocyte differentiation. This protein found in the plasma membrane catalyses 
the conversion of extracellular nucleotides into membrane-permeable 
nucleosides. Low expression has been detected in normal blood leukocytes 
(Adrian et al., 2000). 
 CD90, also known as Thy-1, is a cell-surface protein that was originally discovered 
as a thymocyte antigen. It can be used as a marker for a variety of stem cells and 
for the axonal processes of mature neurons. It positively stains normal immature 
haematopoietic stem cells, neurons, connective tissue, activated endothelial 
cells, fibroblasts (Koumas et al., 2003) and keratinocyte stem cells (Nakamura et 
al., 2006). Its role in the immune response is unclear. It is expressed on 
fibroblasts and brain cells in addition to some T-cells. It is used as a 
haematopoietic stem cell marker as it mediates adhesion of various white blood 
cells to activated endothelial cells. 
It is recommended also that cells lack the expression of haematopoietic antigens in 
2% or less of the assessed cell population. However, only one of the two macrophage 
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and B-cell markers needs to be tested. This additional criterion excludes haematopoietic 
cells most likely to be found in MSC cultures. These negative markers are as follows: 
 CD45, a pan-leukocyte marker; this cell-surface protein is found on white blood 
cell progenitors and is a marker of haematopoietic cells other than erythrocytes 
and platelets. It plays a major role in the immune system and confirms the 
presence of inflammatory cells. 
 CD34 marks primitive haematopoietic progenitors and endothelial cells. It is a 
commonly used marker of haematopoietic progenitor cells and endothelium. 
CD34 staining defines adult haematopoietic stem cells, but CD34+ cells can also 
differentiate into neural cells and CD34+ stromal cells are also called dendritic 
interstitial cells (Reali et al., 2006). 
 CD14 or CD11b are prominently expressed on monocytes and macrophages. 
 CD79a or CD19 are markers of B-cells that may also adhere to MSC in culture and 
remain vital through stromal interactions. 
 HLA-DR molecules are not expressed on MSCs unless stimulated. These 
molecules are involved in the presentation of foreign antigens to the immune 
system. Major histocompatibility classes have been divided into three regions on 
chromosome 6p21.3—class II (centromeric), class III and class I (telomeric)—with 
extended class I and class II regions on either side (Trowsdale, 2001). The 
products of the classical polymorphic class I genes human leukocyte antigen-A 
(HLA-A), HLA-B and HLA-C interact with T-cell receptor molecules, as well as killer 
immunoglobulin-like receptors expressed on natural killer cells and some T-cells 
(OMIM *142800). HLA-DR is used as a negative haemopoietic marker (Dominici 
et al., 2006; Govindasamy et al., 2010). A summary of stem cell markers reported 
in the literature is provided in Section 7.3. 
C. In vitro differentiation 
Cells should be capable of in vitro tri-lineage differentiation to adipogenic, 
chondrogenic and osteogenic cells as a minimum requirement. 
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1.11 Differentiation potential of primary tooth pulp cells 
Dental pulp cells can be reprogrammed into multiple cell lineages and even into 
induced pluripotent progenitor cells (Yan et al., 2011). The differentiation of dental pulp 
cells into a specific cell lineage is mainly determined by the components within the local 
microenvironment, including growth factors, receptor molecules, signalling molecules, 
transcription factors and ECM proteins (Yu et al., 2006b). 
The dental pulp is derived from the neural crest and harbours cells that are 
clonogenic and multipotent (Gronthos et al., 2000). These cells maintain their ability to 
differentiate into dental and non-dental cells such as odontoblasts, hair follicle cells, 
hepatocytes, neural cells, islets of Langerhans, cardiomyocytes and corneal epithelium 
(Gomes et al., 2010; Iohara et al., 2006; Ishkitiev et al.; Monteiro et al., 2009a; Reynolds 
and Jahoda, 2004; Sugiyama et al., 2011). 
Multiple studies have also reported the capability of DPSCs to undergo in vitro 
osteogenic, chondrogenic and myogenic differentiation (d'Aquino et al., 2007; Laino et 
al., 2005; 2006; Zhang et al., 2006). When DPSCs are compared with BMSCs, both are 
found to be regulated by similar factors and share a common protein expression profile. 
However, they exhibit significantly different proliferation profiles in vitro and differ in 
their ability to develop into distinct tissues representative of the tissue of origin. BMSCs 
formed only bone tissue in the mouse model, unlike DPSCs (Batouli et al., 2003; 
Gronthos et al., 2000). DPSCs appear to have a weak chondrogenic potential and are 
weaker in adipogenesis in comparison with BMSCs (Zhang et al., 2006; Sonoyama et al., 
2008). However, neural induction of DPSCs may be more potent than that of BMSCs, 
possibly because of their neural crest origin (Huang et al., 2009c). 
The potential of SHEDs for neural differentiation is well documented in the literature 
(Annibali et al., 2014). SHEDs under non-neuronal inductive conditions expressed 
specific neural markers, which has been attributed to their neural crest cell origin (Ma 
et al., 2012; Miura et al., 2003; Nourbakhsh et al., 2011; Taghipour et al., 2012). The 
glial cell markers GFAP, NFM and CNPase were also expressed by SHEDs without being 
induced to neuronal differentiation and remained unchanged after neuronal induction 
(Miura et al., 2003; Nourbakhsh et al., 2011). 
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Interestingly, when cultured in the presence of B27 Supplement (a serum-free 
supplement used to support the growth and viability of central nervous system [CNS] 
neurons) for 4 weeks, SHEDs lost their fibroblastic appearance, developed 
multicytoplasmic processes and showed an increased expression of βIII-tubulin; a 
protein primarily expressed in neurons and that may be involved in neurogenesis and 
axon guidance and maintenance. Glutamic acid decarboxylase and neuron-specific 
nuclear protein markers of most post-mitotic neuronal cell types were also expressed 
(Kim et al., 2009). 
SHEDs expressed and maintained high levels of the glial cell marker nestin, which is 
an intermediate filament protein that is mainly expressed in early stages of CNS and 
muscle development (Lendahl et al., 1990; Sejersen and Lendahl, 1993) . Nestin is also 
expressed in other tissues, such as the heart (Kachinsky et al., 1995) and neural 
crest (Lendahl et al., 1990). In most of these tissues, nestin is expressed during early 
development and is then down-regulated in mature tissues (Sejersen and Lendahl, 
1993). It is associated with primitive neuroectoderm (NE) formation and is expressed 
primarily and predominantly in stem cells of the CNS in the neural tube. Upon terminal 
neural differentiation, nestin is down-regulated and replaced by neuro-filaments 
(Online Mendelian Inheritance in Man, OMIM *600915). Reactivity for nestin has also 
been detected in odontoblasts, stratum intermedium and some apical processes of 
ameloblasts (Liu et al., 2006). Nestin plays a potential role in odontoblast differentiation 
under normal and pathological conditions. 
The exact function of nestin in odontoblasts has not been established, but its 
expression in odontoblast cell bodies suggests a role in dentine matrix synthesis, while 
its presence in the odontoblast processes is not clear (About et al., 2000b). Odontoblast 
processes are accompanied by small nerve fibres in the dentinal tubules, but direct 
contact between these two structures has not been reported. It has been shown that 
the expression of nestin in myo-fibres is regulated by innervation (Vaittinen et al., 
1999), suggesting a similar effect in odontoblasts. In young permanent teeth, nestin is 
found only in functional odontoblasts, which produce the hard tissue matrix of dentine. 
Expression is progressively down-regulated and nestin is absent from older permanent 
teeth (About et al., 2000b; About and Mitsiadis, 2001). 
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1.12 Dental stem cells in regenerative medicine 
For the purposes of regenerative medicine, the ideal stem cells would be PSCs that 
have broad potential to differentiate into cells from all three germ layers (ectoderm, 
mesoderm and endoderm). The plasticity concept of adult stem cells (e.g., dental stem 
cells) and their ability to trans-differentiate into cells from different germ layers has 
recently evolved (Ratajczak et al., 2011). The proposition that different tissues may 
contain heterogeneous populations of stem cells, including some rare multipotent or 
PSCs that can be utilised in regenerative therapy, has become a captivating research 
direction. 
Transplanted intact SHEDs and SHED-derived spheres were induced into 
dopaminergic neurons in Parkinsonian rats (Wang et al., 2010). Two weeks after 
transplantation, there was an improvement in apomorphine-evoked rotations (turning 
in the same direction) that was sustained for up to 6 weeks for both test groups: SHED-
derived spheres and intact SHEDs. This behavioural recovery was not observed in the 
control group that received a basic medium placebo. However, there was no significant 
difference between the three groups after eight weeks of transplantation. The 
therapeutic potential of SHEDs in neurodegenerative diseases was then established 
(Wang et al., 2010). 
Govindasamy et al. (2011) investigated the potential of SHEDs to differentiate into a 
pancreatic cell lineage resembling islet-like cell aggregates (ICAs). At day 10 in vitro, ICAs 
exhibited the function of releasing insulin and C-peptide in a glucose-dependent 
manner. The in vitro capacity of SHEDs and DPSCs to differentiate in serum-free 
conditions into pancreatic cells has been investigated (Ishkitiev et al., 2013). After 
pancreatic differentiation, the expression of the pancreatic-specific endocrine markers 
glucagon, somatostatin and pancreatic polypeptide, and the exocrine marker amylase-
2a were lower in DPSCs than in SHEDs. The expression of insulin remained weak in both 
SHEDs and DPSCs. After differentiation, SHEDs expressed many key factors for the 
initiation of pancreatic development such as PDX1 and HHEX, which are required for the 
embryonic development of the entire pancreas. In addition, SHEDs expressed the 
endodermal transcription factor MNX1 found in the developing β-cell, NEUROG3 which 
is necessary for the development of the endocrine function in the pancreas, Pax4 which 
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is required for the normal development of β- and δ-cells; Pax6 which is required for the 
development of pancreatic endocrine cell types except α-cells; and finally NKK6-1, 
which is a β-cell differentiation factor. 
SHEDs also showed some in vivo therapeutic potential for type 1 diabetes using 
subcutaneous transplantation of a macrocapsule containing ICAs derived from SHEDs, 
into mice with induced diabetes (Kanafi et al., 2013). Results showed that 90% of 
transplanted mice survived. Their blood glucose levels were normal for 2 weeks after 
the operation and those levels were maintained for 2 months. In addition, mice body 
weights and their urinary glucose levels reverted to normal. Interestingly, the removal 
of the macrocapsules containing ICAs did not cause hyperglycaemia, indicating 
endogenous pancreatic regeneration, which was confirmed by histopathological 
investigation. 
The cornea of the eye develops embryonically from the cranial neural crest. Hence, it 
has been postulated that autologous stem cells derived from other cranial neural crest 
tissues like the dental pulp may have a strong ability to differentiate into corneal cell 
types (Syed-Picard et al., 2015). DPSCs were able to differentiate into keratocytes in 
vitro and in vivo, generating a tissue-engineered corneal stromal-like tissue and proving 
their potential to be used for therapies to repair the corneal stroma (Syed-Picard et al., 
2015). 
SHEDs have also exhibited the potential to differentiate into endothelial-like cells, 
forming parts of blood vessel walls (Bento et al., 2013). This was demonstrated by 
tagging SHEDs with lacZ β-galactosidase, a protein with the ability to signal its presence 
by producing an easily recognisable blue reaction (Juers et al., 2012). SHEDs also formed 
the wall lining of blood-containing vessels within tissues, which were capable of 
anastomosing with the host vasculature (Bento et al., 2013; Sakai et al., 2011). 
Further, SHEDS appear to have immune properties in that they suppress the 
activation of human T-lymphocytes in vitro (Alipour et al., 2013) and have an immune-
regulatory phenotype evidenced by inhibition of lymphocyte stimulation in mice (Silva 
Fde et al., 2014). 
The utilisation of SHEDs and IDPSCs for the treatment of systemic diseases in animal 
models shows promise, as discussed earlier. A significant improvement of many 
disorders such as neurodegenerative diseases, type 1 diabetes, lupus erythematosus-
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associated disorders, muscular dystrophy and osteoporotic disorder are among the 
clinical applications that have been demonstrated (Annibali et al., 2014) with some 
evidence of efficacy. 
1.13 Dental pulp stem cells in regenerative endodontics 
In traumatised permanent non-vital immature teeth, roots are incomplete with wide 
open apices and thin dentine walls liable to fracture under physiological forces (Al 
Ansary et al., 2009). Current treatment first requires the elimination of bacterial 
infection from the root canal, followed by placement of a suitable root filling material to 
prevent re-infection of this space. However, producing a barrier against which a root 
canal filling material can be placed, thereby preventing the extrusion of material into 
the surrounding tissues, is a challenge. This apical barrier is usually achieved by use of 
prolonged dressing of the root canal with calcium hydroxide to perform apexification. 
Although this technique has been reliable in allowing clinicians to obturate root canals, 
there are concerns about the long-term use of calcium hydroxide in root canals, which 
may desiccate dentinal proteins, making dentine more brittle and more predisposed to 
root fractures. Indeed, an increased prevalence of root fractures has been reported for 
teeth that have been treated with this technique (Al Ansary et al., 2009; Cvek, 1972; 
Flores et al., 2001). 
In the last decade, the introduction of mineral trioxide aggregate (MTA) has meant 
that an apical plug can be created immediately to allow obturation of the root canal 
(Lee et al., 1993; Shabahang et al., 1999). However, there is some evidence that MTA 
might also have a weakening effect on the dentine (Twati et al., 2009). 
The paradigm shift in the treatment for such teeth is focused on harnessing stem 
cells at the apical area of the injured permanent immature incisors, which allows the 
root canal to be repopulated with vital tissue and might allow the continued deposition 
of root dentine and further root development (Banchs and Trope, 2004). This technique 
is widely referred to as the regenerative endodontic technique and is based on the 
presence of stem cells in the periapical area, complete disinfection of the root canal, 
establishment of a blood clot scaffold within the root canal and provision of signals to 
the stem cells to differentiate. This cell-homing approach has been developed to 
regenerate the pulp–dentine complex through a cell-free method that encourages 
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recruitment of endogenous resident MSCs to the site of tissue regeneration (Cao et al., 
2015; Mao et al., 2012). 
One of the chemotactic homing factors involved in recruiting MSCs to migrate to 
sites of injury is SDF-1, which facilitates tissue repair and regeneration (Kucia et al., 
2005; Yang et al., 2015; Zwingenberger et al., 2014). Iohara et al. (2011) demonstrated 
that pulp–dentine regeneration did not occur in the absence of pulp MSCs even with 
the presence of SDF-1, bringing into question the capability of homing factors alone to 
recruit MSCs from surrounding tissues to promote dental pulp cell differentiation (Cao 
et al., 2015). This questions the homing theory and highlights the importance of cell-
based approaches for pulp–dentine regeneration. 
The term revascularisation describes the re-establishment of blood supply to a 
tissue, in this case the dental pulp. This term is commonly used in the dental 
traumatology literature where an immature open apex tooth is subjected to trauma, 
leading to complete or partial ischaemia to the pulp tissue and followed by an 
intervention that restores the pulp blood supply from surrounding periapical tissues 
(Banchs and Trope, 2004; Huang and Lin, 2008). The concept of revascularisation 
focuses on the delivery of blood into the root canal space as a means of prompting 
wound healing, similar to healing after tooth extraction (Banchs and Trope, 2004). 
Although angiogenesis and the establishment of a functional blood supply is a key 
feature in the maintenance and maturation of a regenerating tissue, revascularisation 
ignores the potential importance of growth factors and scaffolds that are required for 
histological recapitulation of the pulp–dentine complex (Hargreaves et al., 2015). 
However, regeneration, as in a traumatised dental pulp scenario, has been defined 
as biologically based procedures designed to replace damaged structures, including 
dentine and root structures, as well as cells of the pulp–dentine complex (Murray et al., 
2007). This indicates an overall goal of restoring the original tissue histology and 
function (Hargreaves et al., 2013). Regenerative endodontic procedures consider the 
presence of an enriched source of stem cells within the apical tissues, their delivery into 
root canal systems and the intentional release and use of local growth factors 
embedded into the dentine (Iohara et al., 2008; 2009; Nakashima et al., 2009). 
An important objective of endodontic tissue engineering is to regenerate a functional 
dental pulp that generates new dentine upon demand and is capable of responding to 
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harmful stimuli. This field has received considerable attention over the last decade, 
particularly following the discovery of stem cells in the dental pulp tissue (Cao et al., 
2015; Gronthos et al., 2000; Mao et al., 2012; Miura et al., 2003). 
The discovery of tissue-specific stem cells that can ultimately reconstruct a functional 
dental pulp supported the idea of designing tissue engineering-based interventions that 
involve the transplantation of stem cells or the recruitment of periapical stem cells into 
the pulp chamber to restore tooth viability. Such interventions appear to be particularly 
useful for the treatment of permanent non-vital immature teeth with incomplete, thin 
and short roots (Botero and Nör, 2015). Pre-clinical studies employing cell-based 
therapies for pulp–dentine tissue engineering have highlighted the efficacy of cell 
transplantation for pulp–dentine regeneration compared with pulp canal debridement 
and disinfection alone (Zhu et al., 2013a). In a pulpotomy model conducted in dogs, 
pulp canal debridement and disinfection protocols using a triple antibiotic paste were 
successful in resolving apical periodontitis but failed to induce genuine pulp–dentine 
regeneration. However, the regeneration of pulp–dentine complex was successful after 
the transplantation of a CD31–/CD146–-fractionated sub-population of pulp cells (Iohara 
et al., 2009). 
In vivo studies in a murine model also indicated the possibility of pulp–dentine 
regeneration using human root fragments and MSC transplantation (Huang et al., 
2010b). Control samples with scaffold alone showed no evidence of organised pulp 
tissue but rather demonstrated an ingrowth of fibrous tissues. Pulp–dentine complex 
regeneration and the formation of mineralised dentine was also evident following the 
ectopic transplantation of human dentine disks filled with poly-L-lactic acid scaffold and 
DPSCs (Sakai et al., 2011). The control sample with scaffold alone failed to form a 
functional odontoblast layer. 
Odontoblastic differentiation of DPSCs and SHEDs is dependent on many factors 
within the in situ microenvironment of these cells. This involves many matrix 
components, mineral ions and growth factors (Duailibi et al., 2004; Yu et al., 2006a). 
Individual factors can also play major roles in the differentiation of SHEDs and DPSCs 
into odontoblasts. Dentine matrix protein-1 can significantly promote the odontoblastic 
differentiation of pulp cells and the formation of reparative dentine over the exposed 
pulp tissue (Almushayt et al., 2006). Additionally, pulp cells can be induced into 
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odontoblast lineages when treated with TGF-β1 alone or in combination with FGF2 and 
Notch–Delta1 signalling differentiation-inducing factors (He et al., 2008). 
Cao et al. (2015) raised a controversial question regarding whether cell fractionation 
is required for pulp–dentine regeneration, since unfractionated-pulp MSCs were also 
capable of tissue regeneration, although to a much lesser extent when compared with 
CD105+-enriched cells. In contrast, MSCs from adipose tissues showed a minor potential 
for pulp tissue regeneration, even with CD105+ enrichment, indicating inherent 
differences among MSCs of different tissue origin. 
SHEDs cultured in a scaffold without dentine did not express markers of 
odontoblastic differentiation such as dentine matrix protein (DMP-1), dentine 
sialophosphoprotein and matrix extracellular phosphor-glycoprotein (Casagrande et al., 
2011). When SHEDs were mixed with hydroxyapatite–tricalcium phosphate (HA–TCP) 
ceramic powder they were unable to regenerate a complete dentine–pulp-like complex 
in immunocompromised mice (Miura et al., 2003). However, SHEDs proved to have a 
strong tendency to become odontoblasts after BMP-2 stimulation (Hara et al., 2011) 
and when they were seeded in a tooth slice/scaffold and then transplanted into the 
dorsum subcutaneous tissue of immunodeficient mice—transforming into what 
appeared to be active dentine-secreting odontoblasts (Cordeiro et al., 2008). 
The advantage of transplanting dental stem cells is that they are pre-programmed to 
regenerate dental tissues and could potentially form new dental pulp more rapidly and 
thoroughly. However, obtaining viable sources of these cells might be a limiting factor. 
Ideally, exfoliating primary teeth represents a source of stem cells for pulp tissue 
engineering in necrotic permanent immature teeth during mixed dentition. These 
allografts will limit the possible risk of an immune reaction against the transplanted 
cells. Minimising the risk of contamination and avoiding the use of animal products 
(e.g., FBS) would also be necessary during in vitro culturing and expansion of these cells 
(Bernardo et al., 2011). 
Alternatives that have been explored are the use of serum-free medium (Ali et al., 
2009; Jung et al., 2012) or patient-derived serum (Shahdadfar et al., 2005). Both 
alternatives raise concerns of low cell-proliferation rates and limited in vitro cell 
expansion under serum-free conditions (Bernardo et al., 2011). When using patient-
derived serum, the multiple manipulation steps under clinical grade conditions 
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introduce variability from case to case (Botero and Nör, 2015). Nevertheless, the 
translation of cell-based endodontic therapies and tissue regeneration is considered a 
promising mode for future medicine (Huang et al., 2009c) and will rely upon successful 
resolution of these challenges (Botero and Nör, 2015). 
1.13.1 Induced pluripotent stem cells 
iPSCs are the newest member of a growing list of stem cell populations that hold 
great potential for use in cell-based treatment approaches in the dental field (Hynes et 
al., 2015). Recently, the technique of converting virtually any cell type, including 
differentiated somatic cells, into iPSCs was developed, promising an almost unlimited 
source of easily obtained PSCs (Takahashi and Yamanaka, 2006; Takahashi et al., 2007). 
The technique originally involved the introduction of 24 pluripotency markers into 
somatic cells to achieve a pluripotent-like state in the cells. Through a series of screens, 
these 24 factors were reduced to a cocktail of four transcription factors (Oct3/4, Sox2, 
Klf4 and c-MYC) sufficient for conversion of adult differentiated cells into iPSCs in 
immunocompromised mice. The resulting reprogrammed iPSCs can be re-differentiated 
into cells that represent derivatives of all three germ layers. However, further studies 
revealed that specific reprogramming factors differ among tissues; the substitution of c-
MYC for LIN28 and Nanog also resulted in induced pluripotency, suggesting multiple 
avenues for iPSC formation (Yu et al., 2007). 
More recently, it has been reported that iPSCs can be established from 
mesenchymal-like stem/progenitor cells of dental tissue origin, such as SHEDs, SCAPs, 
DPSCs (Yan et al., 2010), oral mucosa fibroblasts (Miyoshi et al., 2010), periodontal 
ligament stem cells (Wada et al., 2011) and gingival fibroblasts (Egusa et al., 2010; Wada 
et al., 2011). Recent studies describe the successful application of mouse iPSCs 
manipulated ex vivo to generate tissue-engineered tooth-like structures following 
implantation into a mouse sub-renal capsule (Wen et al., 2012). 
There are significant safety concerns regarding the use of iPSCs that must be 
addressed before they can be considered for use in treatment approaches in dentistry. 
One of the major limitations for their use is that iPSCs show a higher predisposition to 
tumour formation following in vivo transplantation, as well as genomic instability (Ben-
David and Benvenisty, 2011; Gore et al., 2011; Miura et al., 2009). In addition, several 
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iPSC lines exhibit a limited capacity for neural differentiation (Hu et al., 2010). Despite 
these differences, global gene expression studies comparing iPSCs and ESCs found no 




A. There is a heterogeneous population of cells that are present in primary tooth pulps 
and express: 
 embryonic stem cell markers 
 neural stem cell markers 
 mesenchymal stem cell markers. 
B. Primary pulp cells can undergo in vitro multilineage differentiation into specialised 
cell types. 
C. The stage of root resorption affects the marker expression and the differentiation 
potential of these cells. 
Objectives 
1. To culture primary pulp cells from the three stages of root resorption and 
characterise them using immunocytochemistry targeting the expression of 
markers for embryonic, neural crest-derived and mesenchymal stem cell markers. 
2. To grow human embryonic stem cells and compare their expression of embryonic, 
neural crest-derived and mesenchymal stem cell markers as well as markers 
associated with their differentiation status, with that of cultured primary tooth 
pulp cells. 
3. To identify the topographical distribution of progenitor cells within the pulps of 
deciduous teeth at various stages of root resorption using three sets of 
immunohistochemical markers indicative of embryonic, neural crest-derived and 
mesenchymal stem cells. 
4. To analyse the expression of mesenchymal stem cell-associated markers on 
primary pulp cells derived from the three stages of root resorption by quantitative 
flow cytometry. 
5. To determine the differentiation potential of cultured primary pulp cells into the 
three germ layer lineages, specialised mesoderm (cardiomyocyte progenitor cells) 
and specialised ectoderm (neural progenitor cells). 
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Chapter 2: Primary Tooth Pulp Cell Culture and 
Immunocytochemistry 
2.1 Introduction 
Primary tooth pulp cells are considered an attractive in vitro model for many 
researchers because of their ease of isolation and high expansion potential (Yildirim, 
2013). However, difficulties in obtaining reproducible results remains an obstacle, 
especially when multiple protocols for cellular isolation and differentiation are used 
(Iohara et al., 2008; Sotiropoulou et al., 2006; Suchanek et al., 2010; Yu et al., 2010). It is 
documented that the differentiation potential of postnatal stem cells is influenced by 
the isolation method (Bakopoulou et al., 2011b; Huang et al., 2006; Liu et al., 2006). 
Despite this, there is no consistent agreed isolation or purification methodology for 
DPSCs (Yildirim, 2013). This inconsistency relates to the media used, the starting and 
passaging cell plating density, the culture surfaces and the addition of supplementary 
factors. 
The following section describes the various isolation techniques, culture media and 
significant protein markers reported in the literature for the characterisation of DPSCs. 
2.1.1 Cell isolation techniques 
The identification of DPSCs and SHEDs mainly depends on their biological 
characteristics, such as small cell size, high proliferative capacity, potent colony 
formation, self-renewal and multi-differentiation potential (Gronthos et al., 2000; 2002; 
Stevens et al., 2008). 
Small cell size is one of the characteristics of adult stem cells (Dutra and Bernard, 
1994; Fujimori et al., 2009; Hung et al., 2002; Tzeng et al., 2004; Yan et al., 2011). A 
common method for size-dependent isolation involves the use of nylon filters for 
separating cells according to size (Al-Essa et al., 1994; Ashkenazi and Dennison, 1989; 
Hara et al., 1989). The size-sieving isolation technique involves separating the dental 
pulp tissue, which is then digested in a solution of 3% collagenase type I for 1 h at 37°C. 
The resulting single-cell suspension is then filtered through a 20-µm strainer followed 
by seeding onto a 3-µm porous sieve. Cells on the upper plate surface of the 3-µm 
sieve, with a diameter of 3–20 µm, are obtained for further culturing and expansion 
(Yan et al., 2011). 
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Magnetic activated cell sorting is an immunomagnetic method used for the 
separation of stem cell populations based on surface antigens such as CD271, STRO-1, 
CD34, CD45 and c-Kit. This approach has been used for the isolation of dental pulp cells 
(Gronthos et al., 2002; 2011) and many other cell types including lymphocytes, dendritic 
cells, foetal cells from maternal blood, granulocytes, megakaryocytic cells, natural killer 
cells, T-cells, tumour cells, epithelial cells and haematopoietic progenitor cells (Marek et 
al., 2008). In this technique, the dental pulp is digested into a single-cell suspension. The 
suspension is then incubated with a primary monoclonal antibody (mAb) against a 
specific stem cell surface marker, followed by incubation with a secondary antibody 
conjugated to immunomagnetic beads. The cell–bead mixture is then put into the 
magnetic field to collect cells attached to the tube wall. Attached cells are repeatedly 
washed and re-suspended, then subcultured to obtain stem cells (Yan et al., 2011). 
FACS is another widely used method for stem cell isolation from cell suspensions 
based on cell size and fluorescence-labelled cellular antigens. This highly sophisticated 
technique requires expensive equipment and skilled personnel. Moreover, FACS-sorted 
cells become physiologically stressed with decreased viability, making the technique 
more suitable for research or diagnostic analysis of relatively small cell populations 
rather than processing the large quantities of cells required for therapeutic applications 
(Nishimoto et al., 2007). In this method, cells are stained with one or more fluorescent 
dyes specific to targeted cell components such as surface antigens or nuclear markers. 
Fluorescence of each cell is quantified as it rapidly transects a laser beam where 
fluorescence wavelength and intensity provide the basis for the separation of cell sub-
populations (Jo et al., 2007; Laino et al., 2005; 2006; Paino et al., 2010; Perry et al., 
2008; Wang et al., 2012a; Yang et al., 2007a; 2007b; 2009; Yang and Fan, 2005). 
Stem cell colony cultivation is a classical method used to purify stem cells from a 
heterogeneous population of cells. Colony culture can be initiated from a single-cell 
suspension made directly from tissues after enzymatic digestion, or subcultured cells 
(Gronthos et al., 2000; 2011; Miura et al., 2003) as discussed in Chapter 1 (Section 1.9). 
The dental pulp explant culture method used in this study was first reported by 
Kerkis et al. (2006) and then Lizier et al. (2012). This method is based on culturing pulp 
tissue explants followed by mechanical (non-enzymatic) transfer (see Section 0). 
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2.1.2 Cell culture media 
Culture systems can be either feeder-free or feeder-based systems (Amit and 
Itskovitz-Eldor, 2006; Chiao et al., 2008; International Stem Cell Initiative et al., 2010; 
Ludwig et al., 2006; Xu et al., 2001). Both systems can be used in combination with an 
undefined conditioned medium or a defined culture medium. 
Media, either defined or undefined, can be combined with defined biological 
matrices to aid adhesion and growth of cells. Matrigel is an ECM extract from mouse 
sarcoma (Braam et al., 2008) that contains collagen IV, entactin, heparin sulphate 
proteoglycan and growth factors, but not VTN (Xu et al., 2001). Other systems combine 
defined matrices such as fibronectin, VTN or laminin (in either native or recombinant 
forms) on tissue culture plastic prior to cell seeding (Lyn and Ludmila, 2015). 
Feeder cells are usually fibroblasts that are mitotically inactivated so that they 
remain viable but cannot replicate and overgrow the stem cell culture. MEFs are the 
most commonly used feeder-cell type for co-culture with mouse ESCs (Evans and 
Kaufman, 1981; Martin, 1981) and hESCs (Thomson et al., 1998). 
Attempts to replace mouse feeder cells with human-derived feeder cells, ECM 
components or growth factors have all shown some success. This has been performed 
to avoid batch-to-batch variability within culture systems (Braam et al., 2008) and to 
prove that hESCs can be maintained on Matrigel, matrices of natural human collagen IV, 
fibronectin, laminin and VTN (Ludwig et al., 2006). 
Another major variable in cell culture is the use of serum and animal (xeno) products 
in the media. The introduction of FCS as a media supplement revolutionised the field of 
tissue culture and allowed the maintenance of stable cell lines in vitro (Shodell et al., 
1972). In these early experiments, it was demonstrated that the presence of FCS in the 
culture system may be responsible for inducing adverse effects such as triggering an 
arthus-like immune reaction in human immunodeficiency virus-infected patients given 
lymphocyte infusions (Selvaggi et al., 1997). Recent studies have demonstrated that cell 
populations intended for therapeutic purposes that are cultured in heterologous animal 
products can acquire xeno-antigens, potentially limiting their clinical utility (Kadri et al., 
2007; Riordan et al., 2015; Sakamoto et al., 2007). The addition of animal products also 
introduces batch-to-batch variability, which leads to experimental variability that can 
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confound the results of studies with therapeutic outcomes associated with cell culture 
(Usta et al., 2014). 
The quest to identify the optimal components of a cell culture medium (Mannello 
and Tonti, 2007; Sotiropoulou et al., 2006) led the International Stem Cell Initiative et al. 
(2010) to conduct a meta-analysis assessing eight cell culture systems. Parameters 
included cell attachment, cell death and differentiated morphology using phase 
contrast microscopy. In addition, cell growth and the maintenance of stem cell surface 
marker expression were evaluated. The International Stem Cell Initiative et al. (2010) 
concluded that only the control and two commercial media, mTeSR1 and STEMPRO, 
supported the maintenance of most cell lines for 10 passages. 
mTeSR1, which was developed by Ludwig et al. (2006), is composed of a DMEM–F12 
base medium supplemented with human serum albumin, vitamins, antioxidants, trace 
minerals, specific lipids and growth factors. Initial experiments with mTeSR1 were 
performed on a Matrigel coated surface, which was later replaced by collagen IV, 
fibronectin, laminin or VTN for long-term cultures of hESCs. The other medium was 
STEMPRO, whose exact formulation is proprietary (Stover and Schwartz, 2011), but it is 
known to be based on a system that acts through different tyrosine kinase pathways to 
maintain pluripotency (Wang et al., 2007). 
2.1.3 Essential 8 medium–VTN-N (human recombinant vitronectin) 
Essential 8 (E8) is a xeno-free and feeder-free medium (Chen et al., 2011a) specially 
formulated for the growth and expansion of human PSCs. The eight essential 
components required for PSC culture are listed in Table 6. 





 L-ascorbic acid-2-phosphate magnesium (64 mg/L) 
 Sodium selenium (14 µg/L) 
 FGF2 (100 µg/L) 
 Insulin (19.4 mg/L) 
 NaHCO3 (543 mg/L) 
 Transferrin (10.7 mg/L) 
 TGF-β1(2 µg/L) or nodal (100 µg/L) 
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Removing albumin or any of the growth factors from mTeSR1 medium led to a rapid 
decline in human ESC culture performance due to the release of BME, which was toxic 
to the cultured cells. Re-optimisation in the absence of albumin and BME resulted in a 
completely defined medium with eight components, including DMEM–F12, with greater 
support for human ESC and iPSC proliferation while maintaining pluripotency markers 
and normal karyotypes for over 25 passages (Chen et al., 2011a). 
VTN was first described as a multifunctional adhesive glycoprotein that supported 
the attachment and spreading on glass (Latin: vitreous, ‘of glass’) of “un-adapted” 
(primary) cells (Holmes, 1967). Later, Bale et al. (1989) reported that it mediates the 
majority of cell attachment activity in cell culture media containing bovine or human 
serum because of its 40-fold higher adsorption to culture dishes compared with 
fibronectin. Moreover, it was proposed that VTN might have an indirect effect on cell 
growth in a yet unidentified manner as reported by Preissner (1991). Accumulating 
evidence indicated that VTN is the primary and the most effective glycoprotein 
supporting cell attachment and spreading on tissue culture plastic (Steele et al., 1991; 
Underwood and Bennett, 1989). 
More recently, VTN recombinant variants such as full-length forms with both N and 
C-terminals (VTN-NC) or a truncated N-terminal (VTN-N) have been introduced (Gibson 
and Peterson, 2001) and compared with multiple matrix proteins such as laminin, VTN 
and fibronectin. VTN-N has been shown to support the initial attachment and survival of 
hESCs growing in E8 medium and when cells were passaged using 
ethylenediaminetetraacetic acid (EDTA) (Chen et al., 2011a). The emerging concept of 
the glycoprotein VTN as a biological ‘superglue’ and key controller of mammalian tissue 
repair and remodelling has been further reinforced (Leavesley et al., 2013), suggesting 
that it is a fundamental organiser or micromanager of the extracellular 
microenvironment essential to mammalian cell and tissue survival. 
In this chapter,  the objective of culturing primary pulp cells from the three stages of 
root resorption and human embryonic stem cells was achieved. This was followed by a 
series of immunocytochemistry characterisation experiments to identify markers for 




2.2.1 Ethics approval, information packs and consent 
Ethics approval was obtained from the Otago University Ethics Committee (approval 
number H13/075). Information packs were provided to patients and parents/caregivers. 
Sample charateristics are described in section 2.3.1 and section 2.32. Consent forms 
were signed before the day planned for the tooth extraction (Section 7.1 and 7.2).  
2.2.2 Cell culture equipment and instruments 
The following  essential equipments were used in this study: 
 Class II laminar flow hood with vacuum 
 Centrifuge (Beckman Coulter Allegra X15-R with SX4750 with swinging bucket 
rotor) 
 Inverted phase contrast microscope (Eclipse Ti-U inverted microscope; Nikon x4, 
x10, x20 and x40 objectives) 
 −80°C freezer (Thermal Scientific) 
 37°C water bath 
 Thermo Scientific Mr Frosty Freezing Container (Cat# 5100-0001) 
 CoolCell LX Cell freezing container (BioCision, BCS-405G) for 1.0 mL or 2.0 mL 
cryogenic vials (cryo-vials) 
 Cryo-vials 1.2 mL (USA Scientific, Cat# 1412-9100) 
 Lab-Tek II Chamber Slides (Thermo Scientific Nunc, Cat# 154534) 
 Greiner Bio-One culture plates (6-well, Cat# 657160) 
 Greiner Bio-One CELLSTAR TC filter cap cell culture flasks (T25 Cat# 690175 and 
T75 Cat# 658175) 
 Greiner CELLSTAR serological pipettes, volumes for 5, 10 and 25 mL (Cat# P7615, 
P7740, P7865) 
 Sterile Millipak-20 Filter Unit 0.22 µm (Millipore, Cat# MPGL02GH2) 
 Sterile BD Falcon conical tubes 50 mL (Cat# 352070) and 15 mL (Cat# 352097) 
 Thermo Scientific Nunc Cell Culture Treated EasYFlasks T25 (Cat# 156340), T75 
(Cat# 156472) and T75 (Cat# 159920) 
 Corning BioCoat Collagen I cell culture T25 flasks with vented cap (Cat# 354484) 
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 Cell culture incubators; Forma Series II water-jacketed CO2 incubator (Thermo 
Fisher Scientific Inc) and Thermo Scientific Heracell 240i CO2 Incubator with 
Stainless-Steel Chambers 
Cells were maintained in normoxic conditions (5% CO2) at 37°C, 95% humidity for all 
culture experiments in this study. 
2.2.3 Instrument tray for sample collection and processing 
All instruments were purchased sterile or were sterilised the day prior to sample 
collection, and included: 
 Gauze 
 Tweezers x 3 
 Hand excavators x 2 
 Scalpel blade handles x 2 
 Calipers for root length measurement 
 Periodontal scalers x 2 
 High-speed burs No. 33 (to be used once) and high-speed hand piece 
 Phosphate-buffered saline (PBS) pH 7.4, no calcium, no magnesium (Life 
Technologies, Cat# 10010001). 
2.2.4 Reagent preparation 
Reagent preparation protocols are described in Section 7.4. The reagents that were 
manually prepared under sterile conditions in the laminar flow hood included: 
 Antibiotic–antimycotic 100x (Invitrogen, Cat# 15240) 
 Sterile PBS without calcium and magnesium (Gibco, Cat# 10010072) 
 VTN-N (Invitrogen, Cat# A14700). (The day before collection of a sample, culture 
plates were coated with VTN-N at 0.5 µg/cm2, then incubated for 1 h at room 
temperature (RT) prior to storing overnight at 2–8°C) 
 Complete E8 medium (Invitrogen, Cat# A1517001) was prepared by mixing E8 
Basal Medium DMEM–F12 (Ham) 1:1 with E8 Supplement (50x). Antibiotic–
antimycotic (1% Anti–Anti, Invitrogen, Cat# 15240) was added to the medium. 
The VTN-N-coated culture vessel and complete E8 medium were warmed to RT 
for at least 1 h prior to use. 
56 
2.3 Methods for cell culture and immunocytochemistry studies 
2.3.1 Primary tooth pulp cell preparation 
For cell culture experiments, 18 caries-free primary canine teeth at the three defined 
stages of physiological root resorption were extracted from 6–12-year-old healthy 
children as part of their treatment plans. The procedure was performed under local or 
general anaesthetic at the University of Otago Dental School. Nine teeth were included 
in the present study (Table 7). Teeth that were excluded because of contamination 
(n = 9) are listed in Table 8. Informed consent was obtained from the patients and their 
caregivers (Section 7.2). Collected teeth root length was measured using calipers and 
teeth were cut open using a sterile high-speed diamond round bur longitudinally from 
crown to root not reaching the pulp cavity. The sample was then transported to the 
tissue culture laboratory in a sterile container with sterile cold PBS. 
In the Class II cell culture hood, teeth were split open longitudinally using side-
cutting bone scissors to expose the pulp tissue. Dental pulp was excavated with a sterile 
excavator, and transferred with minimal dissection into 6-well culture plates containing 
xeno-free, serum-free E8 medium (Invitrogen) supplemented with 1% antibiotic–
antimycotic (Invitrogen). Pulp cells were isolated by the outgrowth method; that is, cells 
outgrow from pulp tissue explants with no enzymatic dissociation. Cell lines were 
cultured in E8 medium on a VTN-N matrix. The growing culture of primary pulp cells was 
maintained for 2 weeks, and then the cells were seeded at 104 cells in 25-cm2 culture 
flasks. 
Cultures were incubated in a 5% CO2 incubator at 37
oC and maintained semi-
confluent. The cells were passaged every 7–10 days using 0.5 mM EDTA solution 
(Sigma-Aldrich) and the culture medium was refreshed daily. For freezing, cells were re-
suspended in E8 medium containing 10% dimethylsulfoxide (DMSO) (Sigma) and the 
temperature was slowly and gradually decreased at a rate of 1°C/min until a final 
temperature of –80oC was reached. Thereafter, cells were transferred to liquid nitrogen 
for storage. For thawing, primary tooth pulp cell cryo-vials were placed into a 37°C 
water bath and recovered on the day of the planned investigation. 
IF studies for the expression of ESC markers (Oct4A, Nanog and Sox2), neural crest 
progenitor cell markers (nestin and Dlx2) and MSC surface markers (CD90, CD73 and 
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CD105) were carried out at passage 4 (P4). Full IF protocols are presented in Section 
7.6. The hESC (GENEA002) positive control cell line was grown in M2 medium 
supplemented with 1% antibiotic–antimycotic (Invitrogen). All cultures were incubated 
at 37°C in a 5% CO2 and high-humidity environment. 









3 53 C353 20/3/14 C CULTURE, E8–VTN, P3 frozen 
6 63 A663 9/6/14 A CULTURE, E8–VTN, P3 frozen 
10 53 A1053 21/7/14 A CULTURE, E8–VTN, P3 frozen 
11 53 B1153 22/7/14 B CULTURE, E8–VTN, P3 frozen 
19 53 A1953 28/1/15 A CULTURE, E8–VTN, P3 frozen 
19 63 B1963 28/1/15 B CULTURE, E8–VTN, P3 frozen 
21 53 C2153 24/2/15 C CULTURE, E8–VTN, P3 frozen 
21 63 C2163 24/2/15 C CULTURE, E8–VTN, P3 frozen 
22 53 B2253 25/3/15 B CULTURE, E8–VTN, P3 frozen 
 









12 63 A1263 5/8/14 A CULTURE, P1 contaminated 
12 53 A1253 5/8/14 A CULTURE, P1 contaminated 
15 53 A1553 15/8/14 A CULTURE, P1 contaminated 
16 53 C1653 2/9/14 C CULTURE, P1 contaminated 
17 53 C1753 23/9/14 C CULTURE, P1 contaminated 
17 63 C1763 23/9/14 C CULTURE, P1 contaminated 
20 53 C2053 17/2/15 C CULTURE, P1 contaminated 
21 73 B2173 24/2/15 B CULTURE, P1 contaminated 
21 83 B2183 24/2/15 B CULTURE, P1 contaminated 
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2.3.2 Root resorption staging 
The extracted tooth was cleaned with sterile PBS to remove any clotted blood. 
Attached gingivae and periodontal tissues were then scraped off using a sterile scalpel 
blade or periodontal scaler. Tooth measurements were carried out from the most 
resorbed part to CEJ on both the buccal and lingual sides of the tooth using sterile 
calipers. Each tooth that was used to generate a cell line was coded as follows: the first 
letter represents one of the three groups of root resorption; the number that follows 
represents the patient’s serial number; and the last two digits represent the tooth 
number using FDI notation. The example below (Figure 7) shows that the patient is 
number 10 from group A and the tooth is the upper right primary canine 53 (FDI 
notation).  
 
Figure 7: Coding example: the tooth is from group A  
The distance between the CEJ and the deepest point of root resorption was 
measured using millimetre-precision calipers (Figure 8). The resulting measurement was 
then divided by the expected preresorption total root length for that specific tooth type 
according to the Kramer and Ireland (1959) published norms.  
   
Figure 8: Average measurements from the buccal and lingual surfaces were calculated and used in the 
formula at the top to generate a percentage of root resorption for each sample 
The overall percentage of root resorption was calculated based on an example tooth 
A1953 from Table 9. 
 CEJ to the most resorbed point of the root measurement (buccal) was 13 mm. 
 CEJ to the most resorbed point of the root measurement (lingual) was 12 mm. 
B u c c a l  L i n g u a l  
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 Average buccal and lingual measurements were 13 + 12 ÷ 2 = 12.5 mm. 
 Expected preresorption root length (Kramer and Ireland’s norms) was 12.84 mm. 
 % 𝑟𝑜𝑜𝑡 𝑟𝑒𝑠𝑜𝑟𝑝𝑡𝑖𝑜𝑛 
= 100 – (
 distance from CEJ to point of greatest resorption in mm ×  100
expected preresorption root length (Kramer and Ireland’s norms)
) 
% 𝐫𝐨𝐨𝐭 𝐫𝐞𝐬𝐨𝐫𝐩𝐭𝐢𝐨𝐧 = 𝟏𝟎𝟎 – (
 𝟏𝟐. 𝟓 ×  𝟏𝟎𝟎
𝟏𝟐. 𝟖𝟒 
) =  𝟐. 𝟔% 
Nine maxillary and mandibular canines from healthy children were included for cell 
culture (Table 9). Teeth that were caries free with no enamel defects or excessive tooth 
tissue loss, and that did not root fracture during extraction were included. The sample 
was divided into three groups according to the degree of root resorption: 
Group A: (n = 3) root resorption <33.33% 
Group B: (n = 3) root resorption 33.33–66.66% 
Group C: (n = 3) root resorption >66.66%. 













A663 11.4 12.0 11.7 12.84 8.9 A 
A1053 12.5 12.4 12.5 12.84 3.0 A 
A1953 12.0 13.0 12.5 12.84 2.5 A 
B1153 6.0 6.5 6.25 12.84 51.3 B 
B1963 7.0 6.8 6.9 12.84 46.3 B 
B2283 7.4 7.0 7.2 12.84 43.9 B 
C353 5.0 3.3 4.15 12.84 67.7 C 
C2153 4.2 3.8 4.0 12.84 68.8 C 
C2163 4.6 4.0 4.3 12.84 66.5 C 
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2.3.3 Isolation and culture of primary tooth pulp cells 
 In the dental clinic, where the tooth was extracted, a 
longitudinal groove was cut into the enamel and dentine 
using a sterile high-speed hand piece with No. 33 bur 
(single use only) with coolant (water). The groove 
originated 1 mm from the root apex without reaching the 
pulp cavity and moved up towards the crown tip (Figure 9A, 
B). The tooth was then transferred to the laboratory in a 
sterile Falcon tube containing ice-cold sterile PBS for 
further processing in a Class II laminar flow hood. 
In complete E8 medium, the tooth was longitudinally 
cracked open using a hand instrument and pulp tissue 
excavated using a sterile spoon excavator and tweezers. 
Side-cutting bone scissors proved to be the least time 
consuming and required minimal manipulation (Figure 9B–
D). 
2.3.4 Pulp explant culture 
The tooth was kept moist in PBS at all times. Pulp tissue 
was diced in E8 medium using two sterile blades; the pieces 
of pulp tissue were transferred into a VTN-N-coated 6-well 
plate containing complete E8 (Figure 9E–G). Primary pulp 
explant cultures were incubated in a 37°C, 5% CO2 
incubator initially for 2 days. The cells were passaged using 
0.5 mM EDTA in PBS and transferred into a T25 flask (P2) 









Figure 9: Explant culture 
preparation 
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Cells were frozen in cryo-vials (Cryo.S, PP, Greiner Bio-One Cat# 82050-154) with E8 
freezing medium made of 90% E8 + 10% DMSO (Sigma Cat# D8418) then transferred 
into a freezing container allowing a cooling rate of 1°C/min for 24 h before 
cryopreservation. Cells were stored in liquid nitrogen vapour phase at –120°C for later 
immunocytochemistry (ICC) and differentiation experiments (Section 7.4.6). 
2.3.5 Human embryonic stem cell culture (GENEA002) 
The GENEA002 embryonic cell line was cultured and maintained in Genea Biocells 
M2 stem cell medium; a fully defined serum-free medium for the maintenance and 
expansion of PSCs. Cryopreserved GENEA002 (5x105 cells/vial) were recovered and 
expanded using M2 medium in collagen I-coated, 25-cm2 culture flasks (Corning 
BioCoat, Cat# 354484). Further expansion of GENEA002 cultures into T75 culture flasks 
coated with rat tail collagen I (Falcon, FAL354236) was performed. Cells were frozen at 
P3 to be used for later experiments (Figure 10). 
Cryopreserved cells were recovered and seeded in collagen I (FAL354236)-coated 8-
well Lab-Tek II Chamber Slides. Cell thawing and expansion protocols were based on 
Genea Biocells recommendations to ensure full recovery and a healthy undifferentiated 
population of stem cells. The recovery and passage plan for GENEA002 cells is 


















Collagen I coated T25’s 
Falcon Collagen I, rat 
tail coated T75’s & 
Chamber slides 
Figure 10: Recovery and passage plan for GENEA002 
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GENEA002 cell line 
GENEA002 hESCs grown initially in stem cell medium (M2) on a collagen I matrix 
were adapted to E8–VTN-N and used as a positive control. Specifications and the 
characterisation sheet for GENEA002 are shown in Table 10. 
Table 10: GENEA002 embryonic cell line description (Genea Biocells) 
Cell line 
(GENEA002) 
Alternate ID: SIVF002 
Sex: Male–Disease status: Unaffected. 
Mycoplasma and Sterility: Cell line tested and negative for 
mycoplasma 
Microbiology: Embryo donors tested and negative for 
Hepatitis B, C and HIV-1 & 2 
NIH Approval Number: NIHhESC-12-0151 
Morphology: Well-defined colonies with compact cells displaying high nuclear to 
cytoplasmic ratio and prominent nucleoli. 
Karyotype analysis: 46, XY Male – no abnormalities detected 
Markers for pluripotency: Positive for Nanog, Oct 4, Tra1-60 and SSEA4 
Additional tests: Teratoma positive, Alkaline phosphatase stain 
positive 
Pluritest: Pass 
NIH Registry Link: http://grants.nih.gov/stem_cells/registry/current.htm?id=500 
Ethics: Ethics approval for the project (‘Development of human embryonic stem cells 
from excess ART embryos’) was obtained from the GENEA Ethics Committee on 21 
February 2001 
Source: Donated embryos originally created by assisted reproduction technology (ART) 
for the purpose of procreation. Embryos were subsequently declared excess to 
reproductive needs 
Consent: Consents were obtained for excess ART embryos for stem cell derivation. 
Donors have received no payment or financial benefits for their donation. 
Regulation: Derived under Australian National Health and Medical Research Council 
(NHMRC) licence 309703. This licence was issued to GENEA on 16 April 2004. 
Derivation date: December 2005 
Derivation location: QLD, Australia 
Derivation conditions: Derived on human 
feeders using 20% Knock out serum in 
standard hESC culture medium 
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2.3.6 Immunocytochemistry experiments on cultured cells 
Cultured primary tooth pulp cells and GENEA002 hESCs were examined for the 
presence of cellular protein markers using fluorescent-labelled antibodies. Cells were 
fixed and permeabilised, blocked and successively incubated with primary and then 
fluorescently labelled secondary antibodies to investigate the expression of the 
previously described sets of stem cell marker proteins (Section 2.5.1). The following 
describes the sample preparation for the IF experiments. Full protocols are provided in 
Section 7.6. 
Nunc Lab-Tek II Chamber Slide System 
GENEA002 hESCs and primary pulp cells from each resorption group were cultured in 
Nunc Lab-Tek II Chamber Slides for the IF experiments. Protocols for VTN-N and 
collagen I coatings are described in Section 0 and 7.5. 
Cell fixation and permeabilisation 
To ensure each antibody could bind to its antigen and then be subsequently 
detected, permeabilisation of the cells was conducted. Cells also needed to be 
adequately fixed to ensure good cellular morphology without compromising the 
accessibility of the antigens of interest. 
Cultured cells on coated Nunc Lab-Tek II Chamber Slides were fixed with ice-cold 
acetone. Permeabilisation with 0.3% Triton X-100 (Sigma-Aldrich) for 45 min at RT was 
performed when intra-nuclear protein antigens were to be detected (Oct4A, Nanog and 
Sox2). For cell-surface markers (CD73, CD90 and CD105) the permeabilisation step was 
omitted. Full protocols are provided in Section 7.6. 
Antibodies 
Affinity-purified antibodies with high specificity were used for detecting the antigens 
of interest. The matching isotype of the primary antibody was used as a control to 
determine the background levels. Pre-adsorbed, fluorescently labelled secondary 
antibodies targeting the primary antibody were used. 
Embryonic stem cell antibodies 
The StemLight Pluripotency Transcription Factor Antibody Kit (#9093) contained a 
panel of antibodies for the detection of key components of the core pluripotency 
transcription network in hESCs and iPSCs: 
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 Oct4A: Rabbit mAb—Clone C30A3 (Cell Signalling, Cat# 2840) 
 Nanog: Rabbit mAb XP—Clone D73G4 (Cell Signalling, Cat# 4903) 
 Sox2: Rabbit mAb XP—Clone D6D9 (Cell Signalling, Cat# 3579) 
Mesenchymal stem cell antibodies 
 CD90: Rabbit mAb—Clone EPR3132 (Abcam, Cat# ab92574) 
 CD105: Mouse mAb—Clone SN6h (Dako, Cat# M3527) 
 CD73: Mouse mAb—Clone 1D7 (Abcam, Cat# ab91086) 
Neural stem cell antibodies 
 Nestin: Mouse mAb IgG1(immunoglobulin G1)—Clone 10c2 (Santa Cruz, Cat# sc-
23927) 
 Dlx2: Mouse mAb IgG2a,k—Clone 2C8 (LifeSpan BioSciences, Cat# LS-B5398) 
Negative control antibodies 
 Dako negative control—Mouse mAb IgG1, Code X0931 
 Dako negative control–Rabbit IgG fraction (solid-phase absorbed), Code X0936 
Fluorescent-labelled secondary antibodies 
 Alexa Fluor 488 goat anti-mouse IgG (H+L), (Thermo Fisher, Cat# A32723) 
 Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen, Cat# A11008) 
Optimisation experiments 
Cells were grown to 50% confluence in the chamber slides and then fixed and 
stained for specific antibody IF characterisation. Having high cell numbers in the slides 
resulted in unclear cell architecture because of overlapping layers of growing cells and 
higher background staining at low magnifications. Low cell numbers, however, reduced 
the probability of finding a field of cells present. 
Experiments were performed to improve immunostaining by adjusting the antibody 
dilution, blocking methods and wash steps. IF staining protocols using Alexa Fluor488 
fluorescent antibodies were validated (Figure 11) on human adipose-derived stem cells 
(ADSCs, Merck Millipore, Cat# SCC038) and squamous cell carcinoma acetone-fixed 
slides (Oral Pathology Department, University of Otago) for the expression of the 
pluripotency intra-nuclear proteins using Oct4A, Nanog and Sox2 antibodies (Figure 12). 
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To control background staining, different blocking methods, as well as different 
concentrations of secondary antibodies and variable washing times between incubation 
steps were used. 
A blocking buffer solution of 20% heat-treated goat serum (GS) in PBS with 1% BSA 
(Sigma, BSA fraction V, A-9306-5G) and 0.3% Triton X-100 was compared with the 
blocking technique used by Cell Signalling Technologies, of PBS, 5% normal serum and 





Rabbit IgG control 
1:160 
Oct4A 1:400 
Rabbit IgG control 
1:160 
Oct4A 1:800 
Rabbit IgG control 
1:320 
Oct4A 1:800 
Rabbit IgG control 
1:320 
Blocking method A: 20% GS 
(Otago method) 
Blocking method B: 5% GS 
(Cell Signalling) 
Figure 11: ADSC slide design for Oct4A optimisation experiment with different antibody dilutions and two 
blocking techniques 
  
SCCs acetone fixed and stained for Sox2 
marker expression (green); DAPI 
counterstaining (blue) 
ADSCs acetone fixed and stained for Oct4A 
(green) marker expression; DAPI 
counterstaining (blue) 
Figure 12: SCC and ADSC cell lines were used to optimise the IF staining techniques. Pluripotency 
antibodies at a 1:400 dilution were found to be efficient for detecting the expression of the intra-nuclear 
marker protein signal while background staining remains low 
The final step in the IF method involved applying a mounting solution to improve the 
refractive index and to help in the preservation of the fluorescent signal. VECTASHIELD 
mounting medium (Vector Laboratories, Cat# H-1200) was used prior to the slide being 
cover-slipped and permanently sealed. 
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Slides of cells were incubated with the relevant isotype negative controls and 
examined to differentiate artefacts from auto-fluorescence and background labelling. 
Experiments also included GENEA002 positive controls where the antigen was known to 
be present for comparison and validation of the immunostaining technique used. The 
results are presented as high-resolution images representative of the marker expression 
pattern observed over the whole sample. 
Immunofluorescence experimental design for cultured cells 
Primary tooth pulp cells from the three stages of root resorption (P4) were plated in 
chamber slides (5x104 cells/well) and cultured in E8 medium until they reached 50–70% 
confluence. The cells were fixed with ice-cold acetone for 10 min, dried and stored. For 
the IF experiments involving nuclear markers, slides were permeabilised with 0.3% 
Triton X-100 (Sigma-Aldrich) for 45 min at RT. Following washing, blocking and 
overnight incubation with primary antibodies or the isotype matched controls listed in 
Section 2.3.6, the slides were incubated with the secondary antibodies (Santa Cruz 
Biotechnology) for 1 h. For IF analysis, nuclei were counterstained with 4',6-diamidino-
2-phenylindole (DAPI) using VECTASHIELD mounting media (Section 7.6). 
Imaging was carried out with an Eclipse Ti-U inverted microscope and superimposing 
of different wavelength photos was performed using ImageJ software (National 
Institutes of Health, Bethesda, MD, United States of America [USA]), an open source 
image processing program for multidimensional image data with a focus on scientific 
imaging (Schindelin et al., 2015). The experiments were performed for each resorption 
group in biological triplicates. 
Experiments were designed to include antibodies raised in the same species together 
(Tables 11 and 12). The rabbit antibodies (Oct4A, Nanog, Sox2 and CD90) were tested in 
one experiment, followed by the mouse antibodies (CD105, CD73, nestin and Dlx2). The 
effect of culturing the GENEA002 cells in different conditions was also examined. 
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Experimental design for Oct4A, Nanog, Sox2 and CD90 studies 
The primary antibodies raised in rabbit (Oct4A, Nanog Sox2, CD90, isotype rabbit 
IgG) were used. Secondary antibodies were Alexa Fluor 488 goat anti-rabbit. Primary 
teeth pulp cells sample included cell lines C353, B1153 and A663 (E8–VTN-N coating). 
The control cells were GENEA002in E8–VTN-N coating and GENEA002 in M2–collagen I 
coating. 
Table 11: Experimental design for primary tooth pulp cells from the three resorption groups and 
GENEA002 control in 8-well Nunc Lab-Tek II Chamber Slides  
Oct4A, E8–VTN 
C353 B1153 A663 Empty 
C353 B1153 A663 Empty 
 
Nanog, E8–VTN 
C353 B1153 A663 Empty 
C353 B1153 A663 Empty 
 
Sox2, E8–VTN  
C353 B1153 A663 Empty 
C353 B1153 A663 Empty 
 
CD90, E8–VTN 
C353 B1153 A663 Empty 
C353 B1153 A663 Empty 
 
Rabbit IgG, E8–VTN 
C353 B1153 A663 Empty 


















Rabbit IgG  
Empty Empty 
Rabbit IgG 





















Rabbit IgG Rabbit IgG 
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Experimental design for CD105, CD73, nestin and Dlx2 studies 
In this experiment, primary antibodies raised in mouse were used (CD105, CD73, 
nestin and Dlx2-isotype mouse IgG). The secondary antibody used was Alexa Fluor 488 
rabbit anti-mouse. Sample included cell lines C353, B1153 and A663 (E8–VTN-N coating) 
and their controls (GENEA002 in E8–VTN-N and GENEA002 in M2–collagen I. 
Table 12: Experimental design for primary tooth pulp cells from the three resorption groups and 
GENEA002 control in 8-well Nunc Lab-Tek II Chamber Slides  
CD105, E8–VTN 
C353 B1153 A663 Empty 
C353 B1153 A663 Empty 
 
CD73, E8–VTN 
C353 B1153 A663 Empty 
C353 B1153 A663 Empty 
 
NESTIN, E8–VTN  
C353 B1153 A663 Empty 
C353 B1153 A663 Empty 
 
Dlx2, E8–VTN 
C353 B1153 A663 Empty 
C353 B1153 A663 Empty 
 
Mouse IgG, E8–VTN 
C353 B1153 A663 Empty 







































Mouse IgG  
Empty Empty 
Mouse IgG 
Mouse IgG Mouse IgG 
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2.3.7 Flow cytometry experiments for mesenchymal stem cell markers 
The flow cytometry characterisation of primary tooth pulp cells was based on the 
phenotypic signature described by the Mesenchymal and Tissue Stem Cell Committee 
of the ISCT for human MSCs. The flow cytometry protocol is described in Section 2.3.7. 
MSC analysis was performed using a BD Stemflow hMSC Analysis Kit (Table 13) at the 
University of Otago Department of Microbiology, flow cytometry facility. 
Table 13: Components of BD Stemflow hMSC Analysis Kit (Cat# 562245) 
Vial Contents Purpose 
hMSC Positive 
Cocktail 
CD90 FITC (Clone 5E10) 
CD105 PerCP-Cy5.5 (Clone 266) 
CD73 APC (Clone AD2) 





mIgG1, κ FITC (Clone X40) 
mIgG1, κ PerCP-Cy5.5 (Clone X40) 
mIgG1, κ APC (Clone X40) 
Corresponding isotype control 
for hMSC positive cocktail 
PE hMSC Negative 
Cocktail 
CD34 PE (Clone 581) 
CD11b PE (Clone ICRF44) 
CD19 PE (Clone HIB19) 
CD45 PE (Clone HI30) 
HLA-DR PE (Clone G46-6) 
Cocktail to identify potential 
contaminants 
PE hMSC Negative 
Isotype Control 
Cocktail 
mIgG1, κ PE (Clone X40) 
mIgG2a, κ PE (Clone G155-178) 
Corresponding isotype control 
for PE hMSC negative cocktail 
FITC mouse anti-
human CD90 





CD44 PE (Clone G44-26) 
Compensation control/MSC-




CD105 PerCP-Cy5.5 (Clone 266) Compensation control 
APC mouse anti-
human CD73 
CD73 APC (Clone AD2) Compensation control 
PE mouse IgG2b, 
κ isotype control 
mIgG2b, κ (Clone 27-35) 
Corresponding isotype control 
for PE mouse anti-human CD44, 
when used as a drop in 
The ISCT position statement (Dominici et al., 2006) proposed that 95% or more of 
cells should express at least the following markers: CD105, CD73 and CD90 to be 
considered mesenchymal stem cells. It has also been recommended that there should 
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be a lack of expression of haematopoietic antigens in 2% or less of the cell population 
and this is used as an additional criterion to exclude the cells most likely to be found in 
MSC cultures. 
Flow cytometry experimental design for each cell line 
Cells were harvested by treatment with BD Accutase cell detachment solution (Cat# 
561527). Detached cells were washed with cold PBS (pH 7.3) and incubated with the 
respective mAb conjugated with either fluorescein isothiocyanate (FITC) or P-
phycoerythrin (PE). 
Two isotype controls of PE- and FITC-conjugated mouse IgGs were used for 
background non-specific binding. After washing with cold PBS, the cells were re-
suspended and the dead/live staining assay was performed. PE- or FITC-labelled cells 
were then fixed with 2% formaldehyde–PBS and analysed using BD LSR Fortessa cell 
analyser. Data were analysed with FlowJo software (Tree Star; Ashland, OR). The 
detailed flow cytometry protocol is provided in Section 7.7. 
Table 14: Flow cytometry experimental design for each cell line 
Tube A1053 B1163 C353 
1 CD90 5 µL + 100 µL of prepared cell suspension 
2 CD105 5 µL + 100 µL of prepared cell suspension 
3 CD73 5 µL + 100 µL of prepared cell suspension 
4 Cells only 
5 
hMSC Positive Isotype Control Cocktail (20 µL) 
PE hMSC Negative Isotype Control Cocktail (20 µL) 
+100 µL of prepared cell suspension 
6 
hMSC Positive Cocktail (20 µL) 
PE hMSC Negative Cocktail (20 µL) 




2.4.1 Culture characteristics of primary pulp cells 
The dental pulp retrieved from the tooth was mechanically dissected into small 
pieces to provide adequate medium exposure during the initial dental pulp outgrowth 
culture. The culture was maintained in E8 on VTN-N-coated 6-well plates. After 5 days 
of culture, migration of spindle-shaped cells from the dental pulp was evident (Figure 13 




Figure 13: Primary tooth pulp cells growing in E8–VTN-N culture. (A) cell line C353 from 24-h pulp explant 
(arrows) at P1; (B) at 48 h, pulp cells can be seen growing out from the tissue explant; (C) at day 7, cell 
line showing the start of colony formation following the first mechanical transfer with patterned colonies 
of spindle-shaped cells with long processes lining up and forming interconnecting networks 
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The same piece of dental pulp without enzymatic treatment was transferred 
sequentially to another VTN-N coated well in a 6-well plate in E8 for further expansion 
(Figure 13C). Following the two transfers without enzymatic treatment, approximately 2 
x 106 new cells in 14 days were observed to be covering the wells of a 6-well plate.  
After 2 weeks of culture, the cells were dissociated in 0.5 mM EDTA solution (Figure 
14), collected in a single-cell suspension, washed twice in PBS and seeded in VTN-N pre-
coated T25 (25 cm2) culture flasks (P2). 
 
Figure 14: C353 cells at day 15 before plating into T25 culture flasks; cells were dissociated using 0.5 
mM EDTA solution 
  
73 
Isolated primary canine pulp cells were initially small, highly proliferative populations 
with reduced cytoplasm. The morphology of primary pulp cell lines cultured in E8 
medium from each resorption group A, B and C after two weeks had a similar 
heterogeneous population of cells that tended to connect together forming colonies as 
shown in Figure 15. 
 
Figure 15: Primary pulp cells at day 10 of growing in E8 culture showing heterogeneous phenotype 
ranging from spindle-shaped elongated cells to broader stellate cells 
Despite the high density of the cells exiting the dental pulp, I observed neither 
differentiation nor slowed proliferation as could be expected for confluent cell cultures. 
However, slowed proliferation was noted during subsequent passages for group A cell 
lines, which had less root resorption than group B-cell lines with intermediate 
resorption, and group C, which had the most root resorption. 
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Established E8–VTN-N cultures showed four cell types that could be identified 
according to their morphology. Cell types identified are labelled and described in 
Figures 16–20. 
 
Figure 16: Heterogeneous morphology of cultured primary tooth pulp cells. (A) spindle-shaped polarised 
cell with long single process; (B) fusiform larger cell with multiple processes and abundant cytoplasmic 
secretory granules representing the majority of cultured cell population; (C) triangular cell with central 
nucleus; (D) large, broader and more flattened cell with very long single process and abundant 






Figure 17: Primary pulp culture with morphologically distinct sub-populations. (A) small triangular or star-
shaped cell with accentuated membrane regions; (B and F) large flat epithelioid-like cell with prominent 
nucleus; (C, D, and E) odontoblast-like spindle-shaped cell with long stretching processes. Cell body 





Figure 18: (A) Heterogeneous morphology of cultured pulp cells. Primary pulp cells at day 15 in E8–VTN-N 
culture; (B) as the cell culture becomes more confluent, cells become more fusiform and triangular with 
central nucleus and a single long process; secretory granules become more concentrated at the flat 




Figure 19: Neural-like cells with elongated and elaborated axon or dendrite-like structures were observed 
throughout cultures of primary pulp cells from all groups, which may further confirm the neural identity 
of these cells 
Cell measurement 
from both ends 
634,93 µm 
Cell measurement 








from basal pole 
end 236.99 µm 
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GENEA002 cultures 
Cultured cells showed characteristic well-defined colonies with compact cells 




Figure 21: GENEA002 grown on collagen I matrix and maintained in M2 medium. (A) 24 h post-plating; (B) 
4 days post-plating; (C) 7 days post-plating before splitting 
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2.4.2 Immunofluorescence results 
Cultured cells from extracted primary canines at the three stages of root resorption 
were cultured and immunostained. Experiments were designed to include antibodies 
originating from the same species together (Tables 11 and 12). Rabbit anti-human 
antibodies to Oct4A, Nanog, Sox2 and CD90 were tested in one experiment, followed by 
mouse anti-human antibodies to CD105, CD73, nestin and Dlx2 in a subsequent 
experiment. Results for each set of markers were as follows. 
Embryonic markers 
mAbs used in this study were produced by immunising rabbits with a synthetic 
peptide corresponding to residues near the amino terminus of human Nanog protein, 
recombinant protein corresponding to the amino terminus of human Oct4A and a 
synthetic peptide corresponding to residues surrounding Gly179 of human Sox2. To my 
knowledge, the StemLight Pluripotency Transcription Factor Antibody Kit has not been 
used before to track the pluripotent potential of human primary tooth pulp cells. 
Several optimisation experiments were performed on different cell lines employing 
different blocking and antigen retrieval (AR) techniques to achieve the best visualisation 
of the three sets of protein markers as described earlier in the optimisation 
experiments section on page 64. Immunostaining protocols are provided in Section 7.6. 
Oct4A expression 
An Oct4A rabbit mAb was used to detect Oct4A protein within primary tooth pulp 
cells. The visualisation of Oct4A expression among all groups was minimal (Figures 22–
24). The protein appeared in clusters of cells within the whole population of the 
cultured primary pulp cells in vitro. 
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Oct4A protein detection in primary tooth pulp cells 








Figure 22: Oct4A protein expression (green) in primary tooth pulp cells from group A (A663) in E8–VTN-N 
culture. Alexa Fluor 488 goat anti-rabbit IgG secondary antibody; counterstaining with DAPI nuclear stain 
(blue) 








Figure 23: Visualisation of Oct4A protein expression (green) in group B (B1163 cell line) E8–VTN-N 
culture. Alexa Fluor 488 goat anti-rabbit IgG secondary antibody; counterstaining with DAPI nuclear stain 
(blue). Oct4A protein expression was visible in the nuclei as well as within the cytoplasm of cultured cells 
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Figure 24: No noticeable expression of Oct4A by IF in E8–VTN-N cultured primary tooth pulp cells from 
group C cells (C353). A lower magnification was used to show a larger field 
The protein was minimally expressed in groups A and B whereas group C, with more 
than two-thirds of root resorption, had no visible evidence of Oct4A protein expression. 
More interestingly, the protein was not only visible intra-nuclear as expected for a 
transcription factor, but also within the cytoplasm of pulp cells as shown in Figures 22 
and 24. This raised several questions regarding the location in which the expression of 
Oct4A protein can be visualised and the possibility of obtaining false-positive results 
caused by the expression of the less known cytoplasmic Oct4B. A full discussion of these 
results is presented in Section 2.5. 
Nanog expression 
Nanog (D73G4) rabbit mAb was used to detect levels of Nanog protein present 




Nanog protein detection in primary tooth pulp cells 








Figure 25: Nanog expression in A663 cells within their nuclei (green); fewer cells showed cytoplasmic 
expression. Alexa Fluor 488 goat anti-rabbit IgG secondary antibody; DAPI counterstaining (blue) 








Figure 26: Nanog expression in B1163 cells. Positive visualisation was noticeable within the nuclei in some 
cells as well as their cytoplasm (green). Alexa Fluor 488 goat anti-rabbit IgG secondary antibody; DAPI 
counterstaining (blue) 
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Figure 27: Nanog expression in C353 cells. The protein appeared within nuclei of pulp cells and within the 
cytoplasm of a few cells (green). Alexa Fluor 488 goat anti-rabbit IgG secondary antibody; DAPI 
counterstaining (blue) 
Nanog protein visualisation among all groups was evident and did not show the same 
difference in Oct4A expression seen among the three resorption groups. The pattern of 
expression was similar to other cell lines from groups A and B. Nanog appeared within 
the nuclei as well as the cytoplasm of a small population of cells forming clusters. 
Sox2 expression 
The Sox2 (D6D9) rabbit mAb was used for ICC characterisation of primary pulp cells 
in vitro (Figures 28–30).   
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Sox2 protein detection in primary tooth pulp cells 








Figure 28: Sox2 expression in A1053 cells. The protein was detected within the nuclei of pulp cells as well 
as within the cytoplasm of cells with a triangular to elongated morphology (green). Alexa Fluor 488 goat 
anti-rabbit IgG secondary antibody and DAPI counterstaining (blue) 








Figure 29: Sox2 expression in B1163 cells. Protein expression was similar to group A cells with intra-
nuclear as well as cytoplasmic patterns 
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Figure 30: Sox2 strong cytoplasmic and nuclear staining in C353 cells (green). Alexa Fluor 488 goat anti-
rabbit IgG secondary antibody and DAPI counterstaining (blue) 
The expression of the transcription factor Sox2 protein was evident in all groups. It 
followed the same pattern as Oct4A and Nanog expression and appeared within clusters 
of nuclei of pulp cells as well as within the cytoplasm. 
Neural stem cell markers 
Anti-human nestin mouse mAb IgG1 and Dlx2 mouse mAb IgG2a,k—Clone 2C8 
antibodies were used in conjunction with fluorescent Alexa Fluor 488 goat anti-mouse 
IgG (H+L) to detect protein expression in primary pulp cells from all groups. 
Nestin in primary tooth pulp cells 
Nestin expression is used extensively as a marker for CNS stem cells in the 
developing nervous system and in in vitro cultured cells (Figure 31). Its transient 
expression is a critical step in the neural differentiation pathway. 
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Figure 31: (A) IHC localisation of nestin in decalcified section of human primary tooth sample. Nestin 
immunoreactivity (brown) is observed in the cell bodies and processes of the odontoblasts. Note that the 
other pulp cells are negative for nestin, 10X magnification. (B) Primary tooth pulp cells in culture 
expressing nestin (red). White arrow highlighting odontoblast-like cell with high nestin expression 
observed in its cell body and its process, 20X magnification 
The presentation of the intermediate filament protein nestin did not differ among 
root resorption groups. It was localised within the cytoplasm and extended into the cell 
processes (Figures 32–34). 








Figure 32: Nestin was highly expressed (red stain) in cultured primary tooth pulp cells from group A 
(A663). DAPI counterstaining (blue). The intermediate filament protein was clearly visible forming the 
cytoskeleton of spindle-shaped cells and extending into their processes 
88 








Figure 33: Nestin expression (red) in group B (B1163) following the same pattern of expression as in 
group A cells. DAPI counterstaining (blue) 








Figure 34: Nestin (red) detected in cultured primary tooth pulp cells from group C (C353). DAPI 
counterstaining (blue). Spindle-shaped cells with long extending processes showing high cytoplasmic and 
nuclear expression. 
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Dlx2 in primary tooth pulp cells 
The nuclear expression of Dlx2 proteins was evident in all groups of cultured primary 
pulp cells. However, it showed a differential pattern of expression within the cell line 
population: some cells showed protein expression while others were negative for Dlx2 
expression. IF studies on primary pulp cells to detect Dlx2 protein showed 
nucleocytoplasmic localisation in all cell lines from the three resorption groups. Positive 
cells were not grouped in a cluster pattern as previously described for ESC markers 
Oct4, Nanog and Sox2. Cells showing strong positivity to Dlx2 were dispersed among the 
pulp cells in culture (Figures 35–37). 








Figure 35: Dlx2 protein in cultured primary pulp cells from group A (A663). The protein was visible within 
the nuclei of pulp cells as well as within the cytoplasm of some cells (red). Alexa Fluor 488 goat anti-
mouse IgG secondary antibody and DAPI counterstaining (blue) 
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Figure 36: Dlx2 protein (red) in cultured primary pulp cells from group B (B1163). Nuclear and cytoplasmic 
expression is shown in cell clusters (red); DAPI counterstaining (blue) 








Figure 37: of Dlx2 protein visualisation in primary canine pulp cells from group C (C353) showing groups 
of cells with higher expression than others. Similar expression patterns were observed in group A and B 
cells 
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Mesenchymal stromal cell markers 
In subsequent experiments, the expression of the positive markers via IF studies was 
performed on cell lines from all groups. The results showed identification of CD105 
(Figures 38–40), CD73 (Figures 41–43) and CD90 proteins (Figures 44–46) with high 
positivity within cells. Expression of mesenchymal stromal markers was evident in all 
cell lines with no noticeable difference between groups. 
Further quantification of mesenchymal stromal cell proteins according to the ISCT 
minimal criteria (Dominici et al., 2006) was performed via flow cytometry. Primary pulp 
cells expressed CD105, CD73 and CD90 and lacked the expression of CD45, CD34, CD14 




CD105 (Endoglin) in primary tooth pulp cells 









Figure 38: CD105 expression in cultured primary tooth pulp cells from group A (A663). The protein was 
visible within the cytoplasm of most cells (green). Arrows in (B) are pointing at the perinuclear pattern of 
expression among different types of cells as well as cell membranes. Alexa Fluor 488 goat anti-mouse IgG 
secondary antibody and DAPI counterstaining (blue) 
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Figure 39: CD105 expression in pulp cells from group B (B1163). There was a clear visualisation of marker 
expression on cell membranes of cells (green) at both lower (A) and higher (B) magnifications. Alexa Fluor 
488 goat anti-mouse IgG secondary antibody and DAPI counterstaining (blue) 
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Figure 40: CD105 expression in group C cells (C353). (A) protein expression was visible on cell membranes 
of long spindle cells (green). Alexa Fluor 488 goat anti-mouse IgG secondary antibody and DAPI 
counterstaining (blue); (B) higher magnification showing clear cell membrane positivity 
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CD73 in primary tooth pulp cells 
CD73 protein expression in all groups (Figures 41–43). 









Figure 41: CD73 protein positive staining (green) can be seen in cultured primary pulp cells from group A 
(A663 cell line). DAPI counterstaining (blue) 
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Figure 42: CD73 protein uniform expression (green) in cultured primary pulp cells from group B (B1163 
cell line).DAPI-positive nuclei are seen in blue 
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Figure 43: CD73 protein expression (green) in cultured primary pulp cells from group C (C353 cell line). 
DAPI counterstaining (blue) 
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CD90 in primary tooth pulp cells 
The CD90 recombinant rabbit mAb was used to detect protein expression in primary 
pulp cells from all groups (Figures 44–46). 









Figure 44: CD90 protein visualisation (green) in cultured primary pulp cells from group A (A663 cell line). 
Positive cells were mostly of the flat polyhedral appearance and some spindle-shaped cells arranged in 
clusters; DAPI-positive nuclei stained blue 
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Figure 45: CD90 protein IF (green) in cultured primary pulp cells from group B (B1163 cell line) showing a 
cell-cluster expression pattern. Positive cells were of different morphology; DAPI-positive nuclei stained 
blue 
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Figure 46: CD90 protein (green) in cultured primary pulp cells from group C (C353 cell line) showing cells 
of different morphology arranged in clusters. DAPI-positive nuclei stained blue 
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Flow cytometry results 
Primary pulp cells cultured in E8 stem cell medium were detached and then stained 
with the positive and negative cocktails (red lines in the histograms below) or the 
positive and negative isotype control cocktails (blue lines). The plots were derived from 
gated events based on the light-scattering characteristics of the MSCs. Flow cytometry 
analyses (Figures 47–53) confirmed the presence of cell populations within primary 
dental pulps that fulfilled the ISCT criteria to be considered MSCs. Cells showed co-
expression of positive markers in 99.9% of the group C cell line and 99.5% of the group 
B-cell line. 
Cell line C353 
 
1.55%  of cell population (<2% 
positive) was positive for 
haematopoietic lineage markers 
CD45, CD34, CD14 or CD11b, 
CD79a or CD19 and HLA-DR in cell 
line C353 
Figure 47: Lack of expression of haematopoietic antigens in 2% or less of cell population 
 
Figure 48: C353 cell line .(A) co-expression of antigens CD73 and CD90 (99.5% positive); (B) co-expression 
of antigens CD105, CD73 and CD90 (99.9% positive)
A B 
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Cell line C353 
 
Expression of antigen CD90 in 99.5% 
of population (>95% positive) in cell 
line C353 
 
Expression of antigen CD105 in 96.2% 
of population (>95% positive) in cell 
line C353 
 
Expression of antigen CD73 in 99.6% 
of population (>95% positive) in cell 
line C353 






Cell line B1163 
 
2.45%  of haematopoietic 
lineage markers CD45, CD34, 
CD14 or CD11b, CD79a or 
CD19 and HLA-DR in cell line 
B1163 (>2% positive) 
Figure 50: Expression of haematopoietic antigens in the B1163 cell population 
 
Figure 51: B1163 cell line. (A) co-expression of antigens CD73 and CD90 (96.7% positive); (B) co-







Cell line B1163 
 
97.3% Expression of 
antigen CD90 (>95% 
positive) in cell line B1163 
 
82.5% Expression of 
antigen CD105  (<95% 
positive) in cell line B1163 
 
99.9% Expression of 
antigen CD73 (>95% 
positive) in cell line B1163 
Figure 52: B1163 cell line expression of positive markers CD105, CD73 and CD90 
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Cell line A1053 
 
Figure 53: A1053 cell line: side and forward scatter showed most cells were dead and lysed. A high side 
scatter background can be caused by cells in the sample that have been lysed and broken up. Further 
analysis was not possibleCells from A1053 were more adherent to the VTN-N coated culture 
plate and required more time to dissociate using Accutase. This may have affected the 
cells’ membrane integrity, causing cell lysis during preparation with insufficient 
numbers of viable cells after dissociation to perform further analyses (Figure 53 and 54). 
 
Figure 54: A1053 culture at day 25 (the day of FACS analyses) before Accutase treatment showing large 
size cells in culture. White bar represents 100 µm 
The planned FACS analysis experiment was conducted on one cell line from each 
root resorption group. 
106 
Immunofluorescence studies on hESCs (GENEA002) 
It had already been confirmed that GENEA002 cells expressed the pluripotency 
markers Nanog, Oct 4, Tra1-60 and SSEA4 by Genea Biocells (Table 10). However, the 
cells had not yet been tested for the presence of Sox2 protein. In this study, cultured 
hESCs were used as positive controls for Nanog, Oct 4 and Sox2 proteins (Figures 55–
57), as well as for the NSC markers nestin and Dlx2 (Figures 58 and 59) and the MSC 
markers CD90, CD73 and CD105 (Figures 60–62). Isotype negative IgG controls in 
primary tooth pulp cells and GENEA002 are presented in Figures 63–66. 
Pluripotency markers (Oct4A, Nanog, Sox2) in GENEA002 









Figure 55: Oct4 positivity. Well-defined colonies of cultured hESC GENEA002 displaying compact cells. The 
protein was visible within the nuclei and cytoplasm (green) in cell clusters rather than showing a diffuse 














Figure 56: Strong Nanog nuclear positivity (green) in colonies of GENEA002. Alexa Fluor 488 goat anti-
rabbit IgG secondary antibody and DAPI nuclear counterstaining (blue) 









Figure 57: Strong Sox2 nuclear staining (green) in GENEA002. Alexa Fluor 488 goat anti-rabbit IgG 
secondary antibody and DAPI nuclear counterstaining (blue) 
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Neural stem cell markers nestin and Dlx2 in GENEA002 
The NSC markers nestin and Dlx2 were of moderate expression within the cultured 
cell line GENEA002. Both proteins were visualised in well-defined colonies of compact 
cells displaying high nuclear to cytoplasmic ratio (Figures 58 and 59). 
Nestin, being an intermediate filament protein, was expressed in the cell cytoplasm 
faintly outlining the cell morphology. Dlx2 was differentially expressed in cell colonies as 
an intra-nuclear protein. 









Figure 58: Nestin staining (red) was detected in cultured GENEA002 colonies within the nucleus as well as 
outlining the cytoskeleton. Nuclei are counterstained with DAPI (blue). Alexa Fluor 488 goat anti-mouse 
IgG secondary antibody was used 
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Figure 59: Dlx2 protein in cultured GENEA002. The protein was visible within the nuclei (red). Nuclei are 
counterstained with DAPI (blue). Alexa Fluor 488 goat anti-mouse IgG secondary antibody was used 
Mesenchymal stromal cell markers CD90, CD73 and CD105 in GENEA002 









Figure 60: CD105 positive (green). GENEA002 colonies showed the surface marker protein within the 
cytoplasm. Nuclei were counterstained with DAPI (blue). Alexa Fluor 488 goat anti-mouse IgG secondary 
antibody was used 
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Figure 61: CD73 positive (green) GENEA002 colonies showing the surface marker protein within the 
cytoplasm and outlining the cell membrane. Nuclei are counterstained with DAPI (blue). Alexa Fluor 488 
goat anti-mouse IgG secondary antibody was used 









Figure 62: CD90 positive (green) in GENEA002 colonies showing the surface marker protein outlining the 
cell membrane. Nuclei are counterstained with DAPI (blue). Alexa Fluor 488 goat anti-mouse IgG 
secondary antibody was used 
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Isotype negative IgG controls in primary tooth pulp cells 
Rabbit IgG antibody (Dako X0936) was used as isotype control (Figure 63) for the 
expression of antibodies raised in rabbit (Oct4A, Nanog, Sox2 and CD90). Mouse IgG1 
(Dako Code X0931) was used as an isotype control (Figure 64) for the expression of 
antibodies raised in mouse (nestin, Dlx2, CD105 and CD73). 






















Figure 63: Isotype IgG control for the expression of Oct4A, Nanog, Sox2 and CD90 in primary tooth pulp 
cells from all groups 
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Figure 64: Isotype IgG control for the expression of nestin, Dlx2, CD105 and CD73 (green) in primary tooth 
pulp cells from all groups. DAPI nuclear staining (blue) 
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Isotype negative IgG control in GENEA002 
Isotype negative IgG controls in GENEA002 are presented in Figures 65 and 66. 









Figure 65: Mouse IgG1 (Dako negative control, Code X0931) was used as isotype control (red) for the 
expression of antibodies raised in mouse (nestin, Dlx2, CD105 and CD73). DAPI nuclear staining (blue) 









Figure 66: Rabbit IgG antibody (Dako X0936) was used as isotype control (green) for the expression of 
antibodies raised in rabbit (Oct4A, Nanog, Sox2 and CD90). DAPI nuclear staining (blue) 
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2.5 Discussion 
2.5.1 Overview of markers investigated in primary tooth pulp cell characterisation 
This study investigated protein expression rather than gene expression for three 
classes of markers involved in the characterisation of progenitor cells and stem cells. 
The combination of embryonic, neural and MSC markers (Figure 67) aimed to 
highlight the unique character of primary pulp cells and assess the differences in marker 
expression between groups based on their root resorption stage. Further quantification 
of MSC-positive marker expression, as well as absence of negative haemopoietic 
markers, was performed using flow cytometry analyses (Figure 68). 
A panel of protein markers that are specific to ESC physiology and fundamental to 
maintaining the undifferentiated state were selected for the current study: Oct4A 
(Scholer et al., 1989), Sox2 (Avilion et al., 2003) and Nanog (Chambers et al., 2003; 
Mitsui et al., 2003). These three key transcription regulators are highly expressed in 
pluripotent cells (Looijenga et al., 2003) and form a transcription network that 
maintains cells in a pluripotent state (Pan and Thomson, 2007; Pesce and Scholer, 
2001). 
 
Figure 67: Immunocytochemistry (ICC) experiments plan for cultured primary tooth pulp cells at three 




Figure 68: The ISCT minimal criteria for cultured cells to be considered multipotent undifferentiated 
mesenchymal cells 
The transcription factor Oct4 (POU5F1) is a main regulator of the pluripotency and 
self-renewal abilities of ESCs (Beltrami et al., 2009; Boyer et al., 2005; Nichols et al., 
1998; Saxe et al., 2009). Such stemness properties are attributed to the Oct4A isoform 
that behaves as a nuclear protein (Alt et al., 2011; Bernardi et al., 2011; Huang et al., 
2008a; Kerkis et al., 2006; Lizier et al., 2012). Oct4A and its protein-binding partners 
form auto-regulatory circuits in which Oct4A, Sox2 and Nanog constitute an auto-
feedback system that is necessary for stem cell self-renewal and maintenance of 
pluripotency (Beltrami et al., 2009; Saxe et al., 2009). 
Sox2 (Entrez Gene ID 6657) is a marker of both stem cells and uncommitted 
neuroepithelium. It is one of the crucial transcription factors in the maintenance of 
pluripotency (Avilion et al., 2003; Mitsui et al., 2003). Its nuclear expression has been 
documented in adult dental pulp cells (Karbanova et al., 2011; Liu et al., 2011; Oda et 
al., 2010), in natal teeth (Karaöz et al., 2010) and in primary teeth (Govindasamy et al., 
2010). 
Nanog is a homeobox-containing transcription factor with an essential function in 
maintaining the pluripotent cells of the ICM and in the derivation of ESCs (Mitsui et al., 
2003). Overexpression of Nanog is capable of maintaining the pluripotency and self-
renewing characteristics of ESCs under what normally would be differentiation-inducing 
culture conditions (Rodda et al., 2005). Expression of Nanog in adult and primary tooth 
dental pulp cells has been reported to fluctuate (Kaukua et al., 2015), reflecting the 
state of differentiation of cells. 
Flow cytometry analyses for 
Primary pulp cells from three 
defined root resorption groups 
cultured in E8TM/VTN-N 
95% or more of the 
cells should at least 
express markers: 
CD105, CD73 & CD90 
2% or less of cells 
should lack negative 
markers: CD34, CD11b, 
CD19, CD45, HLA-DR 
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Nestin (Entrez Gene ID 10763) is an intermediate filament protein that is expressed 
primarily and predominantly in stem cells of the CNS in the neural tube (About and 
Mitsiadis, 2001; Honda et al., 2007; Huang et al., 2008a; Karaöz et al., 2010; Lizier et al., 
2012; Nourbakhsh et al., 2011; Sonoyama et al., 2008; Yang et al., 2009). About et al. 
(2000b) have suggested a potential role for nestin in carious and traumatised teeth; 
they demonstrated the selective up-regulation of nestin in odontoblasts surrounding 
the injury site, suggesting a link between tissue repair and nestin up-regulation. 
Reactivity for nestin could be detected also in the stratum intermedium and in some of 
the apical processes of the ameloblasts. In young permanent teeth, nestin is detected 
only in functional odontoblasts, which produce the hard tissue matrix of dentine. Nestin 
expression is progressively down-regulated and is absent from older permanent teeth 
(Liu et al., 2006). Ex vivo expanded dental pulp cells have been shown to constitutively 
express nestin, an early marker of neural precursor cells (Liu et al., 2006b). 
Dlx homeoproteins (Entrez Gene ID 1746) are encoded by transcription factors 
involved in normal tooth development. All Dlx genes are expressed in the dental 
ectomesenchyme during normal development (Degistirici et al., 2008; Ghoul-Mazgar et 
al., 2005; Lezot et al., 2000; 2008). 
MSCs, surface markers CD105 (Entrez Gene ID 2022), CD73 (Entrez Gene ID 4907) 
and CD90 (Entrez Gene ID 7070) have been used in many studies for the 
characterisation of dental pulp cells and to compare the properties of stem cells from 
different tissue origins (Alongi et al., 2010; Alt et al., 2011; Yalvac et al., 2010; 
Yoshimura et al., 2006; Zhang et al., 2012) .Suchanek et al. (2010) have reported 
moderate expression of CD105 (49.1 %) and high expression of CD90 (96.5 %) and CD73 
(82.3 %) in cultured SHEDs in vitro. 
2.5.2 Primary tooth pulp cell culture 
Heterogeneity of the dental pulp cell population has been extensively reported in the 
literature as described in Section 1.5. In this study, there was no morphological 
difference between cell populations growing from the three resorption groups. The 
predominant histological appearance of cultured cells ranged from fusiform cells with a 
plump cytoplasm and large number of organelles, to unipolar spindle-shaped cells with 
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dense nuclei and a single long process. Desmosome junctions could be observed 
connecting cells, suggesting a communicating network (Figures 18–20). 
Odontoblasts in their active phase have elongated bodies showing a basal nucleus, 
basophilic cytoplasm and prominent Golgi apparatus as described by Couve and 
Schmachtenberg (2011). Cultured primary pulp cells showed polarisation with a nucleus 
positioned at one end (pole). The part of the cell that contains the nucleus is termed the 
basal pole, whereas the opposite region becomes the apical (secretory) pole (Figure 20). 
Cytoskeleton components such as microtubules, microfilaments and intermediate 
filaments accumulated at the apical pole. This morphological appearance of cultured 
primary pulp cells strongly suggests that, among other cell types, a population of active 
functional odontoblasts was growing under the same culture conditions stated earlier. 
To our knowledge, this is the first observation of odontoblasts cultured in vitro in a 
defined E8–VTN-N medium. 
2.5.3 Embryonic stem cell marker proteins in primary pulp cells 
Mouse, rat and human ESCs share a common subset of transcription factors 
specifying stemness, among which Oct4A, Sox2 and Nanog are considered the key 
factors that constitute the core pluripotency circuitry as described by Boyer et al. 
(2005). In ESCs, Oct4A orchestrates a programme of gene activity that suppresses 
differentiation and promotes self-renewal along with transcription co-regulators Nanog 
and Sox2 (Boyer et al., 2005). 
Oct4A expression in somatic stem cells has been described in a variety of somatic 
stem cell compartments and in cultured somatic progenitor cells (Govindasamy et al., 
2010; Kerkis et al., 2006; Liu et al., 2011; Nakamura et al., 2009) where it has been 
suggested to function in a manner similar to its role in ESCs (Yildirim, 2013). The 
proposition that Oct4A may be involved not only in the maintenance of pluripotency in 
ESCs but also in the self-renewal of somatic stem cells has been controversial. Lengner 
et al. (2007) found no significant expression of the Oct4A gene using IHC, quantitative 
RT-PCR or flow cytometric analysis in mice tissues, which have well-defined stem cell 
compartments and a high rate of cell turnover (intestine, bone marrow, hair follicle, 
liver and CNS). 
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Sox2 belongs to the Sox family of transcription factors that is widely distributed in 
the developing embryo, including ICM, epiblast, neural tissues and extra-embryonic 
ectoderm. Sox2 is reported to be essential for ESC self-renewal and pluripotency and 
can act synergistically with Oct3/4 in vitro to activate Oct–Sox enhancers, which 
regulate the expression of PSC-specific genes including Nanog, Oct3/4 and Sox2 itself 
(Masui et al., 2007). 
The homeodomain-containing protein Nanog functions in coordination with Oct4A 
and Sox2 to establish ESC identity. Nanog expression levels fluctuate greatly in mouse 
ESCs to contribute to population heterogeneity (Kalmar et al., 2009; MacArthur et al., 
2012) forming a gene regulatory network (GRN) with other core transcription factors as 
described by Boyer et al. (2005). 
Primary tooth pulp cells variably expressed the pluripotency markers Oct4A, Nanog 
and Sox2 (Table 15) as shown in the ICC results (Figures 24–26). Oct4A protein 
expression was low among the cultured primary pulp cell lines from groups A and B and 
was not detected in group C. 
Table 15: Relative expression of ESC marker proteins among groups 
Marker Oct4A Nanog Sox2 
Group A + ++ ++ 
Group B + ++ ++ 
Group C - ++ ++ 
GENEA002 +++ +++ +++ 
 
The levels of detection of ESC marker proteins were much lower than what was 
observed in the hESCs used as a control. ICC experiments presented in the current study 
were able to detect positive cells within the population of cultured primary pulp cells, 
particularly from groups A and B expressing these proteins. 
Oct4A protein expression in vitro was a rare event, which is expected from postnatal 
somatic cells. The protein appeared in the nuclei as well as the cytoplasm of some cells. 
There are two isoforms of human Oct4A identified in ESCs. Oct4A protein, localised to 
the nucleus of ESCs, is critical for maintaining the pluripotency of ESCs and promoting 
tumorigenesis in human tissues. The second isoform is Oct4B protein, which is localised 
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in the cytoplasm of ESCs and cannot maintain the undifferentiated state of cells. Little is 
known about the properties of Oct4B (Lee et al., 2006). Results of IF studies by Liu et al. 
(2011) suggested that Oct4 retains its nuclear location in early passages (from P0 to P2), 
then is translocated to the cytoplasm, implying the potential loss of pluripotency with 
extended passaging. Liu et al. (2011) backed up their findings by demonstrating the 
alteration of the colony-forming efficiency, cell cycle and multilineage differentiation 
capability of rat dental pulp cells in prolonged in vitro cultures (Ma et al., 2009). Primary 
tooth DPSCs cultured at P4 were used in the current study. Cells positive for Oct4A 
showed protein localisation in both their nuclei and their cytoplasm, which might be 
explained by the translocation process proposed by Lee et al. (2011). However, the 
differentiation ability of cultured primary pulp cells (Chapter 4:) disproves the theory of 
decreased differentiation ability and self-renewal as a result of increased passaging. 
Primary pulp cells exhibited a high degree of heterogeneity in their morphology as 
described earlier in the results section (2.4.1). Heterogeneity could also explain the 
variable expression of the embryonic markers studied in primary pulp cells as well as 
the hESC line GENEA002. It was reported that in cultured ESC cell lines, fluctuations in 
Oct4A, Nanog and Sox2 are related to this cell population heterogeneity and the stage 
of cell immaturity along differentiation pathways (Huang et al., 2009c; Kalmar et al., 
2009). 
Whether the observed Oct4A expression is significant for somatic stem cell 
function in vivo is a question yet to be answered. The argument that Oct4A expressed at 
low levels in somatic cells might not be crucial for self-renewal and regeneration of 
tissue in the adult remains undecided. However, the interaction between Oct4A, which 
is critical for maintaining pluripotency (Ferro et al., 2012; Masui et al., 2007; Pan et al., 
2002; Ratajczak et al., 2007; Saxe et al., 2009), Nanog’s dynamic expression in forming 
the GRN (Cavaleri and Scholer, 2003; Chambers et al., 2003; Kalmar et al., 2009; Mitsui 
et al., 2003; Pan and Thomson, 2007; Rodda et al., 2005) and a Sox2 regulatory role 
(Avilion et al., 2003; Ferri et al., 2004; Liu et al., 2011; Masui et al., 2007; Rodda et al., 
2005) may play a more significant role in deciding cell self-renewal and differentiation 
ability than would a single marker expression. 
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2.5.4 Neural stem cell marker proteins in primary pulp cells 
A small population of pluripotent cells belonging to the NCSC population may persist 
beyond the period of neural crest cell induction and migration and may be isolated from 
various adult tissues (Tomita et al., 2005; Wong et al., 2006). Coste et al. (2015) recently 
classified class VI intermediate protein nestin-positive MSCs as being NCSCs. Cultured 
cells from the dental pulp of primary teeth were no exception from this classification. 
All cell lines from the three groups of root resorption in this study showed high 
expression of nestin. 
The expression of nestin in cultured primary pulp cells from the three groups (Table 
16) was highly positive within the cell bodies, as were the long processes of polarised 
spindle-shaped cells as shown in Figures 32–34. This finding contradicted a reported 
reduced ability of SHEDs to express nestin (Ledesma-Martinez et al., 2016). Nestin is 
expressed in both epithelial and mesenchymal components of the developing rodent 
tooth and its expression progressively becomes restricted to differentiating 
odontoblasts (Terling et al., 1995). 
Table 16: Relative expression of NSC marker proteins among groups 
Marker Nestin Dlx2 
Group A +++ ++ 
Group B +++ ++ 
Group C +++ ++ 
GENEA002 ++ ++ 
 
The pattern of expression in human teeth showed species difference as nestin in the 
human tooth is restricted to the odontoblasts and pulp fibroblasts, unlike rodents 
(About et al., 2000b). In culture, nestin is up-regulated in human dental pulp cells that 
have differentiated into odontoblast-like cells and then produce mineralisation nodules 
in vitro. Hao et al. (1997) reported that their findings confirm the re-expression of 
nestin in the secretory odontoblasts and the potential of pulpal cells to differentiate 
into dentine secretory cells, which may explain the strong positivity of nestin in cultured 
pulp cells that have an odontoblastic appearance (Figure 31). 
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The odontoblast phenotype has been mainly characterised by biochemical analyses 
of the dentine matrix proteins that correspond to terminal differentiation markers 
(Priam et al., 2005). Odontoblasts secrete type I collagen and other non-collagenous 
proteins such as osteonectin, osteopontin, bone sialoprotein, dentine phosphophoryn, 
dentine sialoprotein or DMP-1. These matrix proteins are also synthesised by 
osteoblasts (Qin et al., 2002). The expression of Dlx2 homeobox proteins involved in 
early craniofacial development has been used to distinguish odontoblast precursor cells 
from other mesenchymal progenitors (Priam et al., 2005). Cultured primary pulp cells in 
this study expressed the Dlx2 protein in a clustered pattern in all cell lines. Along with 
the distinct morphology and high positivity of nestin protein expression, these findings 
not only suggest that these cells are from the odontoblastic lineage but also support the 
view that cultured nestin- and Dlx2-positive primary pulp cells have retained the overall 
features of active odontoblasts in vitro (Figures 37–39). 
It was clearly observable that most primary pulp cells cultured and tested in vitro 
have a neural cell-like morphology. Others are very similar to odontoblasts and 
significantly express both the NSC markers nestin and Dlx2. The high expression of 
nestin and Dlx2 in cultured primary tooth pulp cells under non-neuronal inductive 
conditions was a significant finding that supports the neurogenic potential of primary 
tooth pulp cells, which can be related to their neural crest cell origin. This makes them a 
valuable source of postnatal stem cells for neural differentiation and clinical 
applications. 
2.5.5 Mesenchymal stromal marker proteins in primary pulp cells 
The ISCT’s minimal criteria to define human mesenchymal stromal cells (Dominici et 
al., 2006) were applied to characterise cultured primary pulp cells from all groups. The 
ISCT criteria defined the MSC phenotype by the absence of haematopoietic markers, 
the presence of a set of mesenchymal markers and multilineage differentiation 
potential into connective tissue lineages. The ICC experiments described earlier 
involved the analysis of CD105, CD90 and CD73 surface protein expression in primary 
pulp cell cultures in vitro as discussed in Section 2.4.2 and summarised in Table 17. 
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Table 17: Relative expression of mesenchymal stromal markers among groups 
Marker CD105 CD90 CD73 
Group A +++ +++ +++ 
Group B +++ +++ +++ 
Group C +++ +++ +++ 
GENEA002 ++ ++ ++ 
 
2.5.6 Flow cytometry analysis of mesenchymal stem cell markers 
Primary tooth pulp cells cultured in E8 medium–VTN-N coating were examined by 
flow cytometry using a BD Stemflow hMSC Analysis Kit (Cat# 562245). Viable cells were 
characterised using fluorescent mAbs against specific human CD antigens. The ISCT 
position statement (Dominici et al., 2006) proposed that 95% or more of the cells 
should express at least the following markers: CD105, CD73 and CD90. It is 
recommended also that the lack of expression of haematopoietic antigens in 2% or less 
of the cell population be used as an additional criterion to exclude the cells most likely 
to be found in MSC cultures. 
Flow cytometry analyses confirmed the presence of cell populations within primary 
dental pulps that fulfil the ISCT criteria to be considered MSCs, as discussed in Section 
2.4.2. 
2.5.7 Contamination 
Contamination of cell cultures is one of the most common problems encountered in 
cell culture laboratories. Cell culture contaminants can be divided into two main 
categories: chemical contaminants; and biological contaminants such as bacteria, 
moulds, yeasts, viruses, mycoplasma and cross-contamination by other cell lines. When 
cultures become infected with microorganisms, they must usually be destroyed 
because the sources of culture contamination are ubiquitous and difficult to identify 
and eliminate. 
In the mid-1990s, reported statistics showed that 11–15% of cultures in laboratories 
in the USA were infected with mycoplasma species (Ryan, 1994). The incidence of 
mycoplasma growth in laboratory cultures was 23% in one recent study (Drexler and 
Uphoff, 2002) and in 2010, 8.45% of cultures commercially tested from 
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biopharmaceutical sources were contaminated with fungi and bacteria, including 
mycoplasma (Armstrong et al., 2010) 
Bacteria and fungi, including moulds and yeasts, are common in the environment 
and are able to quickly colonise and flourish in the rich cell culture environment. Their 
small size and fast growth rates make these microbes the most commonly encountered 
cell culture contaminants. In the absence of antibiotics, bacteria can usually be detected 
in a culture within a few days of contamination, either by microscopic observation or by 
their direct effects on the culture (pH shifts, turbidity and cell death). Yeasts generally 
cause the growth medium to become very cloudy or turbid, whereas moulds will 
produce branched mycelium, which eventually appear as furry clumps floating in the 
medium. 
This study experienced bacterial contamination of nine cell lines (Table 8), which 
were excluded and terminated. The dental pulps of deciduous teeth are potentially 
contaminated because of bacterial colonisation of the resorbed areas. Disinfection of 
the tooth with chlorohexidine gluconate was performed as a routine procedure before 
extraction. Chlorhexidine 0.12% is active against gram-positive and gram-negative 
organisms, facultative anaerobes, aerobes and yeasts. Collected teeth were further 
washed with PBS, transferred and processed in culture medium containing an 
antibiotic–antifungal agent (Anti–Anti). Despite these precautions and despite following 
aseptic conditions, nine cell lines were lost to bacterial contamination. 
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Chapter 3: Immunohistochemistry of Primary Teeth 
3.1 Introduction 
Within tissues, the unique microenvironment of the SCN regulates progenitor cell 
proliferation, survival, migration, fate and aging through specific interactions between 
the cells and multiple bioactive molecules (Zhu et al., 2013b). Niche formation begins in 
early development and continues after birth and during childhood, providing cells for 
growth and self-renewal of the organism. 
An SCN can be sporadically activated in response to diseases and different types of 
injuries to provide cells for tissue regeneration (Harokopakis-Hajishengallis, 2007; Kerkis 
and Caplan, 2012). Cultured primary tooth pulp cells showed a heterogeneous 
population of cells. The expression and subcellular location of the antigens of interest 
were assessed via IF techniques as described in Chapter 2. A minor proportion of cells 
expressed ESC proteins, which defines a pluripotent subset. Other subsets were 
identified based on having stromal and neuronal stem cell markers in higher 
proportions. In this chapter, the spatial distribution of the three sets of stem cell 
proteins in decalcified sections of primary teeth at the three defined stages of root 
resorption were explored. The aim was to identify the subsets of the SCN in situ that 
express the different classes of stem cell markers, using IHC (Figure 69). 
 
Figure 69: IHC scheme for testing stem cell markers 
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3.2 Materials and Methods 
3.2.1 Antibody list 
mAbs were used that were specific to one epitope (antigen) of a given protein, 
increasing the specificity of localisation. The following sets of primary antibodies were 
used in IHC experiments performed on decalcified sections of primary teeth. 
 StemLight Pluripotency Transcription Factor Antibody Kit (Cell Signalling, Cat# 9093) 
Oct4A: (C30A3) Rabbit mAb (Cell Signalling, Cat# 2840) 
Nanog: (D73G4) XP Rabbit mAb (Cell Signalling, Cat# 4903) 
Sox2: (D6D9) XP Rabbit mAb (Cell Signalling, Cat# 3579) 
 Mesenchymal stem cell antibodies 
CD90: Rabbit mAb—Clone EPR3132 (Abcam, Cat# ab92574) 
CD105: Mouse mAb—Clone SN6h (Dako, Cat# M3527) 
CD73: Mouse mAb—Clone 1D7 (Abcam, Cat# ab91086) 
 Neural stem cell antibodies 
Nestin: Mouse mAb IgG1—Clone 10c2 (Santa Cruz, Cat# sc-23927) 
Dlx2: Mouse mAb IgG2a,k—Clone 2C8 (LifeSpan BioSciences, Cat# LS-B5398) 
 Negative control antibodies 
Dako negative control—Mouse mAb IgG1, Code X0931 
Dako negative control—Rabbit IgG fraction (solid-phase absorbed), Code X0936 
 Biotin-labelled secondary antibodies 
Secondary antibodies used were conjugated to a biotin reporter system: 
 Goat F (ab) 2 anti-rabbit IgG H&L–biotin (Abcam, Cat# ab98429) 
 Rabbit F (ab) 2 anti-mouse IgG H&L–biotin (Abcam, Cat# ab5761). 
3.3 Immunohistochemistry procedures 
Indirect IHC as used in the present study employs highly specific primary and biotin-
conjugated secondary antibodies. The primary antibodies are utilised to identify 
proteins of interest by binding to a specific antigen, while secondary antibodies amplify 
the desired signal by forming complexes with the primary antibody. 
IHC was conducted on paraffin-embedded sections by dewaxing, hydration using an 
alcohol gradient, heat-induced AR and blocking of endogenous peroxidase activity and 
non-specific binding sites (Section 7.8.6). 
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Decalcified teeth were dehydrated before adding molten paraffin wax. Dehydration 
is achieved by immersion in increasing concentrations of alcohol, allowing a gradual 
change in hydrophobicity to minimise cell damage. 
Following dehydration, the sample is incubated with xylene to clear any remaining 
ethanol. Paraffin is heated to 60˚C for embedding and is then allowed to harden 
overnight. The tissue is subsequently cut into ultra-thin slices using a microtome. 
Longitudinal sections in the sagittal plane of primary canines are then dried onto 
microscope slides and stored at RT to be used in IHC assays. 
Sections are then stained with specific primary antibodies, treated with appropriate 
secondary antibodies conjugated to biotin and then developed utilising avidin-
conjugated horseradish peroxidase with 3,3'-diaminobenzidine tetrahydrochloride 
(DAB) as the substrate. Following development, the slides are counterstained with 
haematoxylin for contrast, and mounted under coverslips with mounting medium. After 
adequate drying, the slides are ready for imaging. 
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The experimental variables listed in Table 18 were addressed and the methods 
adjusted to achieve the best quality images (Section 3.5.1). 
Table 18: Variables addressed in the IHC experimental design 
Variable Outcome 
Antigens of interest The localisation of antigens—either nuclear, cytoplasmic or surface 
proteins—dictated the AR or permealisation method to be used. 
Controls Decalcified primary tooth sections without primary antibody and with 
isotype control were used as negative controls. Tissue type positive 
controls including human prostate, kidney, tonsils, bone marrow and 
brain were also used to validate IHC staining techniques. 
Sample preparation Primary canine teeth, classified into three groups based on the stage of 
root resorption were decalcified, paraffin embedded and cut into 5-µm 
longitudinal sections. 
Fixation method Immersion technique with gentle agitation at 4oC. 
Fixative Formaldehyde (10% neutral-buffered formalin). 
Blocking reagent BSA and non-fat milk powder 
Antigen retrieval Heat-induced AR in 95oC water bath. 
Detection method Indirect detection with amplification was used. The signal was amplified 
using the indirect method where at least two labelled secondary 
antibodies were allowed to bind sequentially. Further amplification of 
the signal was achieved by taking advantage of the strong affinity of 
avidin to bind biotin. VECTASTAIN Elite ABC resulted in significant signal 
amplification. 
Primary antibodies Rabbit mAbs: Oct4A–Nanog–Sox2–CD90 
Mouse mAbs: Nestin–Dlx2–CD105–CD73  
Secondary antibodies Biotin-conjugated antibodies raised in goat (anti-rabbit IgG H&L) for 
binding with Oct4A, Nanog, Sox2 and CD90. 
Biotin-conjugated antibodies raised in rabbit (anti-mouse IgG H&L) for 
binding with nestin, Dlx2, CD73 and CD105. 
Labelling method Chromogenic. 
Label Chromogens: DAB, 3-amino-9-ethylcarbazole (AEC). 
Counterstain Haematoxylin. 






3.4 Immunohistochemistry results 
3.4.1 Negative and tissue type controls 
Appropriate controls are critical for the accurate interpretation of IHC results. A 
satisfactory experimental design produces results that demonstrate that the antigen is 
localised to the correct cell types or subcellular location. Optimisation of fixation, 
blocking, antibody incubation and AR steps will generate a strong and specific signal, as 
discussed later in this chapter. 
With regard to validation of the IHC staining protocols, studies were performed on 
positive control slides from human prostate, kidney and tonsils. These tissues were 
known to express the epitopes of interest. This strategy provided a useful reference for 
optimal heat AR and antibody concentration, which was then utilised for later IHC 
experiments on primary tooth pulp tissue. 
Initial IHC optimisation experiments for nestin, Dlx2 and CD90 antibodies on heat-
treated formalin-fixed tissue from normal prostate (Figure 70), kidney (Figure 71) and 
tonsils (Figure 72) provided a validation of the mouse and rabbit antibody staining 
technique. 
In the next sections, tissue control results are presented first, followed by primary 
tooth H&E-stained sections and the negative isotype controls for anti-mouse and anti-




3.4.2 Tissue type controls 
Studies were performed on positive control slides from human prostate, kidney and 
tonsils. Description is presented in Figures 70-72 as follows. 
 
 
Figure 70: Prostate tissue sample. (A) IgG control slide stained with mouse IgG1; (B) Dlx2 mouse mAb 
showing its expression in normal prostate tissue (brown). Rabbit F (ab) 2 anti-mouse IgG H&L (biotin) was 




Figure 71: Kidney tissue sample. (A) IgG control slide stained with mouse IgG1; (B) nestin mouse mAb 
showing its expression in normal kidney tissue (brown). Rabbit F (ab) 2 anti-mouse IgG H&L (biotin) was 





Figure 72: Tonsil tissue sample. (A) IgG control slide stained with rabbit IgG; (B) CD90 rabbit mAb showing 
its expression in tonsil (brown). Goat F (ab) 2 anti-rabbit IgG H&L (biotin) was used as secondary antibody 
with DAB 
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3.4.3 Haematoxylin and eosin-stained sections 
The peripheral aspect of dental pulp in a non-resorbing tooth (Figure 73) shows the 
odontogenic zone containing a layer of dentine-forming odontoblasts. Immediately 
subjacent to the odontoblast layer is the cell-free zone of Weil, which contains 
numerous bundles of reticular Korff's fibres passing from the central pulp region across 
the cell-free zone and between the odontoblasts; their distal ends incorporated into the 
matrix of the dentine layer. Just under the cell-free zone is the cell-rich zone containing 
numerous fibroblasts and perivascular cells. Numerous capillaries and nerves are found 
in this zone.  
 
Figure 73: The pulp cavity exhibits four zones progressing from the dentine–pulp junction towards the 
centre of the pulp cavity: the odontoblast zone, cell-free zone (basal layer of Weil), cell-rich zone and pulp 
core. The dental pulp includes a mosaic of territories, varying in the crown and the root, and in the 
central part versus the peripheral pulp 
The architecture of the pulp zones for samples from the three resorption groups are 
presented in figures 74-76.   
Dentine 
Odontoblast zone 
Cell free zone 







Figure 74: H&E-stained sections from group A representing the incisal (A), middle (B) and apical (C) parts 




Figure 75: H&E-stained sections from group B representing the incisal (A) and middle (B) parts of tooth 




Figure 76: H&E-stained sections from group C representing the incisal (A) and middle (B) parts of tooth 
C753 
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In the dental pulp, a series of characteristic cells are present. The pulp stromal 
fibroblasts (Figure 77 and 78) constitute the most abundant pulp cell population in 
addition to other cell lineages such as odontoblasts, stem cells, neuronal, vascular and 
immune system cells. Most of the pulp cells are resident cells that play a structural role 
in the pulp. Odontoblasts originally for a structured layer made up of around four rows 
of cells. During tooth maturation and aging, the number of odontoblasts gradually 
decreases; because of apoptotic events, cells become smaller, and eventually are 
reduced to a single layer (Couve and Schmachtenberg, 2011). 
 
Figure 77: Fusiform elongated pulp fibroblasts with narrow diameter and long protracted processes. 
Conversely, odontoblasts are formed of a cell body and a cell process. Cell bodies are grouped in four to 
five rows parallel to the tooth surface at the periphery of the pulp. Each cell body comprises a basal third 
containing the nucleus and cell organelles 
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Figure 78: Higher magnification of H&E-stained section from group A at the apical end of tooth A1363 
showing multinucleate giant cells at the pulp–dentine border. The four distinct zones of dental pulp 
become obscure; instead, the pulp core is populated with fusiform, stellate and round cells representing 
the heterogeneous characteristic of primary tooth pulps  
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3.4.4 Immunohistochemistry negative controls 
In this section, decalcified primary tooth sections stained for anti-mouse and anti-
rabbit antibodies as negative isotype controls (Figure 79).  
 
 
Figure 79: Negative controls. (A] decalcified section in A853 of group A stained with mouse IgG1 Dako 
negative control (Code X0931) and rabbit F (ab) 2 anti-mouse IgG H&L–biotin (Abcam ab5761); (B] 
decalcified section in C383 of group C stained with Rabbit IgG (Dako X0936) and Goat F (ab) 2 anti-rabbit 
IgG H&L–biotin (Abcam–ab98429). DAB was used as substrate for the negative control slides 
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3.4.5 Nestin neural stem cell marker in primary tooth sections 
Nestin mAb detection in the three resorption groups of primary teeth decalcified 
sections. Rabbit F (ab) 2 anti-mouse IgG H&L (biotin) was used as secondary antibody 


































Figure 80: Nestin mAb detection in all groups of primary teeth (brown). Nestin expression was clearly 
visible in the odontoblastic layer and extending into dentinal tubules in all groups 
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3.4.6 Dlx2 neural stem cell marker in primary tooth sections 
Dlx2 mAb detection in the three resorption groups of primary teeth decalcified 
sections. Rabbit F (ab) 2 anti-mouse IgG H&L (biotin) was used as secondary antibody 

































Figure 81: Dlx2 mAb detection in all groups (brown). Dlx2 expression was strong in the odontoblastic layer 
extending into dentinal tubules with less visible expression in the pulp core cells 
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3.4.7 CD73 stromal marker in primary tooth sections 
CD73 mAb detection in the three resorption groups of primary teeth decalcified 
sections. Rabbit F (ab) 2 anti-mouse IgG H&L (biotin) was used as secondary antibody 


































Figure 82: CD73 mAb detection in all groups (brown). CD73 expression was strong in the odontoblastic 
layer in groups A and B with less visible expression in the pulp core cells. As the odontoblastic layer 
became less distinct, CD73 detection appeared dispersed involving the entire pulp as in group C 
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3.4.8 CD105 stromal cell marker in primary tooth sections 
CD105 mAb detection in the three resorption groups of primary teeth decalcified 
sections. Rabbit F (ab) 2 anti-mouse IgG H&L (biotin) was used as secondary antibody 





































Figure 83: CD105 mAb detection in all groups (brown). CD105 expression was visible in some cells of the 
odontoblastic layer, cell-rich zone and in the pulp core cells 
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3.4.9 CD90 stromal marker in primary tooth sections 
CD90 mAb detection in the three resorption groups of primary teeth decalcified 
sections. Goat F (ab) 2 anti-rabbit IgG H&L (biotin) was used as secondary antibody with 


































Figure 84: CD90 rabbit mAb detection in all groups of primary teeth (brown). CD90 expression was not 
limited to a specific cell layer. Darker brown staining was observed in the odontoblastic layer of group A 
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3.4.10 Oct4A embryonic stem cell marker in primary tooth sections 
Oct4A rabbit mAb detection at a higher magnifications (Figure 85) and in the three 
resorption groups of primary teeth decalcified sections (Figure 86). Goat F (ab) 2 anti-
rabbit IgG H&L (biotin) was used as secondary antibody with DAB. 
 
Figure 85: A closer view of the cellular expression of Oct4A in a group A sample. Darker 




































Figure 86: Oct4A rabbit mAb detection in all groups of primary teeth (brown). Oct4A expression was not 




3.4.11 Nanog embryonic stem cell marker in primary tooth sections 
Nanog rabbit mAb visualisation at higher magnifications (Figure 87) within the 
odontoblastic zone and sub-odontoblastic cells, suggesting marked expression of Nanog 
in primary tooth pulp cells (Figure 88). This agrees with the results reported by 
Karbanova et al., 2011 for DPSCs from impacted third molars.  Nanog detection in the 
three resorption groups of primary teeth sample (Figure 88) is presented on the 
following page. Goat F (ab) 2 anti-rabbit IgG H&L (biotin) was used as secondary 
antibody with DAB. 
 
Figure 87: Expression of Nanog in group B pulp sample. Note the marked reduction in odontoblastic cell 
































Figure 88: Nanog rabbit mAb detection in all groups (brown). Nanog expression as darker brown staining 
was observed in association with some cells in the odontoblastic layer, the cell-rich zone and the pulp 
core 
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3.4.12 Sox2 stem cell marker in primary tooth sections 
Sox2 rabbit mAb detection is shown at higher magnifications (Figure 89) and in the 
three resorption groups of primary teeth decalcified sections (Figure 90). Goat F (ab) 2 
anti-rabbit IgG H&L (biotin) was used as secondary antibody with DAB. 
 
Figure 89: A closer view of Sox2 expression in a group B sample. Cells appeared migrating from the 



































Figure 90: Sox2 rabbit mAb expression in all groups of primary teeth (brown). Sox2 staining was observed 
in small round odontoblasts as well as the stellate and fusiform cells of the cell-rich zone and pulp core 
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3.5 Discussion 
3.5.1 Experimental design and variables 
The IHC experimental variables are discussed in the following section. Protocols for 
performed experiments are presented in Section 7.8. 
Antigens of interest 
Knowledge of the exact localisation of a certain protein (antigen) in tissue is critical 
for interpreting not only the accuracy of IHC staining results but also the reliability of AR 
treatment (Hawes et al., 2000; Shi et al., 2000). For this purpose, testing of living cell 
lines from primary tooth pulps was performed to localise the markers of interest at a 
subcellular level (Section 2.4). In this chapter, formalin-fixed, paraffin-embedded 
primary teeth from each of the three root resorption stages were studied for in situ 
immuno-localisation of the stem cell proteins of interest. In addition, control groups 
were assessed to rule out any false-positive results. 
Primary tooth sample preparation 
For IHC, the sample consisted of teeth with less than one-third of root resorption 
(group A, n = 6); teeth with one- to two-thirds of root resorption (group B, n = 5); and 
teeth with more than two-thirds of root resorption (group C, n = 4). 
Extracted teeth were cleaned with sterile PBS to remove clotted blood. Attached 
gingivae and periodontal tissues were then scraped off using a sterile scalpel blade or 
periodontal scaler. Teeth were fixed immediately in 100 mL cold 10% neutral-buffered 
formalin (4°C). Samples were measured and classified into three groups based on the 
stage of root resorption as described in Section 2.42 and demineralised in cold EDTA for 
39 days. Protocols are presented in Section 7.8. 
Fixation and decalcification 
Pre-fixation time 
The pre-fixation time refers to the time between the surgical excision of the 
specimen and application of fixative (Godfrey et al., 2000). Significant biochemical 
alterations occur in tissues within 10 min after anoxia (Labat-Moleur et al., 1998). The 
pre-fixation time in this study was less than 5 min as the extracted tooth was directly 
transferred into 10% formalin solution. 
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Formalin fixation 
Fixation is a crucial step in the processing of tissue specimen for IHC studies. It helps 
to preserve cellular architecture during processing and preserves the tissue and cell 
proteins, carbohydrate and other bioactive components in their spatial relationships in 
the cell (Chi and George, 2007). The mechanisms by which fixatives act may be broadly 
categorised into dehydrating agents, heating effects, cross-linking agents and acids or 
combinations of these. 
Formaldehyde as a 10% neutral-buffered formalin is the most widely used universal 
fixative because it preserves a wide range of tissues. The routinely used 10% formalin, 
which is 3.7% formaldehyde in water and 1% methanol instigates its action with an 
initial alcohol fixation phase, followed by a cross-linking phase mediated by its aldehyde 
content (Fox et al., 1985). 
Multiple studies have suggested that tissues fixed in formalin at 4°C exhibit low 
amount of degradation of their nucleic acids (Noguchi et al., 1997; Tokuda et al., 1990; 
Yagi et al., 1996). It was found that formaldehyde fixation at acidic pH causes 
degradation of tissue nucleic acids, unlike neutral-buffered formalin. With regard to the 
duration of fixation, tissues are routinely fixed for 24–48 h; a longer fixation time 
adversely affects the quality of tissue obtained for IHC (Srinivasan et al., 2002). 
EDTA 
Neutral EDTA is a slow-acting decalcifying agent that gives excellent preservation of 
soft tissue integrity and the best viewing quality of both soft tissue and hard tissue 
staining (Sanjai et al., 2012). Its action can be attributed to the mechanism of capturing 
metallic ions such as calcium, which bind to this chelating agent. EDTA acts by removing 
calcium ions from the outer layer of apatite crystals. When they are all removed from 
the outer layer, they are replaced by ions from the deeper layers where EDTA continues 
its action. In this way, the crystal size decreases gradually, producing excellent 
preservation of tissue components (Sanjai et al., 2012). 
Antigen retrieval 
AR is predominantly defined as a high-temperature heating method to recover the 
antigenicity of tissue sections that has been masked by formalin fixation. The term is 
also applied to non-heating methods including the enzymatic method (Shi et al., 2001b). 
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Figure 91 : (A) Antigen partially obscured as a result of formalin fixation; (B) AR exposes the antigen to 
primary antibodies and allows optimisation of the signal 
The epitope (antigen) in (Figure 91) is part of a 3D cross-linked protein complex and 
is partially obscured. Such epitopes usually need AR to optimise the signal and allow 
attachment of the primary antibody. The secondary antibody is usually conjugated to a 
chemical that will serve as the reporter system. The biotin system was used in this 
study, as discussed in the following paragraphs. 
There are currently two major AR procedures based on treatment of de-paraffinised 
tissue sections with heat or, less commonly, with enzymatic digestion. A possible 
mechanism of the action of the AR technique is the loosening or breaking of the cross-
linkages (hydrolysis) induced by formalin fixation (Shi et al. 2000), restoring the 
condition of a formalin-modified protein structure back towards its re-naturation 
through a series of changes driven by thermal energy from the heat source (Shi et al. 
2000). In the present study, AR was performed by heating the slides in 0.01 M citric acid 
buffer (pH 6.0) for 45 min. 
Optimising antibody dilution 
A key variable in IHC, both for signal strength and background, is the concentration 
of antibodies. Several experiments were performed to improve staining by adjusting the 
antibody dilution and comparing the intensity of the staining signal as well as 
background. Immunostaining protocols using biotin-conjugated antibodies were also 
validated on human prostate and kidney tissues for the expression of the markers of 
interest. Additional negative controls from each group of primary teeth were utilised. 
The sample was incubated with a non-immune immunoglobulin of the same isotype 
(e.g., IgG1) and concentration as the primary mAb. These steps were performed to 
ensure that what appears to be specific staining was not caused by non-specific 






















Biotin conjugation and blocking of endogenous avidin-binding activity 
The first key feature of the secondary antibody is that it must recognise any antibody 
from the animal that was used to make the primary antibody. The second is that it is 
conjugated to a molecule (biotin), which will allow detection of the antigen–primary 
antibody–secondary antibody complex. 
Anti-rabbit biotin-conjugated antibodies raised in goat were used for binding with 
rabbit Oct4A, Nanog, Sox2 and CD90 and anti-mouse biotin-conjugated antibodies 
raised in rabbit (IgG) were used for binding with mouse nestin, Dlx2, CD73 and CD105. 
Avidin is a glycoprotein with high affinity for biotin. If a biotinylated secondary 
antibody is employed, the signal can be significantly amplified by subsequent incubation 
with an avidin–biotin complex (ABC method) (Miller et al., 1999). 
Endogenous avidin-binding activity (EABA) has been shown to be a cause of 
unwanted false-positive staining in IHC procedures that employ an ABC method, as 
tissues may have inherent biological properties resulting in background staining that 
could lead to misinterpretation of results (Matsumoto, 1985). In addition, EABA may be 
markedly enhanced by heat-induced AR procedures (Rodriguez-Soto et al., 1997). To 
prevent EABA, with its risk of misinterpretation, it is necessary to block EABA. A variety 
of blocking agents have been used in IHC, including 5–10% FBS, which was used in this 
study. Other blocking agents such as BSA fraction V, gelatine or serum from the same 
species as the secondary antibody can also be used (Miller et al., 1999). 
Blocking endogenous peroxidase activity 
Endogenous peroxidase activity (EPA) is another factor that may affect staining 
results in addition to non-specific antigen blocking procedures, AR, primary antibody 
selection, secondary antibody, fixing solution and antigen location as discussed earlier. 
EPA blocking is a critical step for successful immunostaining when using the 
chromogen DAB in tissues that have inherent peroxidase activity. H2O2 incubation is a 
key step in the IHC protocol using DAB–peroxidase. Endogenous peroxidase is quenched 
by placing the slides in 0.3% H2O2–methanol solution for 10 min and rinsing twice in 
PBS. It is recommended that the H2O2 solution should be prepared immediately before 
use. Studies have used 0.3% and 3% H2O2 for this purpose with no difference in the 
images produced (Gao et al., 2008). 
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Counterstaining 
Haematoxylin was used as a counterstain in all IHC experiments performed. Brief 
dips (a few seconds) were performed to enable visualisation of the tissue morphology 
and the nuclei, without having the counterstaining masking the colour of the IHC 
reaction. 
Data interpretation 
Dental pulp morphology and integrity were evaluated on H&E-stained tooth sections 
from the three root resorption stages (Figures 74–76). Sections were prepared 
according to standard histochemical protocols. 
Sections were examined using a light microscope (Nikon C1 plus; Nikon, Tokyo, 
Japan). ImageJ was used for image processing and adjusting size, brightness and 
contrast. 
3.5.2 Resident and non-resident pulp cells 
A small number of stem cells, or pulp progenitors, are among the heterogeneous 
group of pulp residents. The stem cell population in permanent teeth was reported to 
be around 9% of resident cells (Goldberg, 2014) compared with 0.11–0.40% in young 
rat’s teeth (Kenmotsu et al., 2010). The non-resident population of cells found in the 
dental pulp migrate from the blood originating from the bone marrow to the dental 
pulp through the apical foramen. 
There is much evidence that resident and non-resident cells have a limited life span. 
To maintain a continuous volume and the diverse functions of the tissue, constant 
renewal of pulp cells is required (Goldberg and Smith, 2004). 
3.5.3 In situ stem cell marker expression in primary tooth pulp cells 
In vitro ICC experiments (Chapter 2) provided an insight into the subcellular protein 
expression of stem cell markers in cultured primary tooth pulp cells. This chapter 
examined the topographical expression of these markers. 
Nestin 
Nestin is one of the proteins that forms the type VI intermediate filaments involved 
in cell structure, and is used as a marker for stem cells or progenitors of nervous tissue 
(Lendahl et al., 1990; Wiese et al., 2004). 
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Nestin is expressed in differentiating odontoblasts during normal tooth 
development. Therefore, nestin can be used as a marker for odontoblasts that are 
functioning (Terling et al., 1995). The localisation of nestin within the 
odontoblastic/sub-odontoblastic layer with clear visualisation within the dentinal 
tubules is shown in Figure 80. Data from the current study suggests that nestin 
expression in odontoblasts is not down-regulated as resorption progresses. 
Odontoblasts initially form a structured layer of three to four rows of cells. During tooth 
resorption and aging, the number of odontoblasts gradually decreases and cells become 
smaller and eventually are reduced to a single layer, confirming the findings of Couve 
and Schmachtenberg (2011). In addition, the data suggest the odontoblasts observed in 
this study were highly active with strong nestin expression. 
Dlx2 
Dlx2 protein is described as one of the dentinogenesis nuclear transcription factors 
(Peng et al., 2010); its expression was evident in all the resorption groups of primary 
tooth sample (Figure 81). Dlx2 expression was localised within the odontoblastic and 
sub-odontoblastic cell zones as well as within the dentinal tubules. In addition, it was 
detected in pericytes within the dental pulp core supporting the presence of SCN 
associated with the vasculature throughout the body in the form of pericytes (Birbrair 
et al., 2015). Pericytes display remarkable similarities with MSCs in terms of their 
marker expression, their ability to self-renew and their potential to differentiate into 
multiple mesenchymal cell types. Because of the heterogeneity of pulp cells and 
pericytes, it is difficult to determine conclusively whether these cells represent 
counterparts of the same cell population. Pericytes fulfil the criteria required to define 
an MSC and show great differentiation potential and stem cell-like qualities within 
tissues (Diaz-Flores et al., 2009). 
The differentiation between these two cell types in in vitro cultures can be a 
challenging task. A FACS gating strategy to identify human pericytes based on the 
negative expression of haematopoietic and endothelial cell markers (CD45 and 
CD31/CD34, respectively) and positive expression of CD146 was proposed by Crisan et 
al. (2008). A similar strategy was applied in Section 2.3.7 to identify cells of 
haemopoietic origin from primary tooth pulp cells. 
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Pericytes’ contribution to angiogenesis in early development and tissue regeneration 
is indispensable (Crisan et al., 2011), making their isolation from the SCN within the 
dental pulp questionable if angiogenesis and pulp regeneration is to be achieved. 
CD73, CD105 and CD90 
In Chapter 2, IF studies demonstrated strong expression of mesenchymal stromal 
stem cell markers CD73, CD105 and CD90 within cultured primary tooth pulp cells, 
confirming the results of other researchers in both primary and permanent tooth 
cultures (Agha-Hosseini et al., 2010; Alongi et al., 2010; Huang et al., 2009a; 2009c; 
Karaöz et al., 2010; Pivoriuunas et al., 2010). 
CD73 positivity was strongly detected in the odontoblast layer in groups A and B with 
minimal or no expression in pulp core cells. When the demarcation between pulp cell 
layers became less clear as resorption progressed, CD73+ cells were shown to be 
dispersed within the pulp tissue (Figure 82). 
Primary tooth pulp cells had a weak immune reactivity to CD105 antigen, which was 
observed in the odontoblastic zone and less noticeably throughout the pulp tissue 
(Figure 83). Subsets of cells within the odontoblastic layer showed more reactivity than 
cells in other layers. CD90 protein was detected in the odontoblastic and sub-
odontoblastic cell layer, confirming the findings of Hosoya et al. (2012) in permanent 
tooth pulps. In this context, the sub-odontoblastic cells may be involved in the process 
of odontoblast cell replacement. When their terminal differentiation is activated, they 
become second-generation odontoblasts (Hosoya et al., 2012). This hypothesis was 
reinforced by the fact that the majority of sub-odontoblastic cells expressed CD90 
(Figure 84). 
Oct4A, Nanog and Sox2 
Subcellular localisation of transcription factors is an important regulatory mechanism 
as demonstrated by IF experiments in Section 2.4.2. Many transcription factors localise 
to the cytoplasm in their basal, unstimulated state, needing to be activated and 
imported into the nucleus to initiate the expression of their target genes. Others, such 
as Oct4A in stem cells, are located mainly in the nucleus where they initiate the 
expression of their target genes (Ferro et al., 2012). However, Oct4A is exported from 
the nucleus for recycling and/or regulation (Ferro et al., 2012). 
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IHC staining confirmed that most cells of the odontoblastic layer were positive for 
Oct4A (Figure 86 and 86); this was also true for the dental pulp core cells but to a lesser 
extent. Oct4 protein expression was observed in sections from all resorption groups. 
The significance of Oct4 expression in only part of the odontoblastic layer cells is 
unclear. In this study it was found that Oct4A protein is expressed in cultured primary 
tooth pulp cells (Chapter 2), which agrees with other studies showing its expression in 
several adult stem cells including DPSCs (Ferro et al., 2012; Huang et al., 2014), as well 
as in several human and rat tumour cells, but not in normal differentiated daughters of 
these stem cells (Tai et al., 2005). 
A similar finding was observed in vitro: when differentiated DPSCs were compared 
with undifferentiated cells, they expressed significantly reduced levels of Oct4A and 
Nanog (Ferro et al., 2012), indicating that both Oct4A and Nanog are down-regulated to 
around 50% during DPSC terminal differentiation. The lack of Oct4A expression in some 
cells in culture (Chapter 2) and in situ could be explained by the fact that the dental pulp 
consists of mostly terminally differentiated cells, which would not be expected to 
exhibit Oct4A. Conversely, few progenitor cells that express Oct4A are also present 
within the dental pulp. Unless one is looking for these few stem cells, one might 
conclude that pulp tissue has no cells expressing Oct4A. Tai et al. (2005) screened 30 
normal human skin tissue samples for Oct4A protein expression and found that only a 
few Oct4A+ cells were observed. They were located in and near the basal layer of the 
skin epidermis. As the cells differentiated away from the basal layer, no Oct4A 
expression was observed. This may also be occurring in dental pulp cells along the pulp–
dentine border. 
Nanog is involved in a complicated stemness regulatory network in cooperation with 
other key transcription factors such as Oct4A and Sox2 (Huang et al., 2014; Kuroda et 
al., 2005). In DPSCs, the functional roles and co-expression of these factors are found to 
increase proliferation rates and promote osteogenic/chondrogenic/adipogenic 
differentiation, whereas down-regulation of Oct4A/Nanog reduces stemness properties 
(Huang et al., 2014). 
Nanog overexpression plays a key role in cell growth and apoptosis (Chambers et al., 
2003). It affects stem cell self-renewal by bypassing the signal transducer and activator 
of transcription 3 (LIF-STAT3) pathways, thus enhancing clonal expansion. 
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The observed reduction in the odontoblastic zone cells of the resorbing primary 
teeth sample (Figures 87 and 88), along with Nanog marker detection within these cells, 
highlighted its possible role in cell cycle regulation within the dental pulp. Nanog may 
play a key role in allowing pulp cells to differentiate, thus providing a renewal pool of 
odontoblasts. Oct4A expression, however, does not have the same effect. Studies have 
indicated that Oct4A expression below 50% of the wild-type level is compatible with ESC 
self-renewal and cells with reduced Oct4A expression have a robust self-renewal 
capacity (Karwacki-Neisius et al., 2013). 
The complicated stemness regulatory network involves other key transcription 
factors, such as Sox2, which balances the pluripotency and differentiation tendency in 
stem cells (Kuroda et al., 2005). Sox2 has been shown to interact physically and bind 
with Oct4A synergistically activating target gene expression (Remenyi et al., 2003), 
which makes the expression pattern of both markers temporally similar (Hatano et al., 
2005). Apart from its partnership with Oct4A; Sox2 interacts with a large number of 
proteins including Nanog (Wong et al., 2016). The requirement for Sox2 for maintaining 
ESCs is clear. However, the detailed mechanisms by which Sox2 functions in cells are 
less clear (Wong et al., 2016). Data on Sox2 expression in pulp tissue (Figures 89 and 90) 
are scarce. In vitro data indicate that Sox2+ cells have the potential to improve cell 
proliferation through regulating the cell cycle in DPSCs, whereas overexpression may 
enhance the migration and adhesion capacity of DPSCs (Liu et al., 2015). 
An example of the role of Sox2 in cell migration is found in multipotent precursor 
cells, a population of dermal cells that can be isolated from embryonic and adult 
mammalian skin. These precursor cells exhibit long-term self-renewal in vitro and are 
capable of generating cells that express markers associated with immature neurons, 
dermal fibroblasts, peripheral glial cells, smooth muscle cells and adipocytes (Toma et 
al., 2001). The origin of these cells can be traced to Sox2+ mesenchymal cells found in 
the dermal papilla and dermal sheath within developing and adult hair follicles 
(Biernaskie et al., 2009). Interestingly, dermal papilla cells express genes associated with 
NCSCs, including nestin, suggesting either a neural crest origin or recapitulation of a 
neural crest-like expression profile within this specific follicular niche (Agabalyan et al., 
2016). Evidence of a role for Sox2 in maintaining an undifferentiated dermal stem cell 
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state and as an active participant in proliferation, differentiation and migration might be 
hypothetically applied to its potential role in the dental pulp. 
The topographical expression of NSC markers (Dlx2 and nestin), ESC markers (Oct4A, 
Nanog and Sox2) and mesenchymal stromal markers (CD73, CD105 and CD90) within 
the odontoblastic layer and in the sub-odontoblastic zone observed in this study 
indicates that dental pulp cells in primary teeth undergo continuous cell turnover due to 
apoptosis. This cell turnover becomes more rapid as root resorption progresses. The 
maintenance of a cellular pool within the dental pulp is achieved by a small group of 
slowly replicating cells with the capacity for both self-renewal and generation of the 
required differentiated progeny. This concept agrees with a mathematical model 
described by Morrison et al. (1997). This model shows that not only is symmetric stem 
cell division regulated by differentiated cells, but changes in the population dynamics of 
the differentiated cells can also lead to changes in the population dynamics of the stem 
cells. More precisely, the relative fitness of stem cells can be affected by modifying the 
death rate of differentiated cells. 
The IHC results reported in this chapter showed strong positive expression of NSC 
proteins within odontoblasts and their processes in all root resorption groups. This 




Chapter 4: Differentiation of Primary Tooth Pulp Cells 
4.1 Introduction 
Previous chapters reported culture techniques for primary tooth pulp cells and their 
positive control hESC (GENEA002) (Chapter 2), and characterisation studies, in Chapters 
2 and 3. Experiments were based on the visualisation of the three sets of stem cell 
protein markers (embryonic, neural progenitor and mesenchymal) by IF and by IHC in 
decalcified sections from primary canine teeth at three defined stages of root 
resorption (Chapter 3). In addition, flow cytometric analyses were performed to confirm 
the MSC character of primary tooth pulp cells based on the criteria proposed by ISCT 
(Dominici et al., 2006). This chapter describes the differentiation potential of primary 
tooth pulp cells into the three germ layers, neuronal and cardiomyocyte progenitors. 
Primary tooth pulp cells isolated via the explant culture method were cultured in E8 
medium on a VTN-N matrix, and expanded and cryopreserved in liquid nitrogen at P4. 
Cells were then thawed and cultured in the specific induction medium and assessed for 
the production of protein markers associated with the different lineages. Differentiated 
cells were characterised based on their morphology and IF studies. All experiments 
were conducted in biological triplicate and the results for the primary pulp cells were 
compared with those from the hESC line GENEA002. 
4.1.1 Lineage differentiation of MSCs and dental pulp cells 
In the last decade (Pittenger et al., 1999), human MSCs have been demonstrated to 
differentiate into mesodermal cell types including the classical tri-lineage differentiation 
into adipogenic, chondrogenic and osteogenic lineages. It was generally accepted that 
the differentiation potential of postnatal stem cells was lineage restricted; hence, the 
change of nomenclature of MSCs from “stem” to “stromal” by the ISCT. This hypothesis 
currently faces many challenges as emerging evidence demonstrates that postnatal 
stem cells have the potential to cross lineage boundaries and differentiate into specific 
cells from tissues beyond their origin (Zhang et al., 2006). Currently, there is no well-
accepted definition for this property of some postnatal cells, which has been termed 
plasticity (Brazelton et al., 2000), trans-differentiation (Anderson et al., 2001) or 
unorthodox differentiation (Bianco and Cossu, 1999; Bianco et al., 2008). 
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DPSCs from human permanent teeth have been shown to have the ability to cross 
lineage boundaries and produce cell types other than odontoblasts. In addition to the 
classical tri-lineage differentiation into osteogenic, chondrogenic and adipogenic 
progenitors, neurogenic differentiation of DPSCs has been reported (Gronthos et al., 
2000; 2002; Huang et al., 2008b; Kiraly et al., 2009; Ryu et al., 2009), along with 
pancreatic cell lineage differentiation (Govindasamy et al., 2011; Ishkitiev et al., 2013). 
Primary tooth pulp cells (SHEDs) have been induced into endothelial (Bento et al., 
2013), osteogenic/odontogenic (Gosau et al., 2013) and neural differentiation 
(Morsczeck et al., 2010) in addition to the classical tri-lineage differentiation reported 
by many studies. 
The ability of postnatal cells to generate cell lineages different from the tissue of 
origin has been explained by the existence of cells with pluripotent characteristics that 
may persist into adulthood, or the fact that adult stem cells can be reprogrammed via 
processes of de-differentiation and re-differentiation or via trans-differentiation to 
another lineage (Roelandt et al., 2013). De-differentiation, re-differentiation and trans-
differentiation were explored in this study by inducing primary tooth pulp cells in vitro 
to generate cell lineages different from the tissue of origin (neural and cardiomyocyte 
progenitors) as well as differentiating into the three germ layer progenitor cells, thus 
confirming their pluripotent characteristics. 
4.1.2 Differentiation into the embryonic germ layers 
Germ layers are distinct cell layers that form early during embryonic development 
and give rise to all adult tissues. Ectoderm gives rise to the nervous system, tooth 
enamel and skin epidermis. Endoderm contributes to the midgut and some inner organs 
in vertebrates. Mesoderm contributes to blood, muscle tissue and bones, and some 
inner organs in vertebrates (Technau and Scholz, 2003). However, this distinction is less 
clear when the neural crest is involved. The neural crest is generally regarded as an 
innovation of vertebrates (Holland and Holland, 2001; Yu et al., 2002). Neural crest cells 
can have a large variety of fates as they contribute to the formation of craniofacial 
bones and cartilage as well as the entire peripheral nervous system (Knecht and 
Bronner-Fraser, 2002). Thus, they give rise to tissues that are considered typical of 
either mesoderm (e.g., bones, cartilage and muscle) or ectoderm (neuronal tissues). 
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The ability to self-renew and differentiate into the three germ layers in vitro has been 
considered one of the defining characteristics of PSCs (Marti et al., 2013). 
Ectoderm marker Otx2 
The orthodenticle homeobox-2 gene (Otx2, Entrez Gene ID 5015) encodes a 
transcription factor that plays a role in brain, craniofacial and sensory organ 
development. The encoded protein also influences the proliferation and differentiation 
of dopaminergic neuronal progenitor cells during mitosis. During embryo development, 
Otx2 protein expression is strongest in the retinal pigment epithelium (Larsen et al., 
2009). 
Mesoderm marker T-Brachyury 
T-Brachyury (Entrez Gene ID 6862) is an embryonic transcription factor that affects 
transcription of genes required for mesoderm formation and differentiation. The T-
Brachyury gene encodes a protein that is vital for the formation of posterior mesoderm 
and axial development in all vertebrates (Edwards et al., 1996; Ghebranious et al., 
2008). It is expressed in the nucleus specifically in the notochord and early mesodermal 
cells in the embryo (Kispert et al., 1995). 
Endoderm marker Sox17 
At the molecular level, Sox17 (Entrez Gene ID 64321) is located downstream of the 
master regulator for primitive endoderm (Niakan et al., 2010). The forced expression 
of Sox17 in ESCs results in down-regulation of pluripotency gene expression and up-
regulation of primitive endoderm genes giving rise to endodermal progenitors (Niakan 
et al., 2010; Sarkar and Hochedlinger, 2013; Seguin et al., 2008). 
4.1.3 Neuronal induction and neuronal cell markers 
Two conventional techniques are commonly utilised to initiate neural differentiation 
of PSCs: embryoid body (EB) formation (from dissociated suspension culture) and co-
cultivation with stromal cell lines (Denham and Dottori, 2011). Efficient neural 
differentiation of human PSCs using a chemically defined culture environment 
supplemented with small molecular inducers of neural differentiation has been recently 
reported to be less complicated, less time consuming and to provide more consistent 
results (Yap et al., 2015). 
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The following sections describe markers used to characterise primary tooth pulp cells 
following neuronal induction. 
Neuronal marker nestin 
Nestin (Entrez Gene ID 10763) is an intermediate filament protein that is a known 
neural stem/progenitor cell marker found only in vertebrates. It was first identified 
using a mAb by (Hockfield and McKay, 1985) and the gene was named nestin by Lendahl 
et al. (1990) because it was specifically expressed in ‘neuroepithelial’ stem cells. Since 
its identification, nestin has been unequivocally accepted as a marker of NSCs in 
undifferentiated CNS cells during development, in normal adult CNS cells and in CNS 
tumour cells (Gilyarov, 2008; Suzuki et al., 2010). 
Neural marker Pax6 
Pax6 (Entrez Gene ID 5080) is a pivotal gene in CNS development (Manuel et al., 
2015). It is universally expressed in the human neural plate, necessary for human NE 
specification, represses pluripotent genes and activates neural genes (Zhang et al., 
2010). It is expressed when the major components of the developing CNS first emerge 
after neural tube closure. Pax6 proteins are classified within a sparse group of master 
regulatory proteins that work at the top of genetic networks as molecular switches that 
control cell type specification and differentiation (Cvekl and Callaerts, 2017). 
Sox family of transcription factors 
SRY-related high-mobility-group box (Sox) family proteins comprise a group of 
transcription regulators with a conserved high-mobility group (HMG) domain, which 
mediates DNA binding (Jauch et al., 2012). Sox proteins are divided into groups from 
Sox A to Sox H based on their degree of amino acid identity in the HMG box (Abdelalim 
et al., 2014). 
Several Sox proteins have been identified and found to act as critical transcription 
factors involved in embryonic development and cell fate decisions (Lovell-Badge, 2010). 
They are well-established regulators of cell fate during development and play additional 
roles in adult tissue homeostasis and regeneration (Nelms, 2010; Sarkar and 
Hochedlinger, 2013). Among the Sox B genes, Sox1 (Entrez Gene ID 6656) and Sox2 
(Entrez Gene ID 6657) encode members of the SRY-related HMG box family of 
transcription factors involved in the regulation of embryonic development and in the 
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determination of cell fate (NCBI gene, http://www.ncbi.nlm.nih.gov/gene/6657). The 
protein products of these genes are required for stem cell maintenance in the CNS. 
Sox2 promotes early neuro-ectodermal fate by directly suppressing key regulators of 
the alternative mesodermal fate, such as T-Brachyury (Thomson et al., 2011; Wang et 
al., 2012b). Along with other transcription factors such as Oct4A and Nanog, Sox2 also 
plays a broader role in maintaining multipotency in different stem cell types by 
maintaining the regulatory network responsible for self-renewal and suppression of 
differentiation in ESCs (Park et al., 2008; Takahashi and Yamanaka, 2006; Takahashi et 
al., 2007). 
4.1.4 Cardiomyocyte progenitors and their markers 
Cardiogenesis begins during gastrulation when precursor cells derived from the 
mesoderm are induced by adjacent tissue to migrate away from the primitive streak to 
the lateral–cranial parts of the embryo to form the cardiogenic regions (Martin-Puig et 
al., 2008; Srivastava and Olson, 2000). During this migration, the precursor cells from 
the cardiogenic mesoderm (Figure 92) down-regulate the T-box transcription factor 
Brachyury, which is the earliest mesodermal marker (Yi et al., 2010). At this stage of 
development, progenitors irreversibly commit to the cardiac lineage and express the 
NK2 transcription-related locus 5 (Nkx2.5) transcription factor and cardiac troponin 
cTnT (TNNT2) (Selem et al., 2013), which are essential for the development of 
ventricular cardiomyocytes (Lyons et al., 1995). 
 
Figure 92: Cardiomyocyte differentiation pathways and key marker expression (Yi et al., 2010) 
Troponin T2, cardiac type 
TNNT2 (Entrez Gene ID 7139) is a central player in the calcium regulation of actin 


























et al., 2002). TNNT2 found in the cytoplasm is a heart tissue-specific protein (Townsend 
et al., 1994; 1995; Wei and Jin, 2016). 
NK2 homeobox 5 
Nkx2.5 (Entrez Gene ID 1482) is essential for cardiac development (Shiojima et al., 
1995) and has been categorised as a class I NK-2 homeodomain protein (Granados-
Riveron et al., 2012). This nuclear transcription factor is expressed only in the cardiac 
tissues and is involved in the differentiation and commitment of the myocardial lineage 
(Koss et al., 2012). 
4.2 Materials and methods 
4.2.1 Equipment 
The following  essential equipments were used in this study: 
 Forma Series II water-jacketed CO2 incubator (Thermo Fisher Scientific) 
 Heracell 240i CO2 incubator (Thermo Fisher Scientific) 
 Class II laminar flow hood with vacuum 
 Inverted phase contrast microscope (Eclipse Ti-U, Nikon) with camera (Nikon C1 
plus; Nikon, Tokyo, Japan) 
 Centrifuge (Beckman Coulter Allegra X15-R with SX4750 with swinging bucket 
rotor) 
 Freezer –80°C (Thermal Scientific) 
 Water bath, 37°C 
 Sterile BD Falcon conical tubes 50 mL (Cat# 352070) and 15 mL (Cat# 352097) 
 Greiner Bio-One CELLSTAR TC filter cap cell culture flasks (T25 Cat# 690175 and 
T75 Cat# 658175) 
 Nunc Lab-Tek II Chamber Slides 8 wells (ThermoFisher Scientific Cat# 154534) 
 Greiner CELLSTAR serological pipette, volumes 5, 10 and 25 mL (Cat# P7615, 
P7740, P7865) 
 Culture plates: 6-wells (Greiner Bio-One, Cat# 657160), 24-wells (Greiner Bio-
One, Cat# 662160) and 48-wells (Greiner Bio-One, Cat# 650180) 
 Chamber for cell counting—haemocytometer (Hauser Scientific, Cat# 1492) 
 Sterile Millipak–20 Filter Unit 0.22 µm (Millipore, Cat# MPGL02GH2) 
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 Syringes, 50 mL 
 Cover glass (VWR, Cat# 613-0149). 
4.2.2 Reagents 
The following  reagents were used in differentiation studies: 
 Trypan Blue solution 0.4% (Sigma-Aldrich, Cat# T8154) 
 PBS without calcium and magnesium (Gibco, Cat# 10010072) 
 Paraformaldehyde (PFA), 4% (wt/vol) in 0.1 M PBS (Sigma, Cat# P6148-500G) 
 Triton X-100 (Sigma-Aldrich, Cat# X100) 
 DAPI nuclear DNA stain (Invitrogen, Cat# D21490) 
 NucBlue Fixed Cell Stain (DAPI, Life Technologies Part# R37606) 
 NucBlue Fixed Cell Stain Ready Probes. Part of the Human Neural Stem Cell 
Immunocytochemistry Kit (Gibco, Cat# A24354) 
 Penicillin–streptomycin (Gibco, Life Technologies, Cat# 15140122) 
 Tween 20 (Sigma-Aldrich, Cat# P5927) 
 EDTA (Sigma-Aldrich, Cat# E5134). 
4.2.3 Primary antibodies for identification of germ layers 
The Human Pluripotent Stem Cell Functional Identification Kit (R&D systems, Cat# 
SC027) consists of: 
 Ectoderm marker: goat anti-human Otx2 antigen affinity-purified polyclonal 
antibody (Part# 967331) 
 Mesoderm marker: goat anti-human Brachyury antigen affinity-purified 
polyclonal antibody (Part# 967332) 
 Endoderm marker: goat anti-human Sox17 antigen affinity-purified polyclonal 
antibody (Part# 967330). 
4.2.4 Primary antibodies for neural stem cell identification 
The Human Neural Stem Cell Immunocytochemistry Kit (Molecular Probes, Cat# 
A24354) consists of: 
 Mouse anti-human nestin (Part# A24345) 
 Rabbit anti-human Pax6 (Part# A24340) 
 Goat anti-human Sox1 (Part# A24347) 
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 Rabbit anti-human Sox2 (Part# A24339) 
4.2.5 Primary antibodies for cardiomyocyte identification 
The Human Cardiomyocyte Immunocytochemistry Kit (Molecular Probes, Cat# 
A25973) consisted of: 
 Rabbit anti-human Nkx2.5 (Part# A25974) 
 Mouse anti-human TNNT2 (Part# A25969) 
4.2.6 Isotype IgG antibodies 
Negative control antibodies used are as follows: 
 Rabbit IgG antibody (Dako, Cat# X0936) 
 Mouse IgG1 negative control (Dako, Cat# X0931) 
 Goat IgG negative control (Invitrogen, Cat# 02-6202) 
4.2.7 Secondary antibodies 
Matching secondary antibodies with the antigen of interest were as follows:  
 Donkey anti-goat IgG; Northern Lights NL557 conjugated antibody (R&D Systems, 
Cat# NL001) for germ layer experiments 
 Donkey anti-rabbit; Alexa Fluor 594 (Molecular Probes, Part# A25970) for use 
with anti-Nkx2.5 antibody 
 Donkey anti-mouse; Alexa Fluor 488 (Molecular Probes, Part# A25972) for use 
with anti-TNNT2 and anti-nestin antibodies 
 Donkey anti-goat; Alexa Fluor 488 (Molecular Probes, Part# A24349) for use with 
anti-Sox1 antibody 
 Donkey anti-rabbit; Alexa Fluor 555 (Molecular Probes, Part# A24342) for use 
with anti-Pax6 or anti-Sox2 antibodies 
 Donkey anti-rabbit; Alexa Fluor 594 (Molecular Probes, Part# A24343) for use 
with anti-Pax6 or anti-Sox2 antibodies 
4.2.8 Cell culture 
Primary tooth pulp cells from the three root resorption groups were used in 
multilineage differentiation experiments (n = 9). Cell lines (Table 19) were cultured in 
xeno-free, serum-free E8 medium with VTN-N matrix as described in Chapter 3. 
Cryopreserved cell lines at P4 were thawed and grown in T25 culture flasks. When they 
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were 50% confluent (P5) they were passaged with EDTA into 24- or 48-well Nunc Lab-
Tek II Chamber Slides to be differentiated with selective media. Cultures were 
maintained in a 37°C incubator with 5% CO2 (Section 7.9). 
Table 19: Primary tooth pulp cell lines from three root resorption groups used in differentiation 
experiments and the control GENEA002 pluripotent human cells 
Cell lines 
A663 A1053 A1953 B1163 B1963 B2273 C353 C2083 C2163 GENEA002 
 
IF studies were carried out to detect the expression of the three germ layer cell 
markers (Otx2, Brachyury and Sox17), NSC markers (nestin, Pax6, Sox1 and Sox2) and 
cardiomyocyte progenitor markers (TNNT2–Nkx2.5). The experiments were performed 
for each resorption group in biological triplicates. Differentiation and ICC protocols are 
presented in Section 7.9, 7.10 and 7.11. 
4.3 Differentiation into three germ layers 
4.3.1 Methods 
The Human Pluripotent Stem Cell Functional Identification Kit was used to 
differentiate human PSCs into ectoderm, mesoderm or endoderm (Table 20). 
Differentiation protocols developed by R&D Systems for PSC differentiation (Figure 93) 
were adopted for primary tooth pulp cell differentiation (Section 7.9.1). 
Table 20: Human Pluripotent Stem Cell Functional Identification Kit components (R&D Systems, Cat# 
SC027) 
Differentiation Base Media 
Supplement 
895090 10X concentrated solution 
Endoderm Differentiation Supplement 
1 
390513 
1 vial of lyophilised growth factors for day 1 
of endoderm differentiation 
Endoderm Differentiation Supplement 
2 
390514 
1 vial of lyophilised growth factors for days 
2 and 3 of endoderm differentiation 
Mesoderm Differentiation Supplement 390515 
1 vial of lyophilised growth factors for 
mesoderm differentiation 
Ectoderm Differentiation Supplement 390516 





Figure 93: Germ layer differentiation and detection scheme for lineage markers 
Experimental design for germ layer differentiation 
Differentiation of cultured cells (n = 9) into the three germ layer cells involved three 
experiments. Experiment 1 was performed following the protocol recommended by 
R&D Systems. Cells were cultured into Nunc Lab-Tek II Chamber Slides (ThermoFisher, 
Cat# 154534) and the differentiation scheme summarised in Table 21 was followed. 
Negative controls in this experiment were treated with incubation buffer consisting of 
PBS containing 0.3% Triton X-100, 1% BSA, and 10% normal donkey serum with no 
primary antibody. Differentiated cells were examined for the expression of germ layer 
marker proteins by IF using R&D Northern Lights fluorescent secondary antibodies. 
  
Cultured cells 
(P5) in chamber slides, 
24 & 48-well plates 
Mesoderm 
differentiation 
E8TM medium replaced with 
Mesoderm Differentiation Medium.  
Repeat media change 12-16 h later. 
Immunocytochemistry (ICC) detection of 




Replace E8TM medium with 
Ectoderm Differentiation Medium.  
Repeat media change 24, 48 & 72 h later. ICC 
detection of goat anti-human Otx2 (day 4 
from initial differentiation) 
Endoderm 
differentiation 
Replace E8TM medium with 
Endoderm Differentiation Medium 1.  
16-24 h later, replace medium 1 with 
Endoderm Differentiation Medium 2.  
Repeat with Medium 2 after 24 h. 
ICC detection of goat anti-human Sox17 (day 
4 from initial differentiation) 
Cell lines thawed 
and cultured in 
T25 in  
E8TM/VTN-N 
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Table 21: Nunc Lab-Tek II Chamber Slides experimental design for nine primary pulp cell lines and 
GENEA002 positive control cultured in differentiation media. Germ layer markers Otx2 (for ectoderm), 
Brachyury (for mesoderm) and Sox17 (for endoderm) were tested along with a negative control 
incubation buffer (PBS containing 0.3% Triton X-100, 1% BSA and 10% normal donkey serum). Donkey 
anti-goat IgG Northern Lights NL557-conjugated antibody (Cat# NL001) was used as a secondary antibody 
Mesoderm 
2-3 days 
A1953 B1963 B2253 C353 Brachyury assay 




A1053 B1163 C2173 GENEA Brachyury assay 




A663 B2273 C2163 C2083 Brachyury assay 




A1953 B1963 B2253 C353 Otx2 assay 




A1053 B1163 C2173 GENEA Otx2 assay 




A663 B2273 C2163 C2083 Otx2 assay 




A1953 B1963 B2253 C353 Sox17 assay 




A1053 B1163 C2173 GENEA Sox17 assay 




A663 B2273 C2163 C2083 Sox17 assay 
A663 B2273 C2163 C2083 Incubation buffer 
 
The second germ layer differentiation experiment (Table 22) was performed in 24-
well and 48-well plates. The design incorporated additional negative controls to 
evaluate the expression of the three germ layer marker proteins in undifferentiated 
cells cultured in E8 as well as in base medium with no differentiation supplements. 
Experiment three included matching isotype IgG control, in addition to the three germ 
layer markers as primary antibodies (Table 23). 
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Table 22: 24-well plate control experiment. Three cell lines from each group were grown in E8 as well as 
the base medium (with no differentiation supplements) and tested for the expression of the three germ 
layer markers Otx2 (ectoderm), Brachyury (mesoderm) and Sox17 (endoderm). Donkey anti-goat IgG 

















































E8  Base medium  
 
Table 23: 48-well plate germ layer differentiation experimental design. Cell lines from each group were 
grown in differentiation media and assessed for Otx2 protein expression (ectoderm), Brachyury 
(mesoderm), Sox17 (endoderm) and Goat IgG isotype control (Cat# 02-6202 Invitrogen). Donkey anti-goat 


















A1053 B1153 C2163 GENEA A1053 B1153 C2163 GENEA 









A1953 B1963 C353 GENEA A1953 B1963 C353 GENEA 
IgG 
Ectoderm 
A1053 B1153 C2163 GENEA A1053 B1153 C2163 GENEA 
IgG 
Mesoderm 




Germ layer immunofluorescence procedures 
Differentiated and control primary tooth pulp cells were washed twice with PBS and 
fixed with 4% paraformaldehyde in PBS for 20 min at RT. Culture plates were washed 
with 1% BSA in PBS for 5 min three times, followed by permeabilisation and blocking 
with 0.3% Triton X-100, 1% BSA and 10% normal donkey serum in PBS ( RT for 45 min). 
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Culture plates were then incubated overnight at 4°C with reconstituted primary 
antibodies in PBS as recommended by the manufacturer. Goat IgG was used as a 
primary antibody in negative control experiments matching the class of the germ layer 
antibodies, which were all raised in goat. 
After incubation with primary antibodies, culture plates were washed three times 
with 1% BSA in PBS for 5 min and incubated for 1 h at RT in the dark with the secondary 
antibody. This was followed by three washes with 1% BSA in PBS for 5 min; NucBlue 
Fixed Cell Stain (DAPI) was added into the third wash step and incubated for 5 min. 
Culture plates were examined under the fluorescent microscope. The detailed IF 
protocol is provided in Section 7.9.2. 
4.3.2 Results 
Differentiated primary tooth pulp cells and hESCs (GENEA002) were cultured as 
described in Section 4.2.8 and 7.9. Cells grew into large round colonies within 4 days in 
the three germ layer-specific differentiation media. Differentiated colonies variably 
expressed lineage-specific protein markers for the specific differentiation pathway 
induced, as described below. 
For marker detection, primary tooth pulp cells and GENEA002 were stained with 
antibodies against Otx2 (ectoderm), Brachyury (mesoderm) and Sox17 (endoderm), as 
well as their matching IgG controls, and examined using fluorescent microscopy. The 
differentiation results for GENEA002 (Figures 94 and 95) are presented, followed by the 
primary tooth pulp cell results (Figures 96–107). Each result section presents 
comparisons between undifferentiated cell lines growing in E8 medium and the 
matching isotype IgG antibody. 
Representative images of primary tooth pulp cells from each root resorption group 
are presented. Images have been cropped and magnified to highlight the areas of 




GENEA002 germ layer immunoglobulin G controls 
Negative control experiment.(Figure 94). Donkey anti-goat IgG Northern Lights 


















Figure 94: GENEA002 cultured in E8 and germ layer differentiation base medium with goat IgG control 
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GENEA002 germ layer marker expression 
GENEA002 hESCs were cultured in E8 and germ layer differentiation media. 
Undifferentiated cell cultures showed fewer cells expressing markers of the three germ 
layers, and with weaker signals than for differentiated GENEA002. Donkey anti-goat 
Alexa Fluor 488 secondary antibody was used; DAPI nuclear counterstaining (blue). 
Results are presented on the following page (Figure 95). 
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E8 medium Germ layer differentiation 
 
GENEA002/ectoderm marker Otx2 (green) 
 
Otx2+ GENEA002 colonies (green) 
 
GENEA002/mesoderm marker Brachyury (red) 
 
Brachyury+ GENEA002 colonies (red) 
 
GENEA002/endoderm marker Sox17 (green) 
 
Sox17+ GENEA002 colonies (green) 
Figure 95: Undifferentiated GENEA002 germ layers marker expression in E8 medium compared with 











Germ layer markers in undifferentiated primary tooth pulp cells 
Primary tooth pulp cells from the three resorption groups growing in E8 medium 
(Figure 96) showing no expression of the three germ layer protein markers for 
ectoderm (Otx2), mesoderm (Brachyury) and endoderm (Sox17). Donkey anti-goat 
Alexa Fluor 488 secondary antibody; DAPI nuclear counterstaining (blue). 



















Figure 96: Undifferentiated primary tooth pulp cells from groups A, B and C grown in E8 medium  
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Otx2 expression in primary tooth pulp cells (ectoderm) 
Differentiated large, flat polygonal cells and spindle-shaped polarised cells from all 
groups showed expression within the nucleus and cytoplasm. Nuclei diameters ranged 
from 17 to 40 µm; measurements were taken using ImageJ (Figure 97). Goat anti-
human Otx2 antibody was used with Donkey anti-goat Alexa Fluor 488 secondary 
antibody and DAPI nuclear counterstaining (blue). 
Group A (A1053) differentiated primary tooth pulp cells 
   
   
   
   
   
   
   
   














Protein expression appeared intra-nuclear and in the cytoplasm with higher signals 
detected around the nuclei and in the cytoplasmic processes. Otx2-positive group B 
cells of different morphology appeared to show less variability in their nuclear 
dimensions. Nuclei diameters ranged from 31 to 69 µm (Figure 98). 









Figure 98: Representative Images of ectoderm-differentiated group B cells (B1163) showing the detection 







Group C cell populations appeared more homogeneous in morphology; intra-nuclear 
and cytoplasmic Otx2 protein expression was evident with high signal detection around 
the nuclei. Nuclei measured around 23 µm across at their widest (Figure 99). 
Group C (C353) differentiated primary tooth pulp cells 
   
   
   










Figure 99: Representative images of ectoderm-differentiated group C cells (C353) showing detection of 





Otx2, a closer look 
The pattern of reactivity was uniform and similar in differentiated cell lines from the 
three resorption groups. Cells maintained their heterogeneous morphology of spindle-
shaped cells with long processes and large oval nuclei ranging from 30 to 50 µm at their 
widest (Figure 100). 
 
 
Figure 100: Well-defined, granular cytoplasmic immunostaining for Otx2 protein at higher magnifications 
Otx2 
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Brachyury expression in differentiated primary tooth pulp cells 
Mesoderm differentiation showed cells that were mostly of fusiform morphology. 
Strong fluorescent signals were observed within the nuclei and the cytoplasm extending 
into cell processes. The nuclei’s widest diameter measurements were in the range 23–
30 µm (Figure 101). Goat anti-human Brachyury antibody (red) was used in mesoderm 
differentiation with Donkey anti-goat Alexa Fluor 488 secondary antibody and DAPI 
nuclear counterstaining (blue).  
Group A (A1053) differentiated primary tooth pulp cells 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   



















Mesoderm differentiated group B cells were heterogeneous in morphology with 
strong fluorescent signals within the nuclei and the cytoplasm extending into their 
characteristic cell processes. Nuclei were large compared with those from groups A and 
C, being within the range 50–70 µm (Figure 102). 
Group B (B1163) differentiated primary tooth pulp cells 
   
   
   
   
   














A smaller cell size was observed in mesoderm differentiated group C cells with 
heterogeneous morphology. Intra-nuclear and cytoplasmic protein expression was 
evident with high signal detection around the nuclei (Figure 103). 










Figure 103: Representative images of mesdoderm-differentiated group C cells (C353) 
29.42 µm 
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Brachyury, a closer look 
Fusiform cells (Figure 104) show concentrated protein at the cell membrane and 
outlining the cell boundaries, extending into its processes. Nuclear expression localised 
and central with oval-shaped nuclei ranging from 30 to 60 µm at their widest. Brachyury 
expression was uniform in all resorption groups after 48 h of mesoderm differentiation. 
 




Sox17 expression in differentiated primary tooth pulp cells 
Goat anti-human Sox17 antibody (green) was used with Donkey anti-goat Alexa Fluor 
488 secondary antibody and DAPI nuclear counterstaining (blue) in endoderm 
differentiation experiments. Most differentiated cells had a polygonal morphology, long 
processes and uniformly small size. Nuclei measured within the range 21–25 µm. Few 
cells had a tubular appearance (Figure 105). 
Group A (A1053) endoderm-differentiated primary tooth pulp cells 
   
   
   
   
   










Figure 105: Endoderm-differentiated group A cells (A1053). Intra-nuclear and cytoplasmic Sox17 protein 







Polygonal and triangular cells with long processes and uniformly small-sized nuclei 
were observed. Intra-nuclear and cytoplasmic Sox17 protein expression was detected 
within the nuclei and the perinuclear cytoplasm (Figure 106). 
Group B (B1163) differentiated primary tooth pulp cells 











Figure 106: Endoderm-differentiated group B cells (B1163)  
22.30 µm 
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Nuclear expression in oval-shaped nuclei in group C differentiated cells (Figure 107). 
Sox17 expression was uniform in all resorption groups after 4 days of endoderm 
differentiation. 
Group C (C353) endoderm-differentiated primary tooth pulp cells 
   











Figure 107: Endoderm-differentiated group C cells (C353). (A) Spindle-shaped polarised cells with small 
nuclei. (B) Strong granular cytoplasmic staining for Sox17. (C) Polarised cell types with granular protein 








The concept of de-differentiation of a somatic cell into three germ layers that could 
then differentiate into various cell types introduces a new era in stem cell biology and 
provides potential therapeutic modalities in regenerative medicine. 
The transcription circuits that enable stem cells to maintain naïve pluripotency were 
described in Chapters 1 and 3. The set of transcription factors Oct4A, Nanog and Sox2 
were detected in some primary tooth pulp cells in their undifferentiated state. The 
protein expression of neural progenitor markers nestin and Dlx2 was also confirmed in 
addition to the mesenchymal stromal surface markers CD105, CD90 and CD73. This 
finding strongly suggests that primary tooth pulp cells in their naïve state retain a 
degree of pluripotency when grown in E8 medium. 
The experiments aimed to explore the potential of primary tooth pulp cells to de-
differentiate into the progenitor cells of the embryonic germ layers and express 
relevant protein markers: Otx2 for ectoderm, Brachyury for mesoderm and Sox17 for 
endoderm. The application of differentiation methods without the extra step of EB 
formation allowed for rapid determination of whether the cultured lines met the 
fundamental criterion of differentiation into the three primary germ layers or had 
restricted differentiation capacity. The question of whether these cells can then be 
driven into a differentiation pathway towards less committed germ layer lineage cells is 
answered in this chapter. Primary tooth pulp cells from the three root resorption 
groups and GENEA002 were positive for the three germ layer markers after 
differentiation. The undifferentiated cell lines did not exhibit the markers of interest. 
Germ layer differentiation, a closer look 
Otx2 expression was evident in differentiated primary tooth pulp cells growing in 
ectoderm differentiation medium for 4 days but not in the undifferentiated cell lines. 
The expression pattern of Otx2 in primary tooth pulp cells was localised mainly in the 
cytoplasm of large, spindle-shaped pulp cells and extending into their processes. 
The highly dynamic expression and intracellular localisation of transcription factors 
makes them difficult to study (Fossat et al., 2007). An example of this is Otx2 whose 
dynamic fluctuating expression during development has been reported in areas of the 
CNS (Frantz et al., 1994) and photoreceptors in the retina (Nishida et al., 2003). In 
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adults, aside from a few studies related to its localisation in the retina, no study has 
described Otx2 expression in other organs, particularly dental tissues. Data mostly rely 
on mRNA detection (Rath et al., 2006) rather than on protein localisation. According to 
the Human Gene Database (GeneCard, www.genecards.org), the Otx2 protein is 
expressed in the adult retina—where it has been described as a nuclear protein in the 
retinal pigment and bipolar cells—but is cytoplasmic in photoreceptor cells (Baas et al., 
2000). The current study demonstrated cytoplasmic expression of the Otx2 protein in 
primary tooth pulp cells following ectodermal differentiation (Figure 100). 
Brachyury proteins, a conserved subgroup of T-domain transcription factors, specify 
gut and posterior mesoderm derivatives throughout the animal kingdom. Brachyury 
staining in this study was located in both the nuclear and cytoplasmic compartments. 
Protein localisation has been reported in other studies mainly focusing on lung cancer 
(Postma et al., 2014; Roselli et al., 2012). However, no studies have described its 
presence in the dental pulp cells (Figure 104). 
The early pan-endodermal marker Sox17 was expressed in differentiated cell lines 
from the three resorption groups. Cells were generally smaller with polygonal and 
columnar morphologies (Figure 107), unlike the fusiform spindle-shaped appearance of 
ectoderm and mesoderm-differentiated cells. 
The observed Otx2, Brachyury and Sox17 protein concentration at cell membranes, 
and what appeared to be polar ends, strongly indicates the presence of an active 
protein synthesis function in these cells. The nuclear and cytoplasmic expression results 
suggest active protein synthesis that is transported into the cytoplasm. 
4.4 Neural induction 
4.4.1 Methods 
For in vitro neural induction experiments, cryopreserved primary tooth pulp cells at 
P3 and pluripotent GENEA002 were thawed as described in Section 2.3. Thawed 
primary tooth pulp cells were cultured in E8 medium on a VTN-N matrix coating seeded 
(2×105) in a 25-cm2 tissue culture flask and grown until semi-confluent (70–80%). Cells 
were re-seeded in VTN-N-coated 24-well plates and grown to 50% confluence following 
the experimental design shown in Table 24.  
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Matching IgG controls 
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Culture medium was replaced with PSC Neural Induction Medium (Cat# A1647801) 
prepared by mixing Gibco Neurobasal Medium with Gibco Neural Induction Supplement 
(Section 7.10) as shown in Figure 108. 
The induction medium was changed every 48 h thereafter. On day 7, colonies of 
differentiated primary tooth pulp cells as well as GENEA002 were examined for NSCs 
using an Eclipse Ti-U inverted microscope. 
 
Figure 108: Scheme for neuronal induction of primary tooth pulp cells in vitro using PSC Neural Induction 
Medium 
Neural differentiation immunofluorescence procedures 
ICC staining was used to determine the phenotypes of differentiated cells at day 7 
using the following primary antibodies: goat anti-human Sox1, rabbit anti-human Sox2, 
mouse anti-human nestin and rabbit anti-human Pax6 in conjunction with anti-mouse 
Alexa Fluor 488, anti-goat Alexa Fluor 488 and anti-rabbit Alexa Fluor 555 and 594. 
Nuclear counterstaining was performed using NucBlue Fixed Cell Stain Ready Probes. 
The reagent was provided as part of the Human Neural Stem Cell Immunocytochemistry 
Kit (Cat# A24354) from Gibco. 
Differentiated cells were washed twice with PBS and fixed with 4% formaldehyde in 
PBS fixative solution for 15 min at RT. Plates were washed with 1% BSA in PBS washing 
buffer (Cat# A24348) followed by 15 min of permeabilisation with 0.5% Triton X-100 in 
PBS (Cat# A24352) at RT. Cells were then incubated for 1 h at RT in 3% BSA in PBS 
Blocking Solution (Cat# A24353). 
  
Primary teeth pulp cells at P5 
cultured in E8TM/VTN-N Differentiated primary pulp 
cells at day 7 positive for 
NSC markers (Nestin, Pax6, 






Subsequently, the culture plates were incubated overnight at 4°C with the four 
neuronal primary antibodies and the three matching IgG isotype controls (mouse, rabbit 
and goat) as described in Section 7.10. 
On the second day after incubation, plates were washed with washing buffer three 
times and incubated for 1 h at RT with Alexa Fluor secondary antibodies. After two 
washes, NucBlue Fixed Cell Stain (DAPI) was added into the third wash step and 
incubated for 5 min. Culture plates were examined by fluorescent microscopy for NSC 
marker detection (Section 7.10.1). 
4.4.2 Results 
Differentiation of primary tooth pulp cells into NSCs was confirmed by the IF 
techniques performed. The detection of specific neuronal stem cell markers nestin, 
Sox1, Sox2 and Pax6 was achieved at the protein level. 
Undifferentiated primary tooth pulp cells growing in E8 as a negative control showed 
expression of NSC markers, even without being subjected to the induction medium. This 
result had been observed earlier in characterisation experiments for neural progenitor 
markers, as reported in Chapter 2, and was validated by the neural induction studies in 
this chapter. 
The following section presents the morphological changes in differentiated GENEA02 
(Figures 109 and 110), followed by their negative and positive control experiments 
(Figures 111–114). Differentiated primary tooth pulp cell line morphological changes 
are shown in Figure 115. Their negative and positive control experiments, as well as 
experimental cell lines cultured in the neural induction medium, are shown in Figures 
116–126. 
Morphological changes in differentiated GENEA002 
The morphology of hESC (GENEA002) in culture showed irregular cells with large 
nuclei and scant cytoplasm. With further growth in the neural induction medium, they 
began to form single-cell layered compact colonies, which expanded from the centre 
towards the periphery (Figures 109 and 110). 
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 Figure 109: GENEA002 growing in E8–VTN-N medium in undifferentiated state showing the characteristic 
appearance of hESCs in culture. Most hESCs exhibited a high nuclear to cytoplasmic ratio 
 
 
Figure 110: Neuronal induction of GENEA002 at day 6. Differentiated cells had more cytoplasm than 
undifferentiated cells, indicating they were protein-synthesising cells. Small cells with homogeneous 
morphology growing in tightly packed monolayers with almost no intercellular spaces and resembling 
thick epithelial sheets were observed 
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GENEA002 neural induction immunoglobulin G controls 





































Figure 111: GENEA002 cultured in neural induction medium with IgG antibodies. Secondary antibodies: 
anti-mouse Alexa Fluor 488, Anti-goat Alexa Fluor 488, and Anti-rabbit Alexa Fluor 594. DAPI nuclear 
staining (blue) 
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GENEA002 neural stem cell marker expression 
Protein expression of the NSC markers was assessed by IF microscopy (Figure 112) in 
the differentiated GENEA002 cell line in parallel, and compared with primary tooth pulp 
cell lines from the three resorption groups using the same neural induction media and 
following the protocols described in Section 7.10.1. 
NSC markers, mouse anti-human nestin, goat anti-human Sox1, rabbit anti-human 
Sox2 and rabbit anti-human Pax6 primary antibodies were used. Secondary antibodies: 
anti-mouse Alexa Fluor 488, anti-goat Alexa Fluor 488 and anti-rabbit Alexa Fluor 594. 
DAPI nuclear staining (blue). 
GENEA002 Neuronal induction 
 
Nestin+ GENEA002 colonies (red) 
 
Sox1+ GENEA002 colonies (green) 
 
Sox2+ GENEA002 colonies (green) 
 
Pax6+ GENEA002 colonies (red) 
Figure 112: Differentiated cultures of GENEA002 showing localised expression of the NSC protein markers 




GENEA002 double staining for neural stem cell marker expression 
Double staining of the NSC markers nestin-Sox2 (Figure 113) and Pax6-Sox1 (Figure 114) 
shows Sox2 and Pax6 markers expression at a central cellular location whereas staining 





































GENEA002 neural induction 
 
Nestin (red), Sox2 (green) and DAPI counterstaining (blue) 
Figure 113: Neuronal induction at day 6. Nestin+-Sox2+ cells organised in clusters. The pattern of nestin 
immunoreactivity (red) is predominantly peripheral within the cytoplasm. Cells with peripheral 







































Pax6 (red), Sox1 (green) and DAPI counterstaining (blue) 
 
Figure 114: Neuronal induction at day 6. Pax6+-Sox1+ cells exhibited a rosette pattern of organisation. 
Note the Sox1+-Pax6+ cell tightly packed clusters. Pax6+ cells are present in localised clusters whereas 
Sox1+ cells showed a more widespread expression 
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Neural induction in primary tooth pulp cells—morphological changes 
Neural induction of primary tooth pulp cells resulted in differentiated cells with 
smaller nuclei that were more homogeneous in morphology and size compared with 
the controls (Figure 115).  
 
 
Figure 115: (A) Pre-differentiation and (B) post-differentiation morphological appearance of cells. 
Homogeneous smaller cells with long thin processes replaced the larger-sized, heterogeneous population 





Neural stem cell markers in primary tooth pulp cells after neural induction 
The IF studies presented here include representative cell lines from each root 
resorption group. 
Neural induction IgG controls 
Neural induction negative control antibodies in differentiated primary tooth pulp 
cells from the three groups of root resorption. Matching isotype IgG controls (Rabbit 







































Figure 116: Neural induction negative control antibodies in primary tooth pulp cells from the three 
groups of root resorption 
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Neural stem cell markers in group A undifferentiated primary tooth pulp cells 
The detection of neural markers in group A control cell lines growing in E8 without 
neural induction (Figure 117). Intra-nuclear and cytoplasmic protein expression was 
visible at variable intensities among the groups.  
Control E8 medium – Group A (A1953) 
 
Nestin + Undifferentiated cells 
 
Sox1 + Undifferentiated cells 
 
Sox2+ Undifferentiated cells 
 
Pax6 + Undifferentiated cells 
Figure 117: Undifferentiated primary tooth pulp cells from group A grown in E8 medium, showing the 
expression of NSC protein markers: mouse anti-human nestin (red), goat anti-human Sox1 (green), rabbit 
anti- human Sox2 (green) and rabbit anti- human Pax6 (red). DAPI nuclear stain (blue) 
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Neural stem cell markers in neural induced group A primary tooth pulp cells 
Group A  cell lines grown in neural induction medium (Figures 118). Intra-nuclear and 
cytoplasmic protein expression was evident. Sox2 was clearly more highly expressed in 
differentiated cells of group A compared with undifferentiated ones with more 
cytoplasmic signals detected. 
Neural induction medium – Group A (A1053) 
 
Nestin + differentiated cells 
 
Sox1 + differentiated cells 
 
Sox2+ differentiated cells 
 
Pax6 + differentiated cells 
Figure 118: NSC markers in differentiated group A cells: mouse anti-human nestin (red), goat anti-human 
Sox1 (green), rabbit anti-human Sox2 (green) and rabbit anti- human Pax6 (red). DAPI nuclear stain (blue)  
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Neural stem cell markers in group B undifferentiated primary tooth pulp cells 
Undifferentiated group B cell lines (Figure 119) showing expression of mouse anti-
human nestin (red), goat anti-human Sox1 (green), rabbit anti-human Sox2 (green) and 
rabbit anti-human Pax6 (red). DAPI nuclear stain (blue). 
E8 medium – Group B (B1163) 
 
Nestin + Undifferentiated cells 
 
Sox1 + Undifferentiated cells 
 
Sox2+ Undifferentiated cells 
 
Pax6 + Undifferentiated cells 
Figure 119: Undifferentiated primary tooth pulp cells from group B grown in E8 medium showing positive 
visualisation of the NCS markers 
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Neural stem cell markers in neural induced group B primary tooth pulp cells 
Intra-nuclear and cytoplasmic protein expression (Figure 120) of mouse anti-human 
nestin (red), goat anti-human Sox1 (green), rabbit anti-human Sox2 (green), rabbit anti-
human Pax6 (red) and DAPI nuclear staining (blue). 
Neural induction medium – Group B (B1163) 
 
Nestin + differentiated cells 
 
Sox1 + differentiated cells 
 
Sox2+ differentiated cells 
 
Pax6 + differentiated cells 




Neural stem cell markers in group C undifferentiated primary tooth pulp cells 
Mouse anti-human nestin (red), goat anti-human Sox1 (green), rabbit anti-human 
Sox2 (green), rabbit anti-human Pax6 (red) and DAPI nuclear staining (blue) were used. 
Stronger signals were detected for nestin, Sox2 and Pax6, which appeared to be 
associated with spindle-shaped cells, while Sox1 appeared as an intra-nuclear protein in 
round cell types (Figure 121).  
E8 medium – Group C (C2163) 
 
Nestin + Undifferentiated cells 
 
Sox1 + Undifferentiated cells 
 
Sox2+ Undifferentiated cells 
 
Pax6 + Undifferentiated cells 
Figure 121: Intra-nuclear and cytoplasmic protein expression of NSC markers in undifferentiated group C 
cells 
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Neural stem cell markers in neural induction group C primary tooth pulp cells 
Group C cell lines showed nestin-positive expression (red) within nuclei rather than 
in the cytoplasm as was seen in undifferentiated cells. Sox1-positive round cells (green), 
Sox2 (green) and Pax6 (red) followed the same pattern, being more nuclear and 
perinuclear rather than having widespread cytoplasmic expression as in differentiated 
groups A and B. DAPI was used for nuclear staining (blue). 
Neural induction medium – Group C (2163) 
 
Nestin + differentiated cells 
 
Sox1 + differentiated cells 
 
Sox2+ differentiated cells 
 
Pax6 + differentiated cells 
Figure 122: NSC markers expression in differentiated group C cells 
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Neural stem cell markers, a closer look 
Higher magnifications of nestin expression in differentiated and undifferentiated 
primary teeth pulp cells are shown in Figure 123.  
 
 
Figure 123: Positive nestin expression in A1053 cells (red) at higher magnification in (A) neural 




Higher magnifications of Sox1 expression in differentiated and undifferentiated 
primary teeth pulp cells are shown in Figure 124. 
 
  
Figure 124: Positive Sox1 expression at higher magnification (green) in neural differentiated A1953 cells 




B C  
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Higher magnifications of Sox2 expression in differentiated and undifferentiated 
primary teeth pulp cells are shown in Figure 125. 
 
  
Figure 125: Positive Sox2 expression (green) in neural differentiated A1953 cells (A and B) showing strong 
expression. (C) Undifferentiated A1953 showing the condensed nuclear localisation of Sox2 protein; DAPI 
nuclear stain (blue) 
A 
B C  
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Higher magnifications of Pax6 expression in differentiated and undifferentiated 




Figure 126: Pax6 expression (red) in neural differentiated A1953 cells (A and B); undifferentiated A1953 







Neural stem cell marker expression, a closer look 
The morphology of primary tooth pulp cell lines dramatically changed after 6 days of 
culture in neuronal induction media, with differentiated primary tooth pulp cell lines 
forming spike-like, spindle-shaped networks unlike that of the control GENEA002 and 
very different from the undifferentiated pulp cell lines (Figure 115). 
The undifferentiated primary tooth pulp cell lines also expressed NSC markers with 
different expression intensities. The differentiated GENEA002 positive controls highly 
expressed all four NSC markers. 
A noticeable reduction in cell numbers within differentiation cultures was also 
observed, suggesting significant cell apoptosis and cell death occurred as differentiation 
progressed. This may be attributed to the selective growth of neural-induced cells 
whereas the undifferentiated cells undergo apoptosis. 
Nestin, a protein considered a marker for undifferentiated neural precursor cells 
(Lendahl et al., 1990; Reynolds and Weiss, 1992; Tomita et al., 2005) is a class VI 
intermediate filament protein expressed in the cytoplasm of stem and progenitor cells 
in the mammalian CNS during development. Martens et al. (2012) reported that the 
nestin gene and protein were evident in their undifferentiated control of permanent 
tooth pulp cells. They attributed this finding to the use of animal sera (FBS 10%) with its 
growth factors in culture media promoting the in vitro expression of neural markers in 
cultured undifferentiated pulp cells. 
In the present study, nestin was strongly expressed in both differentiated and 
undifferentiated primary tooth pulp cells growing in serum-free, xeno-free medium. 
Nestin expression at the protein level was clearly visible in primary tooth pulp cells in IF 
studies (Chapter 2, Section 2.5.4) as well as in decalcified tooth sections (Chapter 3, 
Section 3.4.5) and was reconfirmed in the differentiation experiments described in this 
chapter. However, the pattern of nestin expression in primary tooth pulp cells was 
different, appearing juxtaposed to the nuclei of small, round cells in the neural-induced 
lines rather than being within the cytoplasm of larger, spindle-shaped undifferentiated 
pulp cells. In the undifferentiated state, nestin appeared outlining the cell cytoskeleton 
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extending to the cell processes, whereas in the differentiated cell it was localised within 
and around the nuclei (Figure 123). 
Sox1 expression was also different between differentiated and undifferentiated 
primary tooth pulp cells. Undifferentiated cells showed more nuclear and para-nuclear 
localisation whereas differentiated cells showed a more widespread expression within 
the cytoplasm (Figure 124). 
Sox2 is one of the early genes activated in the developing neural plate (Rogers et al., 
2009) but it also has a broader role in neural crest lineages and in maintaining 
multipotency in other stem cell types (Nelms, 2010). Sox2 and Oct4A are involved in the 
reciprocal regulation of each other's expression (Chew et al., 2005) and mediate Nanog 
activity (Rodda et al., 2005). A small increase in Sox2 protein triggers the differentiation 
into cell types that exhibit NE, mesoderm and trophectoderm markers (Kopp et al., 
2008). The expression of Sox2 at the protein level by undifferentiated primary tooth 
pulp cells, and the increased expression after neuronal induction, confirm the change 
into a neural progenitor state after neural induction (Figure 125). 
Pax6 is initially activated in most neural progenitors just before neuronal 
differentiation, and remains restricted to these proliferating progenitors supporting its 
role in maintaining neuronal precursors in the pre-differentiation state (Bel-Vialar et al., 
2007). Pax6 protein expression in primary tooth pulp cells showed relatively weak 
expression in the undifferentiated state but signals were stronger from neuronal-
induced cells, suggesting that primary tooth pulp cells initially were more neuronal in 
character in their naïve state and that the increase in Pax6 protein acts to maintain the 
cells in an immature pre-differentiated state (Figure 126). 
In the neural induction experiments performed in the present study, in vitro neural 
induction relied upon differentiation of primary tooth pulp cell monolayers; a method 
developed for ESCs by Ying et al. (2003). 
Cells are cultured in defined serum- and feeder-free conditions using E8 and Gibco 
Neural Induction Medium on a recombinant human VTN matrix (VTN-N). In such 
conditions, neural commitment relies on an autocrine induction mechanism where cells 
secrete a chemical messenger such as FGF4, as described by Kunath et al. (2007), which 
then binds to autocrine receptors on that same cell, leading to neuronal changes. This 
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occurs in the absence of inhibitors of neural fate such as BMPs, which are present in 
serum-containing media (Ying et al., 2003). 
Differentiated primary tooth pulp cells showed high expression of all NSC marker 
proteins. Markers were also detected in the undifferentiated pulp cell controls but not 
in the undifferentiated ESCs. This highlights the fact that primary tooth pulp cells are 
more committed to a neuronal fate. However, the functional capability of neurally 
induced primary tooth pulp cells still needs to be assessed through detailed 
characterisation investigating the cellular and molecular steps involved in promoting 
their differentiation towards functional neural lineages. This is an important step in 
further defining a more rational cell-based strategy for treating traumatic dental injuries 
that involve the dental pulp, and neurodegenerative diseases affecting the human 
nervous system. 
4.5 Cardiomyocyte differentiation 
4.5.1 Methods 
Primary pulp cells and GENEA002 underwent differentiation for 45 days using the 
PSC Cardiomyocyte Differentiation Kit (Gibco Cat# A25042SA). The kit consists of a set 
of serum-free and xeno-free media, Cardiomyocyte-differentiating Media A and B and 
Cardiomyocyte Maintenance Medium, which enables the differentiation of human PSCs 
into contracting cardiomyocytes. Differentiating media used required no thawing or 
mixing. Protocols developed by the manufacturer for PSC differentiation into 
cardiomyocytes recommends that differentiation media should be used consecutively 
over a total of 14 days to result in functional cardiomyocytes that express 
cardiomyocyte markers and auto-contract in culture. 
Primary tooth pulp cells at P5 were cultured as per the recommended protocols for 
VTN-N-coated chamber slides, as well as in 24- and 48-well culture plates, and 
expanded to 50% confluence prior to initiating the cardiomyocyte differentiation 
experiments. Once differentiation started, the cultures were fed every other day with 




Experimental design for cardiomyocyte differentiation 
Primary tooth pulp cells and GENEA002 were grown in cardiomyocyte differentiation 
media for 14 days as recommended by the manufacturer and then tested for the 
expression of markers. However, the IF signals were not clearly detected. The 
experiment was repeated in 48-well plates (Table 25), doubling the time held in each 
differentiation medium and keeping cells in maintenance medium for 45 days, which 
confirmed the visualisation of early cardiomyocyte progenitor markers. 
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A side experiment to produce functional contracting cardiomyocytes was performed 
using primary tooth pulp cell lines. Cells were grown in 24-well plates (Table 26) and 
maintained in Cardiomyocyte Maintenance Medium for 45 days. The cells were 
examined under an inverted microscope to assess contractility visually. 
 
Table 26: Design for cardiomyocyte differentiation and visual contractility experiments in 24-well plates 
A1953 B1963 C353 A1953 B1963 C353 
A1053 B1153 C2163 A1053 B1153 C2163 
A663 B2253 C2173 A663 B2253 C2173 
EMPTY EMPTY EMPTY EMPTY EMPTY EMPTY 
Cardiomyocyte differentiation Control E8 
 
Cardiomyocyte immunofluorescence procedure 
The Human Cardiomyocyte Immunocytochemistry Kit (Molecular Probes, Cat# 
A25973) was used to detect Nkx2.5 and TNNT2 protein expression in primary tooth pulp 
cells as well as in GENEA002 differentiated cells. 
Differentiated primary tooth pulp cells and controls were washed twice with washing 
buffer (Cat# A24348) and fixed with 4% formaldehyde (Cat# A24344) for 15 min at RT. 
After fixation, culture plates were washed with washing buffer (Cat# A24348), followed 
by 15 min of permeabilisation with 1% saponin in PBS (Cat# A24878) at RT. 
Cells were incubated for 1 h at RT in 3% BSA in PBS Blocking Solution (Cat# A24353) 
followed by an overnight incubation with cardiomyocyte markers anti-Nkx2.5 (Cat# 
A25974) and anti-TNNT2 (Cat# A25969) primary antibodies as well as matching IgG 
controls (mouse and rabbit) in 4°C, as shown in Table 25. 
On day 2, culture plates were washed three times with washing buffer and incubated 
with secondary antibodies for 1 h at RT in the dark. Alexa Fluor 488 donkey anti-mouse 
was used with anti-TNNT2 (Cat# A25972) and Alexa Fluor 594 donkey anti-rabbit (Cat# 
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A25970) with anti-Nkx2.5. After two washes, DAPI NucBlue Fixed Cell Stain (Cat# 
R37606) was added into the third wash step and incubated for 5 min. Plates were 
examined by fluorescent microscopy. Images were processed using Image J software to 
observe the expression of the cardiomyocyte progenitor’s proteins. Detailed IF 




Visual auto-contractility test 
 Functional cardiomyocytes can be effectively differentiated from human ESCs and 
iPSCs using inductive culture conditions to produce cells that beat rhythmically, express 
specific cardiac genes and phenotypically and physiologically resemble normal human 
cardiomyocytes (Gai et al., 2009). In the present study, primary tooth pulp cells induced 
to become cardiomyocytes did not show in vitro spontaneous contraction. The test was 
negative for auto-contraction even after maintaining the cells in Cardiomyocyte 




Figure 127: Undifferentiated primary tooth pulp cell control from group C at day 25 in E8–VTN-N culture 
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A change in cell morphology during the cardiomyocyte differentiation process was 
evident. The heterogeneous population of undifferentiated primary tooth pulp cells 
showed fusiform, spindle- and triangular-shaped cells (Figure 127). As cardiomyocyte 
differentiation progressed, cells grew into tightly packed homogeneous sheets of cells 
with large, flattened irregular cell morphology (Figures 128 and 129). 











Figure 128: Differentiated cells appeared irregular with less cytoplasmic processes. As differentiation 















Figure 129: Primary tooth pulp cells growing into colonies of densely packed cells with less secretory 
vesicles within their cytoplasm. Visible fibrillary organisation started to appear at day 7. Microfilaments 
were arranged in lines parallel to the cell’s long axis 
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After two weeks, primary tooth pulp cells growing in Cardiomyocyte Maintenance 
Medium changed from a patchy irregular orientation into more organised parallel-
arranged cellular sheets with parallel fibrillary patterns (Figure 130). 











Figure 130: At higher magnifications, differentiated primary tooth pulp cells displayed sharp edges and 
visible cytoskeletal fibres. Cells were polygonal, with vacuoles and various degrees of fibrillary 
organisation. More organised parallel intracellular fibrillary structures were observed at later stages of 
differentiation 
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Undifferentiated GENEA002 cardiomyocyte markers 
IF results for controls including undifferentiated (Figure 131) and differentiated 
GENEA002 cell lines (Figure 132) are presented. Mouse anti-human TNNT2 antibody 
(green) and rabbit anti-human Nkx2.5 antibody (red) were used as primary antibodies. 
Secondary antibodies were anti-mouse Alexa Fluor 488, anti-rabbit Alexa Fluor 594 and 












Figure 131: Undifferentiated GENEA002 controls at day 14 growing in E8–VTN-N 
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Differentiated GENEA002 cardiomyocyte markers 
GENEA002 cultured in cardiomyocyte differentiation medium and double stained for 
TNNT2 (green) and Nkx2.5 (red). TNNT2 appeared within the nuclei and, to a lesser 
extent, in the cytoplasm. Nkx2.5 showed weak cytoplasmic expression in association 



















Figure 132: GENEA002 cultured in cardiomyocyte differentiation medium and double stained for TNNT2 
(green) and Nkx2.5 (red) 
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Viable differentiated GENEA002 cells cultured in Cardiomyocyte Maintenance 
Medium on a VTN-N matrix exhibited different morphologies. Cells with nuclei of 
different sizes and shapes showed variable expression of both markers within the nuclei 
and in the perinuclear region as shown in Figure 133. Populations of small apoptotic 
cells were identified in cultures and stained faintly positive for both markers. 
In Figure 133 below, punctate areas of positive protein expression for TNNT2 (green) 
and Nkx2.5 (red) were observed.  
 
Figure 133: Double staining for TNNT2 and Nkx2.5 in differentiated GENEA002 cells. Nuclear marker 
expression varied among cells: larger cells expressed both markers in variable intensities as in (A) and (B) 
whereas others showed one marker (C and D) or no marker expression, as in (E). Apoptotic cells with 
ruptured nuclear membrane were seen, as in (F). Measurements were performed using ImageJ software 
  
B A C  
D E  
F  
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Cardiomyocyte differentiation immunoglobulin G controls 
The isotype negative IgG controls for cardiomyocyte markers in differentiated 
primary tooth pulp cell lines are shown in Figure 134. 





















Figure 134: Differentiated primary tooth pulp cells immunostained with matching IgG antibodies; rabbit 
IgG (Dako, Cat# X0936) and mouse IgG1 (Dako, Cat# X0931). Secondary antibodies: anti-mouse Alexa 
Fluor 488 and anti-rabbit Alexa Fluor 594. DAPI nuclear staining (blue) 
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Cardiomyocyte TNNT2 in primary tooth pulp cells 
TNNT2 protein showed nuclear and weak juxtanuclear expression in samples from 
the three groups of root resorption (Figure 135). Anti-mouse Alexa Fluor 488 secondary 
antibody (green)  was used. Reduced cell numbers in differentiated cultures was very 
clear. DAPI nuclear staining is shown in blue. 
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Figure 135: Cardiomyocyte TNNT2 positive expression in differentiated  and undifferentiated primary 
tooth pulp cells from the three groups (green) 
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Cardiomyocyte Nkx2.5 in primary tooth pulp cells 
The Nkx2 protein was expressed within the nuclei and as well as some weak 
juxtanuclear expression in primary pulp cells from all groups. Anti-rabbit Alexa Fluor 594 
secondary antibody (red) and DAPI nuclear staining (blue) were used. Reduced cell 
numbers were apparent in differentiated cultures compared with undifferentiated 
culture controls (Figure 136).  
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Figure 136: Cardiomyocyte Nkx2.5 positive expression in differentiated primary tooth pulp cells from the 
three groups (red) 
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TNNT2 and Nkx2.5, a closer look 
Cardiomyocyte TNNT2 expression (green) in differentiated primary tooth pulp cells 
at higher magnifications showed cells with spherical nuclei and punctate cytoplasmic 
localisation and to a lesser extent, within the nuclei (Figure 137A). Cells showing 
fusiform nuclear appearance with discrete positive staining for Nkx2.5 (red) is shown in 
Figure 137B.  
 
 
Figure 137: (A) Cardiomyocyte TNNT2 expression (green) in differentiated primary tooth pulp cells from 






Rationale for cardiomyocyte differentiation 
A unique feature of dental pulp cells is that they are of cranial neural crest cell origin. 
The neural crest cell population is extremely plastic in its migratory behaviour and fate 
(Kuo and Erickson, 2010), with remarkable multiple derivatives to which they can give 
rise. At the cranial level, neural crest cells migrate predominantly between the 
ectoderm and the underlying mesoderm, differentiating into the various components of 
the head and neck (Le Douarin, 2004). Cardiac or vagal neural crest cells represent a 
hybrid population of cells located in a transition zone between the head and the trunk; 
they share many characteristics with cranial neural crest cells, as they travel along the 
dorsolateral pathway of migration to reach the heart (Kuo and Erickson, 2010). 
Stem cells from primary and permanent tooth dental pulps have been considered to 
have the capacity for self-renewal and differentiation into mesenchymal lineages such 
as chondrogenic, osteogenic and adipogenic lineages. This classical view is being 
challenged in the present study via attempts to differentiate primary tooth pulp cells 
into cardiomyocyte progenitors. The question of whether primary pulp cells, which are 
descendants of the versatile neural crest cells, can cross lineage boundaries and fate 
restrictions to differentiate into cardiomyocyte progenitors does not appear to have 
been addressed previously. Aiming to answer this question, primary tooth pulp cells 
were here differentiated into cardiomyocyte progenitors. The study detected specific 
progenitor protein markers TNNT2 and Nkx2.5 via ICC. However, the ability of 
differentiated cells to auto-contract was not proven. This result was similar to those of 
Loo et al. (2014) for SHEDs. 
Non-beating cardiomyocyte progenitors 
Cardiomyocyte differentiation experiments have most utilised hESCs, which are a 
rather homogeneous population of ESCs, although hESCs are isolated and purified in 
vitro to produce auto-contractility and achieve structural maturation of hESC-derived 
cardiomyocytes. Beltrami et al. (2003) reported that spontaneous beating of hESC-
derived cardiomyocytes began on day 14 and matured cardiomyocytes with a well-
defined array of myofibrils similar to adult cardiomyocytes could only be identified on 
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day 100. There have been no reports of success in using dental stem cells to generate 
beating cardiomyocytes. 
Auto-contraction is dependent on a guidance system that builds individual myofibrils 
and aligns them into an ordered and coordinated array to produce noticeable auto-
contraction (Petit and Thiery, 2000). It is possible that the irregular arrangement of the 
cultured cells and their irregular fibrillary orientation in the present study resulted in 
failure to initiate auto-contraction. A further factor that may have affected the ability of 
cardiomyocyte progenitors to mature into functional cardiomyocytes was the quality 
and quantity of the population of pluripotent cells available for differentiation. 
It is believed that an ideal stem cell should differentiate into cardiomyocytes that 
integrate both mechanically and electrically with innate myocytes and should be able to 
form blood vessels to boost the blood supply for cardiac regeneration. Conversely, 
studies suggest that paracrine factors secreted by stem cells may play a more important 
role in the improvement of cardiac function (Chimenti et al., 2010). This has altered the 
belief that stem cells must differentiate into cardiac cell types to improve cardiac 
function. Accordingly, it is now thought that stem cell types of different potency can still 
improve cardiac function to a point comparable to stem cells committed to cardiac 
lineages (Urbich and Dimmeler, 2004). 
The aim of the current study was to assess the potential of primary tooth pulp cells 
to differentiate into cardiomyocyte progenitor cells expressing early progenitor 
cardiomyocyte markers rather than producing functional mature cardiomyocytes. Thus, 
IF experiments to detect these markers ended at day 45 and did not proceed further. 
However, exploring the functional aspects of the differentiating primary tooth pulp cell-
derived cardiomyocyte was believed to be worth investigating. 
Non-beating primary tooth-derived cardiomyocyte progenitors raised more 
questions than they answered. This will direct future investigations to clarify these 
outcomes and address potential challenges involved in using primary tooth pulp cells 
for cardiac regeneration in translational research. 
Early cardiomyocyte progenitor markers in primary tooth pulp cells 
Various parameters have been used to describe the changes that occur during 
cardiogenesis and these have involved both contractile and electrical function studies. 
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However, these approaches have limited value at the early stages of stem cell 
differentiation because the development and maturation of the excitation–contraction 
components, including ion channel formation, occur after the assembly of the early 
contractile apparatus (Bird et al., 2003). 
Troponin is an essential protein in cardiac muscle contractility (Zot and Potter, 1987). 
Studies have shown that TNNT2 plays a role in Ca2+ regulation during contraction and is 
expressed in differentiated cardiomyocytes along with desmin, β-myosin heavy chain 
and Nkx2.5 (Asumda and Chase, 2012; Qian et al., 2012; Sharma et al., 2004) in the 
early stages of differentiation. Asumda and Chase (2012) anticipated that early cardiac 
troponin proteins within nuclei could have important cellular functions beyond Ca2+ 
regulation of contraction, which involves cardiac-specific Ca2+-dependent signalling in 
the nucleus. 
The subcellular localisation of transcription factors is an important mechanism to 
regulate their activity. Many factors occupy the cytoplasm in their unstimulated state 
and are then imported into the nucleus to be activated. Others are located mainly in the 
nucleus, thus initiating expression of their target genes. However, both types end up 
being exported from the nucleus for recycling and/or regulating other events within the 
cell (Ferro et al., 2012; Xu and Massague, 2004). 
In the current study, the protein was uniquely expressed in the nuclei of 
cardiomyocyte-differentiated cells. The visualisation of TNNT2 within the nuclei and its 
surroundings (Figure 137) was similar to that reported by Asumda and Chase (2012) 




Chapter 5: General Discussion 
5.1 Stem cell niches in primary tooth pulps 
SCNs within primary tooth pulps located in the sub-odontoblastic and pulp core 
zones expressed a variety of stem cell protein markers in their naïve state without 
attempted differentiation. The in vitro differentiation experiments showed their 
potential for trans-differentiation and de-differentiation into various cell lineages. 
The expression of three different sets of stem cell markers in in vitro cultures of 
primary tooth pulp cell and the distribution of this expression in situ suggests that more 
than one stem cell population exists within primary tooth dental pulp. 
This heterogeneous population may be influenced by its embryonic origin; one 
having a neural crest character and the other having a mesenchymal origin similar to 
the heterogeneity found in permanent tooth dental pulps (Waddington et al., 2009). 
The presence of a heterogeneous stem cell population in primary tooth dental pulp is 
also consistent with the observed differences in genotype and protein expression 
patterns between permanent and primary pulp cells reported by Shi et al. (2005). 
However, this does not explain the expression of the three sets of stem cell markers by 
the odontoblastic and sub-odontoblastic cell layers as observed in the present IHC 
experiments. 
A question could be raised about the plasticity and degree of commitment of 
odontoblasts to their role in forming and maintaining dentine through the life cycle of 
the primary tooth. The present study data reinforce a possible role for odontoblasts as a 
progenitor cell expressing embryonic, mesenchymal and NSC proteins, thus supporting 
the commitment theory of Kardos and Kieser (2000a) discussed in Section 1.5.2. 
Within healthy tissues, progenitor cell niches usually maintain a quiescent state 
(Scadden, 2006) because of the influence of the environment in which they are found. 
Injury or trauma, leading to death of post-mitotic odontoblasts, stimulates a cascade of 
complex events whereby signals are released into the dentine matrix. These signals 
cause the progenitor cell population to become highly proliferative, leading to the 
generation of new terminally differentiated odontoblasts (Sloan and Waddington, 
2009). The present study IHC results showed that NSC and pluripotency marker 
expression was concentrated within the odontoblastic cell zone and to lesser degree 
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within the sub-odontoblastic zone, whereas MSC marker expression was spread among 
the pulp core cells, sub-odontoblastic and odontoblastic layers. 
The philosophical concept of ‘tabula rasa’, a Latin phrase often translated as ‘blank 
slate’ in English, can be used to describe the pluripotency state of stem cells. PSCs 
resemble the Roman blank tubula, being in a ground state or blank state as described by 
Smith (2010). However, stem cells are highly sensitive to their environment, interacting 
with specific signalling pathways to maintain their self-renewal and pluripotency. 
Orchestrated by transcription organisers like Oct4A, Nanog and Sox2, stem cells can 
begin an exit process from the tabula rasa state and select somatic lineage or germline 
differentiation paths. When these pathways are active, however, a destabilised 
transition state is created. Cells in this critical state are intermediate between 
commitment to a cell fate and a return to tabula rasa. 
This gradual mode of changing of the stem cell-associated protein expression in 
these cells, from the pulp core towards the odontoblastic layer, may denote a blank 
slate status where uncommitted cells begin to replace apoptotic cells within the dental 
pulp. Few primary tooth pulp cells showing intra-nuclear and cytoplasmic pluripotency 
protein markers can be considered to be in a tabula rasa state. More pulp cells 
expressed NSC proteins, pointing to their neural crest origin and their bias towards a 
neural fate. Finally, most cells within the dental pulp expressed MSC proteins, 
highlighting their well-documented mesenchymal stromal cell character. 
5.2 Pluripotential competence of primary tooth pulp cells 
Cultured cells from primary tooth pulp explants were studied to elucidate their 
pluripotential and differentiation capabilities. The IF studies performed to detect 
marker expression indicated that primary tooth pulp cells in their naïve state in vitro 
expressed mesenchymal and neural progenitor protein markers and, to a lesser extent, 
ESC markers (Chapter 2). These results imply that cultured cells can be destabilised into 
a transitional state and maintained in this state using E8–VTN-N. This is supported by 
the expression of ESC markers Oct4A, Nanog and Sox2 in culture by different 
populations with different morphologies. Moreover, cultured cells from all cell lines 
showed consistent high expression of the NSC proteins nestin and Dlx2, verifying their 
neuronal progenitor signature. Finally, the transitional state primary pulp cells showed 
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marked positive protein expression of MSC markers. This was demonstrated by IF 
experiments and confirmed by high levels of MSC-positive markers and low levels of 
haemopoietin negative markers, fulfilling the requirements by ISCT as MSCs. 
The expression of nestin and Dlx2 proteins as markers of NSCs was evident in situ 
within odontoblasts and their tubules via the IHC studies performed and in vitro via IF 
studies without attempting neuronal induction. The high protein expression visualised 
by both IHC and IF experiments was independent of the stage of root resorption. Nestin 
and Dlx2 appeared stronger in naïve cultured cells that show the typical neuronal 
perikaryal appearance (i.e., spherical cell bodies with long cytoplasmic extensions and 
secondary branches) and in odontoblasts in situ. Following neuronal induction, 
differentiated primary tooth pulp cells showed high expression of all NSC marker 
proteins assessed, including nestin, Sox1, Sox2 and Pax6. 
Pluripotential competence, which is defined as the ability to generate all types of 
specialised tissues including germ cells (Hatano et al., 2005), has been shown here in 
primary tooth pulp cells for the first time, as far as is known. Protein expression of the 
three lineage-determining transcription factors Otx2, Brachyury and Sox17 was 
visualised, demonstrating that ectoderm, mesoderm and endoderm progenitors can be 
established from human primary tooth pulp cells. Finally, in vitro cultured primary tooth 
pulp cells were differentiated into cardiomyocyte progenitors showing the expression of 
early cardiomyocyte protein markers TNNT2 and Nkx2.5. These findings support the 
idea that primary tooth pulp cells have pluripotential competency that may be utilised 
in regenerative medicine. 
5.3 Future directions, dental pulp regeneration and the whole tooth model 
Stem cell populations residing in primary tooth pulps can theoretically be utilised to 
regenerate damaged pulp tissue in developing teeth with incomplete apical closure. 
This concept has been explored using stem cells from apical papillae of developing teeth 
in dogs (Huang et al., 2008c; Sonoyama et al., 2008), raising the possibility of whole pulp 
regeneration after pulpectomy in permanent immature teeth. The regeneration of pulp-
like tissue with odontoblast-like cells in an empty root canal space was achieved (Huang 
et al., 2010b) by transplanting human stem cells from apical papilla and DPSCs into an 
immunocompromised mouse model. 
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To achieve regeneration, transplanted cells require nutrition and oxygen in the 
empty root canals, as well as stem cells that can induce angiogenesis de novo (Iohara et 
al., 2008; Nakashima et al., 2009). 
 
Figure 138: Whole tooth culture system (adopted from Tecles et al., 2008). The tooth is fixed by the 
crown to a wire (A) and suspended in culture medium in 12-well culture plates (B), thus permitting 
diffusion of the medium through the apex In the modified model presented in Figure 138, 
impacted third molar teeth that are freshly extracted could be used as a whole tooth 
culture to assess the regeneration potential of different sub-populations of primary 
tooth pulp cells. Pulp cavities of extracted wisdom teeth are exposed and root canals 
are debrided and disinfected, mimicking a non-vital tooth situation. The teeth are then 
placed in a 12-well culture plate with E8 medium and a fibrin hydrogel scaffold is 
injected directly into the pulp space followed by transplantation of FACS sub-
populations of primary tooth pulp cells divided into three groups: nestin+/Dlx2+; 
CD105+/CD73+/CD90+; and Oct4A+/Nanog+/Sox2+. The access is then sealed with glass 
ionomer cement. Transverse sections are cut in the cultured tooth 8–12 weeks after the 
regenerative treatment, fixed with 4% formalin, decalcified with buffered 10% EDTA 
and then embedded in paraffin. De-paraffinised sections can then be prepared for 
histological and immunological analysis. This model can potentially allow for the 
characterisation of FACS sub-populations from primary pulp cells compared with an un-
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sorted population of cells growing in ex vivo models with a serum-free, xeno-free E8 
medium. This will allow assessment of the ability of pulp cells to reorganise and lay 
down dentine under the influence of root dentine and a fibrin scaffold.  
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Chapter 6: Conclusion 
Regeneration methods based on progenitor cell recruitment and subsequent 
stimulation provide an attractive alternative to conventional root canal therapy because 
of the possibility of replacing diseased or non-vital dental tissues with natural vital 
tissue. An understanding of the characteristics of primary tooth pulp cells is critical for 
the future development of regenerative therapies based on utilisation of these 
progenitor cells in the primary dental pulp. It is tempting to speculate that such novel 
clinical treatments will come to fruition, but we are some way from taking this 
knowledge from the laboratory to the clinic. We clearly have an opportunity to move 
regenerative dentistry into a new era, harnessing the biological activity of primary 
dental pulp cells to facilitate pulp tissue regeneration. However, we are still some 
distance from fully understanding the potentiality and behaviour of primary tooth pulp 
progenitor cells in vivo, and subsequent clinical treatment modalities. 
Primary pulp cells isolated by explant culture techniques described in this study and 
grown in vitro with serum-free, xeno-free system of E8–VTN-N are strongly adherent, 
highly proliferative cells. The use of E8 medium in combination with VTN-N coating as 
described previously provided an optimal environment for pulp cells to maintain a 
progenitor state while expressing the three sets of stem cell marker proteins. The 
methods used in this study quantitatively assessed the expression of mesenchymal 
stromal cell markers according to the ISCT criteria using flow cytometry analyses. 
In this study, the majority of cultured primary pulp cells from the three resorption 
groups expressed the protein markers of mesenchymal stromal cells confirming the 
current study’s first hypothesis. Most cells expressed the early neural progenitor 
markers nestin and Dlx2 and some expressed ESC transcription factors Oct3/4, Nanog 
and Sox2. Cultured cells were capable of multilineage differentiation, qualifying them as 
a unique class of ecto-mesenchymal cells, confirming the second hypothesis proposed 
in the present study (page 48).  
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Experimental results provided evidence that primary tooth pulps harbour different 
sub-populations of progenitor cells that are capable of de-differentiation and trans-
differentiation, which qualifies them to be classified as PSCs.  
In the present study there was no evidence of a difference in marker expression or 
differentiation potential between primary teeth at different stages of root resorption. 
Thus the third hypothesis could not be confirmed.  
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Chapter 7: Appendices 




7.2 Information packs and consent forms 
7.2.1 Information sheet for parents/guardians 
Study title: 
Isolation and characterisation of multipotent cells in primary human tooth pulp at 
three different stages of tooth resorption 
Principal 
investigator: 
Name Bernadette Drummond 






Thank you for showing an interest in this project. Please read this information sheet carefully. 
Take time to consider and, if you wish, talk with relatives or friends before deciding whether to 
participate. If you decide to participate, we thank you. If you decide not to take part there will be 
no disadvantage to you and we thank you for considering our request. 
About the study 
The aim of this project is to study the cells from extracted baby teeth under the microscope 
with special staining. The study is part of Mr Al Ansary’s PhD research, which will examine the 
cells from extracted baby teeth and determined if they could regenerate the different tissues of 
the tooth including nerves, blood vessels, and the hard tooth tissue. The teeth will be examined 
under a microscope using a staining technique known as immunohistochemistry, which allows 
the identification of different types of cells in the tooth. Cells from the pulp (centre of the tooth) 
will also be grown in the laboratory to understand better how they behave. They will be 
characterised using immunohistochemistry and how key genes and proteins respond in culture 
will be determined. This research will help to improve the way damaged teeth are treated thus 
improving outcomes after dental injuries. This research is funded by grants from the University 
of Otago and New Zealand Dental Association Research Foundation. 
Who are we seeking to participate in the project? 
Healthy children aged from 4 to 12 years who require extractions of primary (baby) teeth as 
part of their treatment plans. Teeth, which have minimal damage, only will be included in the 
study. 
If you participate, what will you be asked to do? 
Should you agree to take part in this project; you will be asked to give written informed 
consent to allow us to collect your child’s extracted tooth/teeth. Your child will also be given 
information about the study and asked if they would like to donate their extracted teeth. 
Children will be given $3.00 for each tooth as a replacement for the Tooth Fairy payment. Your 
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child will not take any medication or undergo any procedure additional to that was part of their 
original dental treatment plan. 
Please be aware that you may decide not to take part in the project without any 
disadvantage of any kind to you or your child. 
What data or information will be collected, and how will they be used? 
Information collected will include your child’s age, sex, general medical health, reason for 
extraction, and a copy of the X-ray of the tooth to assess the shape and condition of the tooth. 
This information will confirm the stage of development of the tooth. If you wish to be informed 
about the results of this study, your postal address will be also recorded to send you the results 
by mail. 
It is planned to collect a total of 60 extracted teeth from patients in this study. The teeth will 
be divided into three groups based on the shape of the tooth, which indicates how close it was to 
falling out. Five teeth from each group will be fixed and embedded so they can be stained using 
the procedure known as immunohistochemistry. The inside (pulp) of the remaining teeth will be 
removed and cultured in sterile conditions in the laboratory looking at what types of cells they 
can become. We will be examining these cells using immunohistochemistry and investigating 
how key genes and proteins respond in culture. 
Storage and use of tissue for future research: 
At the end of the study we would like to store your child’s teeth or cells taken from their teeth 
for future studies looking at these types of cells. Any such future studies will only be carried out 
with appropriate ethical approval. Please notify the researchers if you do not want this to occur. 
As samples of human tissue will be taken during this study, there may be cultural issues 
associated with storing tissue that need to be discussed with your family/whanau. Some Iwi 
disagree with storage of human tissue citing whakapapa and advise their people to consult prior 
to participation in research where this occurs. To avoid problems at a later stage, we suggest 
your family/whanau is involved with you at all stages of the research. However, we also 
acknowledge that individuals have the right to choose to participate. 
What about anonymity and confidentiality? 
No material that could personally identify your child will be used in any reports in this study. 
The information collected about your child will be securely stored in such a way that only those 
mentioned below will be able to gain access to it. In the laboratory the tissue/cells will only be 
identified by a number. At the end of the project any personal information will be destroyed 
immediately except that, as required by the University's research policy, any raw data on which 
the results of the project depend will be retained in secure storage for 10 years after your child 
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turns 16 years, after which it will be destroyed. Access to this information will be limited to 
researchers, supervisors, research assistants, and staff making photocopies. 
The results of the project will be included in Mr Al Ansary’s thesis and may be published in an 
international publication. They will be available in the University of Otago Library (Dunedin, New 
Zealand) but every attempt will be made to preserve your anonymity. 
If you agree to participate, can you withdraw later? 
You may withdraw from participation in the project at any time before donated teeth are cut 
into sections and processed in the laboratory without any disadvantage to yourself or your child. 
Any questions? 
If you have any queries or concerns about your rights as a participant in this study you may 
wish to contact a Health and Disability Services Consumer Advocate. This is a free service 
provided under the Health and Disability Commissioner Act. 
Telephone: (03) 479 0265 or free phone: 0800 555 050 or free fax: 0800 2787 7678 
 (0800 2 SUPPORT) or email: advocacy@hdc.org.nz 
You are welcome to have a friend or family support to help you with any other explanation you 
may require. You may bring another person to your clinical visit. 
If you have any questions about our project, either now or in the future, please feel free to 
contact either: - 
Mohammad Alansary   and/or Professor Bernadette Drummond 
Department of Oral Sciences    Department of Oral Sciences 
University Telephone Number: 479 5667 Telephone Number: 0272724332 
Email: Email bernadette.drummond@otago.ac.nz 
Thank you 
This study has been approved by the University of Otago Human Ethics Committee (Health). If you have 
any concerns about the ethical conduct of the research you may contact the Committee through the 
Human Ethics Committee Administrator (ph 03 479 8256). Any issues you raise will be treated in 




7.2.2 Consent form for parents/caregivers 
Principal Investigator: Professor Bernadette Drummond 
(bernadette.drummond@otago.ac.nz). Telephone Number: 0272724332 
Following signature and return to the research team, this form will be stored in a secure 
place for 10 years after your child turns 16 years. 
Name of participant (Child):  
Name of parent/caregiver: 
I have read the information sheet concerning this project and understand what it is about. 
All my questions have been answered to my satisfaction. I understand that I am free to 
request further information at any stage. I know that: - 
My child’s and my participation in the project is entirely voluntary; we are free to withdraw 
from the project at any time without any disadvantage; we know whom to contact if we have 
any questions about this study. 
Personal identifying information will be destroyed at the conclusion of the project but any 
raw data on which the results of the project depend will be retained in secure storage for 10 
years after my child turns 16 years of age. 
The results of the project may be published and available in the University of Otago Library 
(Dunedin, New Zealand) but every attempt will be made to preserve my anonymity. 
During and at the end of the study, I consent to any remaining samples being disposed of 
using: 
 Standard disposal methods Postal Address 
(If you wish to 
receive the results 




Disposed with appropriate 
karakia 
At the end of the study we would like to store your child’s teeth or cells 
taken from their teeth for future studies. Any such future studies will only 
be carried out with appropriate ethical approval 
Agree  
Don’t Agree  
I agree to take part in this project. 
Signature of Parent/caregiver: 
 Date: 
   
Signature and name of witness: 
 Date: 
   
   
This study has been approved by the University of Otago Human Ethics Committee (Health). If you 
have any concerns about the ethical conduct of the research you may contact the Committee through the 
Human Ethics Committee Administrator (ph 03 479 8256). Any issues you raise will be treated in 
confidence and investigated and you will be informed of the outcome. 
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7.2.3 Information for children 
 
Study of Baby Teeth and How they Grow and Get Loose 
INFORMATION FOR CHILDREN 
Thank you for reading about this study. 
What is the study about? 
The study is part of Mr Al Ansary’s research. He is going to look at baby teeth 
that children give him and study them under a microscope to see how they 
grow and if they can repair adult teeth that have been broken in accidents. 
What do you need to do?    
You are having a tooth or teeth taken out to help your new teeth grow. We 
would like you to give your teeth for science to help us learn more about how 
teeth grow and how they can help repair broken teeth. If you can help us we 
will give you $3.00 for each tooth. We will also tell you later what we find out 
about the teeth we study. If you don’t want to give up your tooth, there is no 
problem; you can take it home with you. 
What if you have any questions? 
If you have any questions for us, you can call Mohammad or Bernadette: - 
Mohammad Alansary   Bernadette Drummond 
479 5667     0272724332 
This study has been approved by the University of Otago Human Ethics Committee (Health). If you have 
any concerns about the ethical conduct of the research you may contact the Committee through the 
Human Ethics Committee Administrator (ph 03 479 8256). Any issues you raise will be treated in 
confidence and investigated and you will be informed of the outcome. 
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7.2.4 Consent form for children 
 
Study of Baby Teeth and How they Grow and Get 
Loose 
CONSENT FORM FOR CHILDREN 
I have read about the study and my questions have been answered and I 
know I can ask more questions about it if I want to. 
I know that: - 
1. I can choose to give my tooth/teeth to the study or not; 
 
2. I can decide not to give my tooth/teeth for the study; 
 
3. I will get $3.00 for each tooth I give to the study; 
 
4. I know whom to call if I have any questions about this study 
 
4. I know that Mr Al Ansary will write about the teeth but no one 
will know which teeth are mine. 
 
I agree to take part in this study. 




.............................................................................  .............................. 
 (Signature)         (Date) 
 
This study has been approved by the University of Otago Human Ethics Committee. 
If you have any concerns about the ethical conduct of the research you may contact the Committee 
through the Human Ethics Committee Administrator (ph 03 479 8256). Any issues you raise will be 
treated in confidence and investigated and you will be informed of the outcome. 
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7.3 Cell markers used in characterisation of dental stem cells 
Databases used: 
 Entrez (http://www.ncbi.nlm.nih.gov/) 
 OMIM (http://omim.org/) 
 Wikigenes (http://www.wikigenes.org/) 
 UniProt KB (http://www.uniprot.org) 
 Human Protein Reference Database (http://www.hprd.org/) 
 SIB ExPASy/Bio Informatics Resource Porta (http://enzyme.expasy.org) 
Markers proposed by the ISCT and their citations (Table 27) 
Table 27: Minimal criteria for defining multipotent mesenchymal stromal cells 
Criteria Description and citations 
95% or more of the cells should 
express at least these markers to be 
considered multipotent 
undifferentiated mesenchymal cells 
according to the ISCT position 
statement (Dominici et al., 2006). 
CD105, also known as CXCR4 (OMIM *162643) 
CD73, also known as NT5E 5’-nucleotidase (OMIM 
*129190) 
CD90 also known as THY-1 (OMIM *188230) 
Citations: Abe et al., 2,012; Adrian et al., 2000; Alongi et 
al., 2010; Alt et al., 2011; Bakopoulou et al., 2012; Blasi et 
al., 2011; Chen et al., 2011b; Dissanayaka et al., 2011; 
Huang et al., 2010b; I et al., 2011; Ikeda et al., 2006; 
Iohara et al., 2011; Marchionni et al., 2009; Mokry et al., 
2010; Nakashima et al., 2009; Struys et al., 2011; 
Tomokiyo et al., 2012; Yalvac et al., 2010; Yamada et al., 
2010; Yamaza et al., 2010; Yoshimura et al., 2006; Zhang 
et al., 2012 
The lack of expression of 
haematopoietic antigens in 
2% or less of cell population 
is to be used as an 
additional criterion. 
CD45, also known as leukocyte–common antigen (OMIM 
*151460) 
CD34, also known as haematopoietic progenitor cell antigen 
(OMIM *142230) 
CD14, also known as monocyte differentiation antigen (OMIM 
*158120) 
CD11b, also known as integrin alpha M (OMIM *120980) 
CD79a, also known as B lymphocyte-specific MB1 protein (OMIM 
*112205) 
CD19, also known as B lymphocyte antigen (OMIM *107265) 
Citations: Alongi et al., 2010; Alt et al., 2011; Bakopoulou et al., 
2011a; b; c; 2012; Bernardi et al., 2011; Blasi et al., 2011; Chen et 
al., 2011b; Dissanayaka et al., 2011; Goldman et al., 2009; Huang 
et al., 2010a; I et al., 2011; Iohara et al., 2008; 2009; Ishikawa et 
al., 2012; Karaöz et al., 2010; Karbanova et al., 2011; Lin et al., 
2011a; Marchionni et al., 2009; Nakashima et al., 2009; 
Nourbakhsh et al., 2011; Russell et al., 2010; Seo et al., 2004; Shi 
and Gronthos, 2003; Struys et al., 2011; Tete et al., 2008; Yamaza 
et al., 2010; Yoshimura et al., 2006 
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Pluripotent and neural stem cell markers (Tables 28 and 29) 
Table 28: PSC markers used in dental stem cell characterisation 
Marker Description and citations 
Oct4 
(POU5F1) 
(OMIM *164177) This transcription factor is considered a main regulator of ESC 
pluripotency and self-renewal abilities (Beltrami et al., 2009; Boyer et al., 2005; 
Nichols et al., 1998; Saxe et al., 2009). It is involved in maintaining the 
undifferentiated pluripotent state and may also prevent expression of genes 
activated during differentiation. Such stemness properties are attributed to 
Oct4A, an isoform produced by the Oct4 gene that behaves as a nuclear protein 
(Lee et al., 2006). Bernardi et al. (2011) used RT-PCR to detect Oct4A expression 
in resorbing primary tooth pulps; Huang et al. (2008a) used the same technique 
but on supernumerary teeth. 
Cited in: Alt et al., 2011; Bernardi et al., 2011; Boyer et al., 2005; Cavaleri and 
Scholer, 2003; Chambers et al., 2003; Ferro et al., 2012; Govindasamy et al., 
2010; Huang et al., 2008a; 2009b; Karaöz et al., 2010; Kerkis et al., 2006; Lizier 
et al., 2012; Marynka-Kalmani et al., 2010; Miyoshi et al., 2010; Nichols et al., 
1998; Osathanon et al., 2011; Pan et al., 2002; Rodda et al., 2005; Saxe et al., 
2009; Sridharan et al., 2009; Thomson et al., 2011; Wada et al., 2011; Wang and 
Dai, 2010; Yalvac et al., 2010; Yu et al., 2007 
Sox2 
(OMIM *184429) A marker of both stem cells and uncommitted 
neuroepithelium. One of a set of transcription factors that are crucial for the 
maintenance of pluripotency. 
Cited in: Boyer et al., 2005; Clewes et al., 2011; Ferri et al., 2004; Govindasamy 
et al., 2010; Karaöz et al., 2010; Karbanova et al., 2011; Liu et al., 2011; Mitsui et 
al., 2003; Oda et al., 2010; Pan and Thomson, 2007; Rodda et al., 2005; 
Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Thomas et al., 2008; 
Thomson et al., 2011; Yalvac et al., 2010 
Nanog 
(OMIM *607937) A homeobox-containing transcription factor with an essential 
function in maintaining the pluripotent cells of the ICM and in the derivation of 
ESCs (Mitsui et al., 2003). Overexpression of Nanog is capable of maintaining the 
pluripotency and self-renewing characteristics of ESCs under what normally 
would be differentiation-inducing culture conditions. 
Cited in: Alt et al., 2011; Amit and Itskovitz-Eldor, 2006; Boyer et al., 2005; 
Cavaleri and Scholer, 2003; Chambers et al., 2003; Dissanayaka et al., 2011; 
Ferro et al., 2012; Govindasamy et al., 2010; Huang et al., 2008a; Karbanova et 
al., 2011; Kaukua et al., 2015; Mitsiadis et al., 2003; Mitsui et al., 2003; Pan and 
Thomson, 2007; Takahashi and Yamanaka, 2006 
Pax6 
(OMIM *607108) A paired box (Pax) transcription factor expressed in region-
specific neural progenitors is uniformly expressed in hESC-derived NE. May play 
a novel role in human NE specification. Overexpression of Pax6 in hESCs down-
regulates pluripotent gene expression. 
Cited in: Govindasamy et al., 2010; 2011; Ishkitiev et al., 2013; Morsczeck et al., 
2010; Wada et al., 2011; Zhang et al., 2010 
Podocalyxin  
(OMIM *602632) A protein expressed on undifferentiated hESCs, embryonic 
carcinoma cells and embryonic germ cells. Podocalyxin is a carrier of the TRA-1-
60 and TRA-1-81 human stem cell antigens found on the surface membrane of 
human stem cells. 
Cited in: Guest and Allen, 2007; Kerkis et al., 2007; Nielsen and McNagny, 2008; 
Schopperle and DeWolf, 2007 
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Table 29: Neural crest progenitor cell markers used in dental stem cells characterisation 






(OMIM *600915) An intermediate filament protein expressed primarily and predominantly in 
stem cells of the CNS in the neural tube. About et al. (2000b) suggested that nestin plays a 
potential role in odontoblast differentiation. Reactivity for nestin could be detected in the 
odontoblasts, stratum intermedium and in some of the apical processes of the ameloblasts. In 
young permanent teeth, nestin is found only in functional odontoblasts. Its expression is 
progressively down-regulated and it is absent from older permanent teeth (Liu et al., 2006). 
Cited in: Abe et al., 2012; About and Mitsiadis, 2001; About et al., 2000a; 2000b; Ali et al., 2009; 
Chen et al., 2007; Gosau et al., 2013; Govindasamy et al., 2010; Hirata et al., 2010; Honda et al., 
2007; Huang et al., 2008a; 2008b; Ishikawa et al., 2012; Karaöz et al., 2010; Karbanova et al., 
2011; Kerkis et al., 2006; Kiraly et al., 2009; Lendahl et al., 1990; Liu et al., 2006; Lizier et al., 
2012; Miura et al., 2003; Nourbakhsh et al., 2011; Reali et al., 2006; Ryu et al., 2009; Sasaki et al., 




(OMIM *608160) A transcription factor expressed in neural crest cells. Mori-Akiyama et al. (2003) 
found that inactivation of Sox9 in mouse neural crest resulted in a complete absence of cartilage 
and endochondral bone derived from the cranial neural crest. However, all of the mesodermal 
skeletal elements and intramembranous bones were essentially conserved. 




 (OMIM *602229) Member of the Sox (SRY-related HMG box) family of transcription factors 
involved in the regulation of embryonic development and the determination of cell fate. This 
protein is important for neural crest and peripheral nervous system development. 




 (OMIM *123101) Msx2 is a transcription repressor whose normal activity may establish a balance 
between survival and apoptosis of neural crest-derived cells required for proper craniofacial 
morphogenesis. 
Cited in: Bei and Maas, 1998; Degistirici et al., 2008; Peng et al., 2010 
The Dlx gene family is composed of six genes arranged in three clusters. During normal 
development, all Dlx genes are expressed in the dental ectomesenchyme. Dlx2 (OMIM *126255), 
Dlx5 (OMIM*600028) and Dlx3 (OMIM *600525) have received the greatest attention (Ghoul-
Mazgar et al., 2005). Dlx3 is a transcription factor expressed in the neural crest and implicated 
during development of epithelial tissues such as skin, hair follicles, otic and olfactory placodes, 
limb bud and tooth germ. Both Msx and Dlx homeoproteins are encoded by transcription factors 
involved in normal tooth development. Their expression is regulated by several molecular signals 
including the bone morphogenetic proteins Bmp2 and Bmp4 (Bei and Maas, 1998). 
Cited in: Bei and Maas, 1998; Degistirici et al., 2008; Ghoul-Mazgar et al., 2005; Lee et al., 2011; 










 (OMIM*604238) A master regulator of epithelial to mesenchymal transition (Vinas-Castells et al., 
2010). 





(OMIM *6016221) A transcription factor essential for mesoderm specification and 
differentiation. Highly expressed in the mesoderm-derived embryonic mesenchyme (Qin et al., 
2012). It is believed to maintain mesenchymal cells in an undifferentiated state by negatively 
regulating Runx2, which is a critical osteoblast differentiation transcription factor essential for 
bone formation. 
Cited in: Bialek et al., 2004; Degistirici et al., 2008; Li et al., 2011; Qin et al., 2012; Vinas-Castells 




7.4 Culture, expansion, freezing and thawing of primary pulp cells 
All procedures are conducted under aseptic conditions in a Class II culture hood. 
7.4.1 VTN-N preparation and application 
VTN-N, truncated recombinant human VTN (Invitrogen, Cat# A14700) 
Procedure 
i. Stock VTN stored at –80oC should be thawed at RT and aliquots in polypropylene 
tubes prepared. Aliquots are kept frozen at –80°C until used. 
ii. Remove VTN aliquots from –80°C storage as needed and thaw at RT (10 µL stock 
VTN makes 1 mL diluted solution at a recommended concentration of 0.5 µg /cm2). 
iii. Recommended working concentration of VTN (0.5 µg/cm2) is prepared by mixing 
sterile PBS without calcium and magnesium (Gibco, Cat# 1000072) with stock 
concentration VTN-N (0.5 mg) based on the required volume (Table 30) needed for 
each culture vessel in a sterile Falcon tube at RT. VTN is gently suspended by 
pipetting the solution up and down. 
iv. Aliquot 2.5 mL diluted VTN-N solution for each T25 flask and 7.5 mL for each T75 
flask (Table 29). 
v. Incubate at RT for 1 h. Aspirate the excess VTN-N solution and discard just before 
use. Do not allow the vessel to dry. Coated plates can be used or stored at 2–8° C 
sealed in laboratory film for up to 1 week. 
 
Table 30: Recommendations by Life Technologies for VTN-N coatings—publication part number 
MAN0007035 
Approximate surface area Required volume of diluted vitronectin 
T25 25 cm2 2.5 mL 




7.4.2 E8 medium preparation 
Complete E8 used in this study is prepared by mixing the following: 
 E8 Basal Medium (Invitrogen, Cat# A1517001) 
 E8 Supplement (Invitrogen, Cat# A15171-01) 
 Antibiotic–Antimycotic 100X (Anti–Anti; Invitrogen, Cat# 15240) 
Procedure 
i. Remove 15 mL from E8 Basal Medium bottle under sterile conditions in a Class II 
culture hood. 
ii. Add 10 mL E8 Supplement to 485 mL of E8 Basal Medium . The supplement is 
stored at –20°C and should be thawed overnight at 2–4°C. 
iii. Add 5 mL Anti–Anti. Pre-aliquoted frozen Anti–Anti vials are thawed in 37°C water 
bath. Allow time to thaw completely. 
iv. Complete media can be stored at 2–8°C for 1 month. 
7.4.3 EDTA 0.5 mM 
To prepare 50 mL of 0.5 mM EDTA in PBS, the following steps are performed 
aseptically: 
i. 50 mL PBS Ca2+ and Mg2+ free (Gibco, Cat# 10010072) is mixed with 50 µL of 0.5M 
EDTA (Invitrogen UltraPure 0.5M EDTA, Cat# 15575020). 
ii. The solution is then sterilised using a 0.22-µM filter (Merck Millipore, Cat# 
SLGP05010) to be used immediately or stored at 2-8°C for up to 6 months. 
iii. 2.5 mL of 0.5 mM EDTA in PBS is needed for one T25 flask. 
7.4.4 Passaging with EDTA in E8 complete medium 
(Timing: 10–12 min per plate) 
i. Place a new 6-well plate that has been coated with VTN-N and warmed to RT (20–
25°C) in the tissue culture hood. Warm the 0.5 mM EDTA solution to RT. 
ii. Label the new VTN-N coated plate and aspirate the VTN-N from the well. Replace 
with 1.5–2 mL complete E8 medium (E8 Basal Medium + E8 Supplement + Anti–
Anti) per well. 
iii. Aspirate media from the primary explant culture flask when cells are 80% confluent 
and ready to split. Rinse the wells with 1 mL/well PBS solution calcium and 
magnesium free (Gibco, Cat# 10010072). Repeat the wash. 
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iv. Add 1 mL/well of 0.5 mM EDTA solution and let it sit for 5–8 min at RT in the hood. 
Keep movement of the plate to a minimum to avoid lifting the colonies completely 
off the plate during this step. 
v. After 5–8 min, examine under the inverted microscope to assess cell detachment 
and rounding (Figure 139). Carefully aspirate the EDTA solution, leaving the cells 
attached. Add 1–2 mL of complete E8 medium rapidly to wash the colonies off the 
plate and disperse the cells. The calcium and magnesium in the medium will 
neutralise any remaining EDTA. This should be performed quickly as the colonies 
start to reattach to the plate rapidly after the addition of E8. 
 
Figure 139: Primary pulp cells starting to detach and lift off the VTN-N-coated culture plate after 
5 min treatment with EDTA solution at RT. Cells develop a round outline as they detach from 
the plate 
vi. Ensure that the cell suspension is well mixed and then plate the desired number of 
cells per well into the newly prepared plate. The procedure for cell counting is 
described in Section 7.4.5 below. Pulp tissue explants are left in the original culture 
plate with 2 mL complete E8 medium (Basal Medium + Supplement + Anti–Anti) per 
well and incubated for further primary cell outgrowth. 
vii. Move the new culture plate in a figure-of-eight pattern to distribute the cells. Place 
the plate in a cell culture incubator at 37°C with 5% CO2. Let it sit undisturbed 
overnight for maximum attachment. 
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viii. On the following day, remove E8 medium from a 4°C refrigerator, let it sit for 1 h at 
RT to warm. Remove the medium from cells and add 2 mL fresh E8 medium to each 
well in the 6-well plate. 
ix. On each following day, repeat step viii, monitor the cells daily and when confluence 
reaches ~80%, repeat steps i–vii. Passage the cells for the desired number of 
passages. Proceed with freezing or begin immunostaining experiments. 
7.4.5 Viable cell counting—Trypan Blue exclusion method 
Cell viability is calculated as the number of viable cells divided by the total number of 
cells within grids on the haemocytometer (Figure 140, Table 30). Cell counting is 
conducted with 0.4% solution of Trypan Blue in PBS, pH 7.2–7.3 (Gibco, Cat# 10010072) 
as follows: 
i. Add 15 μL Trypan Blue + 15 μL cell suspension to a 1 mL tube in the culture hood. 
ii. With the cover slip in place, use a pipette to transfer a small amount of the Trypan 
Blue–cell suspension mixture to both chambers of the haemocytometer. Carefully 
touch the edge of the cover slip with the pipette tip and allow each chamber to fill 
by capillary action. Do not over- or under-fill the chambers. Examine immediately 
under an inverted microscope at low magnification. 
iii. Starting with chamber 1 of the haemocytometer, count all the viable cells in the top 
left (4 x 4) square and follow a systematic sequence. Non-viable cells will stain blue. 
Keep a separate count of viable and non-viable cells. Repeat for chamber 2. 
 




Table 31: Counting cells with a haemocytometer 
Calculations: 
Total viable cells (number of blue cells) and number of total cells are counted 
% viable cells = total viable cells ÷ total cells × 100 
Average viable cells ÷ square = total viable cells ÷ no. of squares counted 
Dilution factor = final volume ÷ volume of cells 
Concentration (Viable cells/mL) = average viable cells ÷ square × dilution factor × 104 
 
7.4.6 Cryopreservation and recovery of primary tooth pulp cells 
Preparation: 
 E8 complete medium at RT; VTN-N-coated T75 culture flask at RT for 1 h 
 E8 freezing medium: to prepare 1 mL of freezing medium combine the following 
in a 15 mL Falcon tube: 
o 0.9 mL complete E8 medium + 0.1 mL 10% DMSO (keep tube on ice) 
o for 6-well plates use 1 mL of E8 freezing medium/well 
o for a T25 plate use ~2.6 mL. 
Procedure: 
i. Allow pulp cells (P3) to grow for a minimum of 3 days after passaging from T25 
plates into VTN-N-coated T75 culture plate (1:3 split ratio) as described in the 
passaging protocol in Section 7.4.4 above. 
ii. When cells reach 70–80% confluence, aspirate waste media from the T75 and rinse 
twice with PBS (5 mL each wash). Dissociate the cells with EDTA as described in 
Section 7.4.4. Cells will round up and separate and colonies will show vacuoles 
under microscope, after 5–8 min of EDTA treatment. Carefully aspirate the EDTA 
solution and add 5 mL of complete E8 medium to the T75 (swirl the plate in a 
figure-of-eight movement and then give 2–3 firm taps to the side of the plate). 
iii. Remove the cells by gentle pipetting several times using a 5 mL pipette. Collect in 
15 mL Falcon tube. Avoiding making bubbles while pipetting. 
iv. Viable cell counting can be performed here as described in Section 7.4.5. 
v. A considerable number of attached cells will remain in the original T75 after EDTA 
dissociation. An option here is to regrow the attached cells by adding 15 mL 
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complete E8 and incubating in a 37°C, 5% CO2 incubator as described earlier for 
further expansions. 
vi. For cryopreservation, add equal volumes of ice-cold prepared E8 freezing medium 
(1 mL) and cell suspension (1 mL) in a dropwise manner into each cryo-vial 
(Cryo.S,PP, with screw cap, Greiner Bio-One Lot# E130600R). Re-suspend cells 
gently by pipetting. 
vii. Quickly place in isopropanol cryo-freezing container, which decreases temperature 
by 1°C/min, and transfer to –80°C overnight. Next day, transfer into liquid nitrogen 
for long-term storage. 
7.4.7 Thawing and passaging primary tooth pulp cells (T25 plates) 
i. Warm the required amount of E8 medium and VTN-coated T25 plates to RT. 
ii.  Remove pulp cells from liquid nitrogen storage. If plating several cell lines, it is 
preferable to process one cell line at a time, keeping cryo-vials on dry ice. 
iii. Partially immerse the cryo-vial containing frozen cells in a 37°C water bath without 
submerging the cap. Swirl the vial gently. When only a small floating ice crystal 
remains, remove the vial from the water bath, spray the outside with 70% ethanol 
and transfer the tube into the cell culture cabinet. 
iv. Pipette cells gently into a sterile 15 mL conical tube using a 5 mL sterile pipette. 
v. Slowly add 10 mL of E8 medium dropwise onto cells in the 15 mL conical tube. 
While adding medium, gently move the tube back and forth to mix the contents. 
This reduces osmotic shock to the cells. 
vi. Rinse the cryo-vial with 1 mL E8 and add to the 15 mL tube with cells. 
vii. Centrifuge the cell suspension at 200 × g for 5 min. 
viii. Aspirate and discard the supernatant. 
ix. Suspend the cell pellet in 5 mL E8 medium by gently pipetting the cells up and 
down in the tube a few times. 
x. Count the viable cells using Trypan Blue and a haemocytometer. 
xi. Slowly add the cell suspension into RT pre-warmed VTN-coated T25 flasks. Seed the 
cells at a concentration of 1 x 107 cells/cm2. 
xii. Move the plate in several quick figure-of-eight motions to disperse cells across the 
surface of the wells. 
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xiii. Place the plate gently into a 37°C, 5% CO2 incubator and incubate the cells 
overnight. Replace media with fresh media daily. 
7.4.8 Nunc Lab-Tek II Chamber Slide System Preparation 
Table 32: Nunc Lab-Tek II Chamber Slide System specifications 
CAT# 154534 Specifications 
Thermo Scientific Nunc Lab-Tek II Chamber 
Slide System 
 
Culture Area 0.7 cm² 





Vitronectin coating for Nunc Lab-Tek II Chamber Slide 
VTN-N (Cat# A14700) coating at 0.5 µg/cm2 as recommended by Life Technologies. 
Procedure: 
 Remove VTN aliquots from –80° C storage and thaw at RT. (For VTN-N 
preparation, refer to Section 7.4.1.) 
 Aliquot 70 µL diluted VTN-N solution to each well of the chamber slide (Table 32). 
 Incubate at RT for 1 h. 
Aspirate the excess VTN-N solution from the well and discard just before use. Do not 
allow the chamber slide to dry out. Coated plates can now be used or stored at 2–8°C 
wrapped in laboratory film for up to 1 week. 
7.5 Methods for thawing, culture expansion and freezing of GENEA002 
cells 
7.5.1 Reagent preparation for thawing and passaging of GENEA002 cells 
The following equipment and reagents are required for thawing and passaging: 
 Biosafety cabinet 
 Water bath set to 37°C 
 Sterile 5 mL and 1 mL pipettes 
 Sterile PBS, calcium and magnesium free, warmed to 37°C 
 Genea M2 medium (thawed overnight); aliquot the amount required in a sterile 
15mL Falcon tube to be warmed to 37°C in a water bath 
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 Genea Neutralising Solution (37°C); warm the required amount in a water bath 
then transfer to culture hood before removing the cell vial from the liquid 
nitrogen 
 Collagen I-coated flasks (Corning BioCoat Collagen I, 25 cm2 TC-treated flasks 
354484) 
 Antibiotic–Antimycotic 100X (Anti–Anti, Invitrogen Cat# 15240). Stock 
concentration of Anti–Anti contains 10,000 U/mL penicillin and 10,000 μg/mL 
streptomycin. 
7.5.2 M2 medium preparation 
Complete medium is prepared by mixing 500 μL of Anti–Anti stock concentration 
with 100 mL of M2 base medium as recommended (Table 33). Medium can be stored at 
2–4°C for 4 weeks. 
Table 33: Volumes of reagents required as recommended by Genea Biocells 
Reagent Volume per cm2 T25 
Genea Passaging Solution 0.05 mL 1 mL 
M2 plating/media change 0.25–0.3 mL 6–7 mL 
 
7.5.3 Collagen I, rat tail, 100 mg (Falcon FAL354236) preparation 
Prior to use, bring culture vessel to RT for at least 1 h. Collagen stock solution (3.83 
mg/mL) is diluted with PBS (Ca2+ & Mg2+ free) to the desired working concentration and 
used as a thin coating layer of 5–10 μg/cm2 of culture flask area. 
To make 50 mL of collagen I working stock solution at a concentration of 10 μg–cm2 
of culture vessel, add 130.5 μL of stock concentration (3.83 mg/mL) to 49.87 mL sterile 
PBS (Ca2+ & Mg2+ free). The diluted collagen I solution can be stored in sterile Falcon 
tubes for up to 2 weeks at 2–8°C. Volumes required for coating are calculated based on 
data provided by Corning (Table 34). 
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Table 34: Recommended collagen I coating volumes, which were calculated, based on Corning 
recommendations for Collagen I, rat tail, 100 mg–FAL354236 
Culture vessel Culture surface area Coating volume 
8-well chamber slide 0.7 cm²/well 1.56 mL 
T25 culture flask 25 cm² 5.58 mL 
T75 culture flask 75 cm² 16.74 mL 
 
Collagen I-coated culture vessels should be incubated at RT for 1 h in the culture 
hood before use. 
7.5.4 Coating Nunc Lab-Tek II Chamber Slide with collagen I 
Procedure: 
1. Prior to use, bring culture vessel to RT for at least 1 h. 
2. Dilute collagen stock solution (3.83 mg/mL) to the desired working 
concentration of 5–10 μg/cm2 with PBS, calcium and magnesium free. 
3. Collagen I diluted solution is prepared by adding 2.61 μL of stock concentration 
to 997.39 μL PBS. This will result in a 1 mL working concentration of 10 μg/cm2. 
Aliquot volumes required to a sterile Falcon tube in RT. 
4. For a chamber slide with culture area of 0.7 cm²/well, 156.25 μL of diluted 
collagen is required per well. 
5. Coat each well of the chamber slide and incubate at RT for 1 h in the hood. 
6. Aspirate excess collagen I solution and discard just before use. Alternatively, 
coated plates can be sealed with laboratory film and stored at 2–8°C for up to 1 
week. Stored collagen I-coated plates should be rehydrated for 5 min with 
sterile PBS (Ca2+ & Mg2+ free) or culture medium before use. 
7.5.5 GENEA002 thawing and recovery in M2 medium 
Procedure: 
1. Warm required reagents, M2 complete medium and Genea Neutralising 
Solution, in a water bath (37oC). 
2. Collagen I-pre-coated T25 culture plate at RT; rehydrate with 2.5 mL PBS for 5 
min. 
3. Remove hESC frozen vial from liquid nitrogen storage. 
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4. Immerse the cryo-vial containing frozen cells in a 37°C water bath without 
submerging the cap. Swirl the vial gently until only a floating ice crystal remains. 
5. Transfer the cryo-vial from the water bath just prior to complete thawing or 
immediately once thawed. It is critical to remove cells from the freezing solution 
as soon as possible. Spray the outside of the vial with 70% ethanol and transfer 
the tube into a Class II cell culture cabinet. 
6. Using a 5 mL pipette, add thawed vial contents dropwise into 4 mL Genea 
Neutralising Solution warmed to 37oC. 
7. Rinse the cryo-vial with an additional 1 mL Genea Neutralising Solution and add 
to the 15 mL tube with cells. Mix gently by inversion. 
8. Centrifuge the cell suspension at 300 g for 4 min. 
9. Aspirate and discard supernatant. Re-suspend cell pellet in 5 mL of complete M2 
medium by gently pipetting the cells up and down in the tube a few times. 
10. Determine cell viability using Trypan Blue and a haemocytometer. Typically, 70% 
of viable frozen cells are recovered with viability >90%. 
11. Add the cell suspension into the hydrated collagen I-coated plate at a 
recommended plating density of 20,000 cells/cm2 (500,000 cells/T25). 
12. Move the plate in several figure-of-eight motions to disperse cells across the 
surface. Incubate at 37°C in a 5% CO2 incubator. Change medium on the second, 
fourth, then every day until 70% confluence. Grow cells for at least two passages 
in M2 medium before refreezing. 
7.5.6 GENEA002 passage protocol 
1. Warm the required amount of reagents, M2 complete medium and Genea 
Passaging Solution, in a water bath to 37oC. 
2. Label and place a new collagen I-coated T75 plate in the Class II culture hood. 
3. Aspirate waste medium from the parental GENEA002 culture. Rinse with 2.5 mL 
sterile PBS (Ca2+ & Mg2+ free), warmed to 37oC. 
4. Add 1 mL Genea Passaging Solution and incubate for 3 min in a 37oC, 5% CO2 
incubator. 
5. Examine under the microscope to assess cell detachment and lifting off the 
plate. Add 3 mL Genea Neutralising Solution. Tap the sides of the culture plate 
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three times to detach the colonies from the plate. Pipette approximately 10 
times to disperse the cells into a single-cell suspension. Avoid excess pipetting 
and creation of air bubbles. 
6. Centrifuge the cell suspension at 300 g for 4 min. 
7. Aspirate and discard the supernatant. Re-suspend the cell pellet in 6 mL 
complete M2 medium and add into a collagen I-coated T25 flask. 
Cell counting can be performed at this stage to determine the cell plating 
density. Low plating density (<8,000 cells/cm2) may result in spontaneous 
differentiation. The recommended seeding density is 8,000–12,000 cells/cm2 of 
GENEA002 viable cells before freezing (Table 35). 
Table 35: Viable cell calculation 
 
(10X magnification) 
Trypan Blue staining 
Total viable cells (number of blue cells) and number of total cells is counted 
% viable cells = total viable cells ÷ total cells × 100 
Average viable cells ÷ square = total viable cells ÷ no. of squares counted 
Dilution factor = final volume ÷ volume of cells 
8. Move the new culture plate in a figure-of-eight movement to distribute the cells 
and incubate at 37°C, 5% CO2 for 48 h. 
9. After 48 h, replace medium with 6 mL complete M2 medium warmed to 37°C. 
10. Repeat the previous step after 48 h and monitor cells daily. 
11. On each following day, replace medium with 6 mL 37°C warmed complete M2 
medium. When confluence reaches ~70%, cells are ready for further expansion 
(1:3 split ratios) or cryopreservation. 
7.5.7 GENEA002 cryopreservation 
Warm the amount of reagents required, including M2 complete medium and Genea 
Neutralising Solution, in a water bath to 37°C. 
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Genea freezing medium 
In a 15 mL Falcon tube, mix the following: 
 90% M2 medium + 10% DMSO 10% (keep on ice) 
 for a T25 culture plate, use ~2.6 mL. 
Procedure: 
1. Allow Genea hESCs to grow for a minimum of two passages before freezing as per 
the passaging protocol in Section 7.5.6. 
2. Aspirate waste medium from the culture plate and rinse with PBS (Ca2+ & Mg2+ 
free) warmed to 37°C (5 mL is required for a T75 culture flask). 
3. Dissociate the cells with Genea Passaging Solution and incubate for 3 min in a 
37°C, 5% CO2 incubator. Repeat steps iv–viii in Section 7.5.6. 
4. Viable cell counting can be performed here as described in Section 7.4.5. 
5. After centrifuging, flick the formed cell pellet once to re-suspend followed by 
gentle pipetting once using a 5 mL pipette. Collect in 15 mL Falcon tube. 
6. For cryopreservation, in a dropwise manner, quickly add equal volumes of ice-cold 
prepared M2 freezing medium (1 mL) and cell suspension (1 mL) into each cryo-
vial (Cryo.S,PP, with screw cap, Greiner Bio-One Lot# E130600R). 
7. Quickly place in isopropanol cryo-freezing container, which decreases 
temperature by 1°C/min, transfer to –80°C overnight. 
8. Next day, transfer to liquid nitrogen for long-term storage. 
7.6 Immunofluorescence experiments for primary pulp cells and GENEA002 
7.6.1 Acetone fixation 
Primary pulp cells and GENEA002 were fixed with ice-cold acetone. The pre-fixation 
step makes the cells more resistant to potentially damaging effects created by changes 
in surface tension. 
Procedure: 
1. Pre-fixation: add an equal volume of acetone to the volume of culture medium 
present to pre-fix the cells for 2 min. 
2. Replace pre-fixation culture medium with a fresh volume of ice-cold acetone (25 
μL/well in 8-well chamber slides). Fix slides in acetone on ice for 10 min. 
3. Disassemble chamber slides. 
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4. Wash slides at RT with PBS with 1% BSA for 30 sec. 
5. Store slides in the fridge (2–4°C).  
7.6.2 Oct4A, Nanog, Sox2 and CD90 antibody preparation 
Antibodies: 
 Anti-human Oct4A (C30A3) rabbit mAb (Cell Signalling, Cat# 2840) 
 Anti-human Nanog (D73G4) XP rabbit mAb (Cell Signalling, Cat# 4903) 
 Anti-human Sox2 (D6D9) XP rabbit mAb(Cell Signalling, Cat# 3579) 
 Anti-human CD90 rabbit antibody (EPR3132) (ab92574) 
 Rabbit IgG antibody (Dako X0936) 
 Alexa Fluor 488 goat anti-rabbit (Invitrogen–A11008) 
Reagents: 
 1% BSA–PBS preparation: 
o 100 mL (prepare required amount as stock and store on ice/fridge) 
o 1% BSA in 10 mL PBS = 0.1 g BSA (Fraction V, Aa306) in 10 mL PBS 
o Mix gently and do not shake 
 Blocking buffer preparation (3 mL), 20% GS in 1% BSA–PBS: 
o 600 µL GS + 2,400 µL of 1% BSA–PBS = 3000 µL blocking buffer 
 Antibody dilution buffer 5% GS in 1% BSA–PBS (6 mL) 
o 300 µL GS + 5,700 µL (1% BSA–PBS ) = 6 mL antibody dilution buffer 
 Anti-CD90–Thy1 (EPR3132) (ab92574) rabbit mAb preparation (100 µL): 
o 1 µL + 99 µL of 5% dilution buffer = 100 µL of 1:100 dilution 
o 0.25 µL + 99 µL of 5% dilution buffer = 100 µL of 1:400 dilution 
 Anti-Oct4A, Nanog and Sox2 (recommended 1:400 dilution) 
o Preparation: 600 µL of each antibody 
o Oct4A (C30A3) rabbit mAb (Cell Signalling, Cat# 2840) 
o Nanog (D73G4) XP rabbit mAb (Cell Signalling, Cat# 4903) 
o Sox2 (D6D9) XP rabbit mAb (Cell Signalling, Cat# 3579) 
o 1.5 µL antibody + 598.5 µL of 5% dilution buffer = 600 µL of 1:400 
dilution 
 Rabbit IgG antibody (Dako X0936) preparation (800 µL): 
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o 2 µL IgG + 798 µL of 5% dilution buffer = 800 µL of 1:400 dilution 
Day 1 procedures 
1. Hydrate the acetone-fixed cells within the chamber slides by gently washing 
with the already-prepared washing solution (1% BSA–PBS + 0.1% Tween 20) 
once for 5 min. Draw off the washing solution. 
2. Wash twice with 1% BSA–PBS for 10 min each wash. 
3. Incubate all slides with the blocking solution (20% GS in 1% BSA–PBS) for 60 min. 
Draw off and add prepared primary antibodies. 
4. From each primary antibody, 50 µL is required for each well in a chamber slide. 
5. Incubate TEST slides + positive control GENEA002 overnight at 4°C (cold room) 
with Oct4A, Nanog and Sox2 + negative control wells with IgG (rabbit IgG). 
6. Keep slides in moist conditions in a covered container (add a few drops of PBS to 
the container). 
Day 2 preparation 
 Washing solution (0.5% skim milk powder wash) 
Preparation: 1000 mL 
5 g NFM made up to 1000 mL with PBS 
 Fluorochrome-conjugated secondary antibody (prepare in the dark) 
Antibody: Alexa Fluor 488 rabbit anti-mouse IgG (H+L) (Cat# A-11059) 
Recommended concentration: 11% BSA–PBS 10 µg/mL (for IF experiments) 
Stock concentration: 2 mg/mL–Concentration used: 5 µg/mL (1:400 dilutions) 
Preparation: 1 mL 
Prepare 2.5 µL of Alexa Fluor + 997.5 µL antibody dilution buffer = 1000 µL 
Day 2 procedures (in the dark) 
1. Add 50 µL prepared secondary antibody to each well of the chamber slide. 
2. Incubate slides for 60 min in dark. 
3. Wash with PBS once (5 min) then twice (10 min each). 
4. Counterstain with DAPI mounting media (VECTASHIELD Mounting Media H-
1200). 
5. To mount cells on a slide, dispense one drop of mounting medium onto the 
slide; then add a coverslip and allow VECTASHIELD mounting medium to 
263 
disperse over the entire section. The special pipette supplied with the product is 
designed to deliver small drop volumes of ~25 µL. 
6. Slides are now ready for examination. 
7. For prolonged storage, coverslips can be permanently sealed around the 
perimeter with nail polish or a plastic sealant. Mounted slides should be stored 
at 4°C and protected from light. 
7.6.3 CD105, CD73, nestin and Dlx2 antibody preparation 
Antibodies: 
 Anti-human CD105, mouse mAb—Clone SN6h (Dako M3527, Agilent 
Technologies) 
 Anti-human CD73, (1D7) mouse mAb (Abcam, ab91086) 
 Anti-human nestin, (10c2) mouse mAb IgG1 (Santa Cruz Biotechnology, sc-
23927) 
 Anti-human Dlx2, mouse mAb IgG2a,k—Clone 2C8 (LifeSpan Biosciences, LS-
B5398/51177) 
 Mouse IgG1 (Dako negative control, Code X0931) 
 Alexa Fluor 488 goat anti-mouse IgG (H+L) (Thermo Fisher, Cat# A32723) 
Reagents: 
 1% BSA–PBS preparation (10 mL): 
1% BSA in 10 mL PBS = 0.1 g BSA (Fraction V, Aa306) in 10 mL PBS; mix gently 
and do not shake 
 Blocking buffer 20% GS in 1% BSA–PBS preparation (3 mL): 
600 µL GS + 2400 µL of 1% BSA–PBS = 3000 µL blocking buffer 
 Antibody dilution buffer 5% GS in 1% BSA–PBS preparation (6 mL): 
300 µL GS + 5700 µL (1% BSA–PBS ) = 6 mL antibody dilution buffer 
 CD105 (Dako M3527) mouse mAb—Clone SN6h preparation (600 µL): 
Recommended dilution by Dako of 1:10 
60 µL CD105 + 540 µL of antibody dilution buffer 
 CD73 (LS-B3897) mouse mAb IgG1 preparation (600 µL): 
Recommended dilution by LifeSpan Biosciences of 1:200 
3 µL CD73 + 597 µL of antibody dilution buffer 
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 Nestin (sc-23927) mouse mAb: 
Recommended dilution by Santa Cruz of 0.5–5.0 µg/mL 
Stock concentration is 200 µg/mL 
Preparation: 1 mL at 2 µg/mL and 1 mL at 1 µg/mL 
Nestin (2 µg/mL) 10 µL + 900 µL of antibody dilution buffer 
Nestin (1 µg/mL) 5 µL + 995 µL of antibody dilution buffer 
 Dlx2 (LS-B5398/51177) mAb 
Recommended dilution by LifeSpan BioSciences of 5 µg/mL 
Stock concentration is at 200 µg/mL 
Preparation: 1 mL at 5 µg/mL) + 1 mL at 10 µg/mL 
25 µL Dlx2 + 950 µL of antibody dilution buffer = 1 mL (5 µg/mL) 
50 µL Dlx2 + 950 µL of antibody dilution buffer = 1 mL (10 µg/mL) 
 Mouse IgG1 (Dako negative control – Code X0931): 
Recommended dilution: Concentration matched to the upper range of the test 
antibodies 
Stock concentration 100 µg/mL 
Preparation: 1 mL (10 µg/mL) 
10 µL mouse IgG1 + 900 µL of (5% GS + 1% BSA–PBS) = 1 mL (10 µg/mL) 
Day 1 procedures 
1. Hydrate the acetone-fixed cells in the chamber slides by gentle incubation with 
the already-prepared washing solution (1% BSA–PBS + 0.1% Tween 20) once for 
5 min. Draw off the washing solution. 
2. Wash twice with 1% BSA–PBS (10 min each wash). 
3. Incubate slides with blocking solution (20% GS–1% BSA–PBS) for 60 min. Draw 
off and add prepared primary antibodies. 
4. For each primary antibody, 50 µL is required for each well in the chamber slide. 
5. Incubate TEST slides + positive control GENEA002 overnight at 4°C (cold room) 
with CD105, CD73, nestin and Dlx2 and the negative control wells with mouse 
IgG antibody. 
6. Keep slide container covered in moist conditions (add a few drops of PBS to the 
container). 
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Tip: A Dako wax pen (Dako Pen, Code S2002) can be used to mark out sections on 
the slide. This provides a barrier to liquids such as antibody solutions and washing 
buffers applied to the sections. After drying, the sections that have been delineated 
are water-repellent and acetone- and alcohol-insoluble. 
Day 2 preparation 
 Washing solution (NFM 0.5% skim milk powder wash) 
Preparation: 1000 mL 
5 g NFM in 1000 mL PBS will result in NFM 0.5% washing solution 
 Fluorochrome-conjugated secondary antibody (prepare in the dark) 
Alexa Fluor 488 rabbit anti-mouse IgG (H+L) (Invitrogen, Cat#: A-11059) 
Recommended concentration: 1–10 µg/mL for IF experiments 
Stock concentration: 2 mg/mL 
Concentration used: 5 µg/mL (1:400 dilutions) 
Preparation: 1 mL 
Prepare 2.5 µL of Alexa Fluor + 997.5 µL antibody dilution buffer = 1000 µL 
Day 2 procedures (in dark) 
1. Add 50 µL of prepared secondary antibody to each well in chamber slide. 
2. Incubate all slides for 60 min covered in the dark. 
3. Wash with PBS once (5 min) then twice (10 min each). 
4. Counterstain with DAPI mounting media (VECTASHIELD mounting media, Cat# 
H-1200). 
5. To mount cells on a slide, dispense one drop of mounting medium onto the 
section and then add a coverslip and allow VECTASHIELD mounting medium to 
disperse over the entire section. The special pipette supplied with the product is 
designed to deliver small drop volumes of ~25 µL. 
6. Slides are now ready for examination. 
7. For prolonged storage, coverslips can be permanently sealed around the 
perimeter with nail polish or a plastic sealant. Mounted slides should be stored 
at 4°C and protected from light. 
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7.7 Flow cytometry for primary tooth pulp cells 
7.7.1 Human Mesenchymal Stem Cell Analyses Kit 
BD Stemflow, Cat# 562245 
7.7.2 Primary pulp cell line preparation 
Cell lines: A1053, B1163 and C353. 
Each cell line was expanded into six T75 culture flasks as stated in Section 2.3.7. 
Reagents: 
 FACS buffer 
PBS, 0.01% sodium azide (Tris and protein free) 
 BD Multicolour CompBeads 
BD Multicolour CompBeads are composed of micro particles coated with anti-
mouse Ig-kappa (Ig κ), which binds kappa light chain-bearing Ig. Unstained CompBeads 
were used in the experiment to calculate a compensation matrix for spectral overlap 
values for each fluorochrome onto each of its non-primary detectors. This 
compensation matrix was then used to correct spectral overlap for any combination of 
fluorochrome-labelled mouse Ig κ anti-human antibodies conjugated to the following 
used dyes: FITC, PE, PerCP-Cy5.5, PE-Cy7 and APC. 
 Zombie NIR dye 
Zombie NIR is an amine-reactive fluorescent dye that is non-permeant to live cells, 
but permeant to cells with compromised membranes. Thus, it can be used to assess the 
live versus dead status of mammalian cells. Zombie NIR is a polar water-soluble dye 
providing red fluorescence, making it suitable for multicolour detection: 
 The Zombie NIR Fixable Viability Kit contains lyophilised Zombie NIR dye and 
anhydrous DMSO. 
 For reconstitution, bring the kit to RT and add 100 µL of DMSO to one vial of 
Zombie NIR dye until fully dissolved. Dilute Zombie NIR dye into PBS that does 
not contain BSA, serum or any other soluble protein, at the optimised 
concentration for your cell type. It is recommended to use a 1:100–1:1000 
dilution range, but the optimal dosage will vary with cell type. 
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 Zombie NIR dye is excited by a red laser and has a fluorescence emission 
maximum at 746 nm. If using in a multicolour panel design, filter optimisation 
may be required depending on other fluorophores used. Zombie NIR dye has a 
similar emission to APC/Cy7. 
 BD Accutase 
Cell Detachment Solution (Cat# 561527) 
7.7.3 Flow cytometry assay protocol 
1. Wash the cells with PBS at RT. Use 5 mL PBS per T75 flask for washing. 
2. Add Accutase cell detachment solution adequately to cover the entire area of the 
culture plate (3 mL for each T75). 
3. Incubate at RT for 3 min or until cells are detached. Dissociate cells by tapping firmly 
on the culture flask. 
4. Triturate the cells to aid in obtaining a single-cell suspension. 
5. Add the dissociated cells from each flask (6 x T75) into one 50 mL Falcon tube. 
6. Additional cell culture medium (E8) is added to make 45 mL of single-cell suspension. 
N.B. The additional cell culture medium will neutralise the Accutase. 
7. Remove a small aliquot of the cell suspension and examine under a microscope to 
confirm the presence of single cells. 
8. Centrifuge at 300 g for 4 min. Re-suspend in FACS buffer according to cell count to 
achieve 1 x 107 cells/mL. 
9. Add 100 µL cell suspension per labelled FACS tube for Zombie NIR fixable viability 
dye. 
10. Add 0.5 µL of Zombie NIR fixable viability dye to 100 µL of cells in the appropriate 
tubes. Incubate at RT 15–30 min in the dark. 
11. Wash once in cold FACS buffer (2 mL). 
12. Centrifuge at 300 g for 4 min and re-suspend cells in 100 µL FACS buffer. 
13. Add 100 µL of cell suspension from the cell lines into corresponding labelled tubes 
and add antibodies as shown in Table 36. 
14. Incubate on ice for 30 min in the dark. 
15. Wash once with FACS buffer (2 mL). 
16. Centrifuge at 300 g for 4 min and re-suspend cells in 100 µL FACS buffer. 
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17. Add 200 µL 2% PFA fixative per tube, mix well and incubate at RT for 15 min. 
18. Wash off fixative with FACS buffer; centrifuge at 300 g for 4 min and re-suspend 
cells in 300–500 µL FACS buffer. 
19. Analyse by flow cytometry. 
Flow cytometry experimental design (Table 36) 




Sample Antibody 1 Antibody 2 
1 CD90 FITC CompBeads CD90-FITC 
none 





4 CD73 APC CompBeads CD73-APC 
5 Viability dye Pulp cells  Zombie NIR FVD 
CELLS-ONLY CONTROLS 
6 Pulp cells only  none none 
TEST SAMPLES 
7 
Compensation control Antibody 1 Antibody 2 
Isotype control + pulp cells 
hMSC Positive Isotype Control 
Cocktail (20 µL) 
PE hMSC Negative Isotype 
Control Cocktail (20 µL) 
9 TEST pulp cells 
hMSC Positive Cocktail 
(20 µL) 





7.8 Immunohistochemistry for primary teeth decalsified sections 
 
7.8.1 Teeth sampled for IHC experiments 
Collected sample (Table 37) was treated by 48-h formalin fixation–39 days 
decalcification in 10% EDTA–paraffin blocks cut into 5 µm thick longitudinal sections. 
Table 37: Tooth samples used for IHC experiments 
Group Patient No. Tooth No. Research ID 
A 1 63 A163 
A 7 63 A763 
A 8 53 A853 
A 8 63 A863 
A 13 73 A1373 
A 14 63 A1463 
B 3 73 B373 
B 5 53 B553 
B 9 53 B953 
B 14 53 B1453 
B 18 53 B1853 
C 3 83 C383 
C 7 53 C753 
C 13 53 C1353 




7.8.2 Immunohistochemistry methods for primary tooth fixation and decalcification 
10% EDTA solution preparation (100 mL) 
 10 g EDTA (disodium salt, Sigma, Cat# E5134) 
 50 mL distilled water 
 Adjust pH to 7.4 using NaOH pellets and adjust volume to 100 mL 
 Sterilise by autoclaving at 121°C for 15 min 
Procedure: 
1. Extracted tooth should be immediately rinsed in 100 mL PBS to remove blood, and 
placed in 100 mL of 10% neutral-buffered formalin for 1 h. 
2. Place the tooth in fresh 10% neutral-buffered formalin and agitated gently for 48 h at 
4oC. 
3. Wash the tooth with PBS twice for 5 min each time. 
4. Place the fixed tooth sample in 100 mL of cold 10% EDTA solution for 39 days at 4°C 
with gentle agitation. Change the solution at 3–4-day intervals. 
5. Test for complete decalcification by using the ammonium oxalate test (see below). 
6. After decalcification, trim the tooth using a scalpel blade to orient the cutting plane 
and assess the degree of decalcification. 
7. When decalcification is complete, wash the tooth twice in PBS and keep it overnight 
to be embedded in paraffin the next day. 
Ammonium oxalate test 
 Take 5 mL of EDTA–tooth decalcification solution and add concentrated HCl 
dropwise (in the fume hood) until a pH of 3.2–3.6 is reached. pH can be 
measured using a pH paper dip stick (Hydrion Brilliant pH dip stiks, Aldrich Cat# 
Z264776). 
 Add 5 mL of 3% saturated aqueous solution of ammonium oxalate and mix. 
 Wait for 30 min and assess the presence of a precipitate. In the final 
decalcification solution, there should be no visible precipitate after performing 
this test, indicating that the desired level of decalcification of the tooth has been 
achieved. 
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7.8.3 Methods for paraffin embedding and tooth sectioning 
After fixation and decalcification, the tooth sample is dehydrated to enable 
embedding with paraffin, which is water insoluble. The tissue is dehydrated gently by 
immersion in increasing concentrations of a dehydrating agent as follows. 
Dehydration (graded alcohol–xylene gradient) 
A gradual change in hydrophobicity minimises cell damage. The dehydrating agent is 
then cleared by incubation in xylene prior to paraffin embedding as follows: 
i. 2 x dH2O—2 min each 
ii. 50% ethyl alcohol—5 min 
iii. 70% ethyl alcohol—5 min 
iv. 95% ethyl alcohol—5 min 
v. 100% ethyl alcohol—5 min 
vi. xylene (3)—5 min 
vii. xylene (2)—5 min 
viii. xylene (1)—5 min. 
Paraffin embedding and sectioning 
Paraffin is heated to 60°C and then allowed to harden overnight. The tissue is 
sectioned using a microtome. Tissue sections may be dried onto microscope slides and 
stored for extended periods at RT. Tissue sections are then rehydrated prior to 
commencing the immunostaining protocol. 
Materials and reagents: 
 Water bath 
 Container with ice 
 Glass microscope slides 
 Microtome and blade 
 Oven 
Procedure: 
1. Chill paraffin-embedded tissue blocks on ice before sectioning. Cold wax allows 
thinner sections to be obtained by providing support for harder elements within the 
tissue specimen (enamel, dentine and cementum). The small amount of moisture 
that penetrates the block from the melting ice will also make the tissue easier to cut. 
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2. Fill a water bath with ultrapure water and heat to 40–45°C. 
3. Place the blade in the holder, ensure it is secure and set the clearance angle. The 
clearance angle prevents contact between the knife facet and the face of the block. 
Follow the microtome manufacturer’s instructions for guidance on setting the 
clearance angle. 
4. Insert the paraffin block and orientate so the blade will cut straight across the block. 
5. Carefully approach the block with the blade and cut a few thin sections to ensure the 
positioning is correct. Adjust if necessary. 
6. Trim the block to expose the tissue surface to a level where a representative section 
can be cut. Trimming is normally done at a thickness of 10–30 µm. 
7. Cut sections at a thickness of ~5 µm. 
8. Pick up the ribbons of sections using tweezers and float them on the surface of the 
water in the water bath so they flatten out. Use the tweezers to separate the 
sections and pick them out of the water bath to be placed on slides and stored 
upright in a slide rack. 
9. Place the slide rack into an oven and allow sections to dry overnight at 37oC. 
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7.8.4 Immunohistochemistry experimental design 
This design (Table 38) was applied to n = 15 teeth from the three groups. 
Table 38: Slide design for IHC experiments.  
Oct4A Rabbit–1:400 dilution 
 
Nanog Rabbit–1:400 dilution 
 
Sox2 Rabbit–1:400 dilution 
 
CD90 Rabbit 1:400 dilution 
 
 
 CD105 Rabbit –1:400 dilution 
 
CD73 Rabbit –1:400 dilution 
 
NESTIN Rabbit –1:400 dilution 
 
Dlx2 Rabbit–1:400 dilution 
 
 
7.8.5 Immunohistochemistry procedures (day 1) 
Reagent preparation: 
 1% BSA–PBS (prepare 10 mL). 
 0.1 g BSA (fraction V, Aa306) in 10 mL PBS. Do not shake. Can make stock and 
store at 4°C. 
 1% BSA–PBS + 0.1% Tween 20 solution for wash. 
 Tween 20 preparation: 1% BSA–PBS 900 mL + 900 µL Tween 20 to make 900 mL. 
 Blocking buffer 20% GS in 1% BSA–PBS (Sigma A-9306-5G): 
for each slide, prepare 100 µL of blocking buffer (100 µL x10 slides) 
200 µL GS + 800 µL of 1% BSA–PBS. 
 Antibody dilution buffer, 3% GS in 1% BSA–PBS (Sigma A-9306-5G): 
45 µL GS + 1455 µL (1X 1% BSA–PBS ). 
CONTROL  Dako negative control—Rabbit IgG 1:320  dilution 
CONTROL  Dako negative control—Mouse IgG1  
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Antibodies used for immunohistochemistry experiments 
Primary antibodies 
 Oct4A (C30A3) rabbit mAb (Cell Signalling, Cat# 2840) 
 Nanog (D73G4) XP rabbit mAb (Cell Signalling, Cat# 4903) 
 Sox2 (D6D9) XP rabbit mAb (Cell Signalling, Cat# 3579) 
 Nestin: mouse mAb IgG1 (Santa Cruz, SC23927) 
 Dlx2: mouse mAb IgG2a,k—Clone 2C8 (LifeSpan Biosciences, LS-
B5398/51177) 
 CD90: anti-CD90 (EPR3132) rabbit mAb (ab92574) 
 CD105: mouse mAb—Clone SN6h (Dako, M3527) 
 CD73: anti-CD73 mouse mAb IgG1 (LifeSpan Biosciences, LS-B3897) 
 Negative control normal rabbit IgG antibody (Santa Cruz, SC2027) 
 Negative control mouse mAb IgG1 (Dako, Code X0931) 
Secondary antibodies 
 Goat F(ab)2 anti-rabbit IgG H&L–biotin (Abcam, ab98429) 
 Rabbit F(ab)2 anti-mouse IgG H&L–biotin (Abcam, ab5761)  
Antibody preparation 
 Oct4A, Nanog and Sox2 antibody preparation 
Recommended dilution 1:400 
For IHC use 1:200 dilution = 1 µL antibody + 199 µL of antibody dilution buffer 
 Nestin antibody preparation 
Recommended dilution 0.5–5.0 µg/mL in 3% dilution buffer 
1 µg/mL for IHC experiments 
Stock concentration 0.25 mg/mL = 250 µg/mL 
To prepare 150 µL nestin antibody: 6 µL stock nestin antibody + 144 µL antibody 
dilution buffer (3% GS + 1% BSA–PBS) 
 Dlx2 antibody preparation 
Recommended concentration for IHC is 5 µg/mL in 3% dilution buffer 
Stock concentration 0.25 mg/mL 
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To prepare 150 µL: 3 µL Dlx2 antibody to 147 µL antibody dilution buffer (3% GS + 1% 
BSA–PBS). 
 CD105 antibody preparation 
Recommended dilution by Santa Cruz for IHC is 1:10 or 11.4 µg/mL of CD105 in 3% 
dilution buffer. 
To prepare 100 µL at 1:10 dilution: 10 µL CD105 antibody + 90 µL antibody dilution 
buffer (3% GS + 1 % BSA–PBS). 
 CD90 antibody preparation 
Recommended dilution by Abcam for IHC is 1:100 in 3% dilution buffer. 
To prepare 100 µL at 1:100 dilution: 1 µL of CD90 antibody in 99 µL of antibody dilution 
buffer (3% GS + 1% BSA–PBS). 
 CD73 antibody preparation 
Recommended dilution by LifeSpan BioSciences for IHC is 1:200 
Used at 1:100 dilution in 3% dilution buffer 
To prepare 100 µL at 1:100 dilution: 1 µL CD73 antibody + 99 µL of antibody dilution 
buffer (3% GS + 1% BSA–PBS). 
 Negative control—rabbit IgG antibody (Santa Cruz, SC2027) 
Recommended dilution 1:320 
1 µL rabbit IgG antibody + 319 µL antibody dilution buffer (3% GS + 1% BSA–PBS) 
 Negative control—mouse IgG1 preparation (Dako, Code X0931) 
Stock concentration 100 µg/mL. Used at 5 µg/mL 
To make 100 µL: 10 µL mouse IgG preparation + 90 µL of antibody dilution buffer (3% 
GS + 1% BSA–PBS). 
Slide preparation 
Heat water bath to 95oC and clearly label slides while waiting. 
Tip slides to remove reagents after each step. 
Avoid drying of specimens between steps. 
Use sufficient reagent to cover the specimen (approximately 100 µL per slide). 
De-paraffinisation and rehydration (xylene–graded alcohol): 
i. de-wax slides with xylene (1), 5 min 
ii. xylene (2), 5 min 
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iii. xylene (3), 5 min 
iv. hydrate through a series of graded alcohol. 100% alcohol, 5 min 
v. 95% ethyl alcohol, 5 min 
vi. 70% ethyl alcohol, 5 min 
vii. 50% ethyl alcohol, 5 min 
viii. 2 x dH2O, 2 min each 
ix. soak in PBS for 5 min (hold as necessary) 
Antigen retrieval (water bath heat treatment) 
Sodium citrate buffer 10 mM, pH 6.0 preparation 
Prepare 800 mL of 10 mM buffer in a large container to fit slides held in a metal rack. 
Avoid using a thick glass container as it will break with the heat. Add buffer then water 
to mix: 
1. Heat citrate buffer to 95oC and cover with tinfoil before adding slides. 
2. Heat the slides in the citrate buffer at 95oC for 10 min in the hot water bath. 
3. When finished, place in RT PBS immediately and leave to cool. 
4. Wash gently with 1% BSA–PBS + 0.1% Tween 20 solution for 3 x 5 min. 
5. Wash with 1% BSA–PBS for 2 x 10 min. 
6. Wax pen around the tissue sections. 
7. Incubate all slides with blocking serum (20% GS in 1% BSA–PBS) for 60 min. 
Adding primary antibodies 
1. Draw off blocking solution and add 100 µL primary antibody to each section. 
2.  Incubate slides overnight at 4oC with primary antibodies in a moist environment. 
7.8.6 Immunohistochemistry procedures (day 2) 
Reagent preparation: 
 Wash buffer: 0.5% skim milk powder (NFM) in PBS. Prepare 1000 mL as stock by 
adding 0.5 g powder to 100 mL PBS 
 Primary antibody wash: 0.5% NFM–PBS–0.1% Tween 20 
Add 300 µL Tween 20 to 300 mL 0.5% NFM–PBS 
 Prepare goat F(ab')2 anti-rabbit IgG H&L (biotin) (ab98429) 
Recommended dilution 1:500–1:5000 
Stock concentration 500 µg/mL diluted to 1:500 and used at 1 µg/mL 
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Add 1 µL antibody + 499 µL antibody dilution buffer (1% BSA–PBS–3% GS) 
 Prepare rabbit polyclonal to mouse IgG H&L–F(ab)2 fragment (biotin) (ab5761) 
Recommended dilution 1:100–1:400 
Stock concentration 500 µg/mL diluted 1:100 to 5 µg/mL 
Add 5 µL antibody + 495 µL antibody dilution buffer (1% BSA–PBS–3% GS) 
Blocking and washing 
Wash slides with three changes of wash buffer containing 0.5% NFM–PBS for 5, 10 and 
10 min 
Secondary antibodies 
1. Incubate for 1 h at RT in the dark 
2. Wash with three changes of antibody wash buffer containing 0.5% skimmed milk–
PBS–0.1% Tween 20 for 5, 10 and 10 min 
Endogenous peroxidase blocking 
1. Block EPA with 0.3% H2O2 in methanol for 10 min: prepare 100 mL of 0.3% H2O2 in 
methanol (just prior to use) by adding 1 mL of 30% H2O2 to 100 mL methanol. 
Incubate slides in 0.3% H2O2 (in methanol) for 10 min 
2. Wash with PBS three times for 5 min each 
Avidin–biotin conjugate 
A streptavidin–horseradish peroxidase (strep–HRP) complex is bound to the biotin 
sites using a VECTASTAIN Elite ABC Kit Strep HRP label (Vector Laboratories). N.B. 
Prepare VECTASTAIN while washing as it needs 30 min to complex prior to use: 
1. To 15 mL PBS, add 3 drops of reagent ‘A’, mix and then add 3 drops of reagent ‘B’ 
2. Mix and wait for 30 min 
3. Add 100 µL per section; incubate slides for 45 min 
4. Wash with three changes of PBS for 5, 10 and 20 min. 
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3,3'-Diaminobenzidine tetrahydrochloride chromogen 
Prepare DAB–peroxidase substrate (Sigma, Cat# D3939) in 5 mL dH2O in a glass vial 
immediately before use, as follows: 
1. Add 1 drop DAB to 1 mL of buffer stock solution and mix (mixture should become 
slightly brown). 
2. Drop the DAB substrate on top of the tissue sections and watch for brown colour 
development. Leave for a maximum of 3 min. 
3. Tip excess into waste flask for proper disposal. 
4. Dip slides into dH2O and wash 3 × 5 min to stop the reaction. 
Haematoxylin counterstaining 
Counterstain with haematoxylin (Fisher, CS401-D) and rinse in tap water until water 
comes out clear, as follows: 
i. Haematoxylin 2 dips (5 sec each) 
ii. Rinse in tap with running water until clear 
iii. Scotts tap water 1 min 
iv. Dehydrate through alcohol gradient starting at 50% ethanol for 2 min 
v. 90% ethanol 2 min 
vi. 100% ethanol 2 min 
vii. Xylene 2 x 5 min. 
Mounting 
Mount with Permount (Fisher # SP15-100) by adding above the section on the slide 
and pressing slowly onto the section with a coverslip to seal without air bubbles. 
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7.9 Methods for germ layer differentiation 























Figure 141: Germ layer differentiation experimental plan for A663, B1163, C353 and GENEA002 cell lines 
in 8-well chamber slides. Each cell line was grown in four chamber slides with basal differentiation 
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Germ layer differentiation protocol 
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Day 4 ICC detection of Otx2 ICC detection of Sox17 
Procedure: 
Remove primary tooth pulp cells and GENEA002 cryo-vials from the liquid nitrogen 
storage following thawing protocols (Section 7.4.7 and 7.5.5) and follow the 
differentiation protocol in Table 39. 
7.9.2 Germ layer immunocytochemistry 
Human Pluripotent Stem Cell Functional Identification Kit (R&D Systems, Cat# SC027) 
Kit contents 
 Differentiation Base Media Supplement (10X) 
 Endoderm, Ectoderm and Mesoderm Differentiation supplements 
 Ectoderm marker: goat anti-human Otx2 antigen affinity-purified polyclonal 
antibody 
 Mesoderm marker: goat anti-human Brachyury antigen affinity-purified 
polyclonal antibody 
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 Endoderm marker: goat anti-human Sox17 antigen affinity-purified polyclonal 
antibody 
 Reagent preparation 
 Wash buffer: 1% BSA–PBS solution. Add 5 g BSA (fraction V, Aa306) in 500 mL 
PBS. Filter sterilise using a syringe filter and store at 2–8°C. 
 Triton X-100 buffer: 0.3% Triton X-100–1% BSA–PBS. Add 30 µL of Triton X-100 to 
10 mL 1% BSA–PBS. 
 Blocking buffer: 10% donkey serum in 0.3% Triton X-100–PBS–1% BSA. 
 Endoderm Differentiation Supplement I (500X): Reconstitute with 50 μL sterile 
0.1% BSA in PBS. Mix gently. 
 Endoderm Differentiation Supplement II (500X): Reconstitute with 100 μL sterile 
0.1% BSA in PBS. Mix gently. 
 Mesoderm Differentiation Supplement (500X): Reconstitute with 100 μL sterile 
0.1% BSA in PBS. Mix gently. 
 Ectoderm Differentiation Supplement (500X): Reconstitute with 150 μL sterile 
0.1% BSA in PBS. Mix gently. 
 Endoderm Differentiation Media I: Dilute stock solution 500-fold in 
Differentiation Base Media. Prepare fresh as needed. 
 Endoderm Differentiation Media II: Dilute stock solution 500-fold in 
Differentiation Base Media. Prepare fresh as needed. 
 Ectoderm Differentiation Media: Dilute stock solution 500-fold in Differentiation 
Base Media. Prepare fresh as needed. 
 Mesoderm Differentiation Media: Dilute stock solution 500-fold in Differentiation 
Base Media. Prepare fresh as needed. 
Preparation of lyophilised antibodies 
 Polyclonal goat anti-human Sox17 (10X). Reconstitute with 250 μL sterile PBS. 
 Polyclonal goat anti-human Otx2 (10X). Reconstitute with 250 μL sterile PBS. 




For each preparation, mix gently and then: 
a. Tap or briefly centrifuge the vial before opening to dislodge any lyophilised 
material that may be dispersed on the wall or cap of the vial. 
b. For optimal recovery, reconstitute using RT buffer. 
c. After adding the buffer, re-cap the vial and invert gently by hand or place on a 
slow rocking platform. This will allow the reconstitution buffer to coat all the 
surfaces inside the vial. Do not mix by vortexing or by pipetting the material up 
and down. 
d. Allow the vial to sit at RT with gentle agitation for at least 15 min before using. 
e. Store the reconstituted protein in polypropylene or silicon tubes as 15 µL 
aliquots. Avoid repeated freeze–thaw cycles. 
Isotype IgG control antibodies 
Goat IgG negative control (Invitrogen, Cat# 02-6202) 
Secondary antibodies 
Donkey anti-goat secondary: NL557 (R&D systems, Cat# NL001): 
 dilute 1:200 in PBS containing 1% BSA. 
Germ layer immunofluorescence procedures 
1) Wash the fixed cells twice in 200 µL wash buffer (1% BSA–PBS solution). 
2) Block non-specific staining by adding 200 µL blocking buffer (10% donkey serum in 
0.3% TritonX-100–PBS–1% BSA) and incubate for 45 min at RT. Remove blocking 
buffer (no rinsing is necessary). 
3) Add primary antibodies and isotype IgG control according to the scheme in Table 
40. Incubate slides overnight at 2–8°C. 
4) On day 2, wash slides twice in 200 µL wash buffer. 
5) Dilute the secondary antibody in dilution buffer according to the manufacturer’s 
instructions. 
6) Add 100 µL to the wells, and incubate at RT for 1 h in the dark. From this step 
forward, samples should be protected from light. Rinse twice in 200 µL wash buffer. 
7) Add 200 µL of the diluted DAPI solution to each well and incubate 2–5 min at RT. 
N.B. DAPI counterstaining can obscure visualisation of targets localised in cell 
nuclei. Rinse once with PBS and once with water. 
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8) Dispense 1 drop of anti-fade mounting medium onto the microscope slide per 
coverslip. Mount the coverslip with the cells facing towards the microscope slide. 
9) Visualise using a fluorescence microscope and filter sets appropriate for the label 
used. Slides can also be stored in a slide box at 4°C for later examination. 
Table 40: Germ layer marker detection experimental design 
MESODERM 
A663 B1163 C353 GENEA Brachyury ASSAY 
2–3 days A663 B1163 C353 GENEA 
 
ECTODERM 
A663 B1163 C353 GENEA Otx2 ASSAY 
4 days  A663 B1163 C353 GENEA 
 
ENDODERM 
A663 B1163 C353 GENEA Sox17 ASSAY 
4 days  A663 B1163 C353 GENEA 
 
Goat IgG 
A663 B1163 C353 GENEA 
Control 4 days 
A663 B1163 C353 GENEA 
 
MESODERM 
A1953 B1963 C2173  Brachyury ASSAY 
2–3 days A1953 B1963 C2173  
 
ECTODERM 
A1953 B1963 C2173  Otx2 ASSAY 
4 days  A1953 B1963 C2173  
 
ENDODERM 
A1953 B1963 C2173  Sox17 ASSAY 
4 days  A1953 B1963 C2173  
 
Goat IgG 
A1953 B1963 C2173  
Control 4 days 
A1953 B1963 C2173  
 
MESODERM 
A1053 B2253 C2083  Brachyury ASSAY 
2–3 days A1053 B2253 C2083  
 
ECTODERM 
A1053 B2253 C2083  Otx2 ASSAY 
4 days  A1053 B2253 C2083  
 
ENDODERM 
A1053 B2253 C2083  Sox17 ASSAY 
4 days  A1053 B2253 C2083  
 
Goat IgG 
A1053 B2253 C2083  
Control 4 days 
A1053 B2253 C2083  
 
284 
For the experimental design of the basal media controls, refer to Section 4.3.1. 
7.10 Methods for neuronal induction 
PSC Neural Induction Medium by Gibco (Cat# A1647801) is a serum-free medium that 
provides neural induction of human PSCs in 7 days. It does not require the intermediary 
step of EB formation. NSCs generated using PSC Neural Induction Medium have high 
expression of NSC markers and can be further differentiated into other neural cell types 
(Table 41). 
PSC Neural Induction Medium specifications: 
Table 41: PSC Neural Induction Medium by Gibco 
Cell type Stem cells (neural), stem cells, stem cells (iPS-induced pluripotent 
stem), stem cells (embryonic), stem cells (human) 
Contents and 
storage 
500 mL Basal Medium (store at 2–8oC) 
10 mL Supplement (store at –5 to –30oC) 
 
Procedures 
 Medium preparation 
To prepare 500 mL of complete PSC Neural Induction Medium, aseptically mix 490 
mL Neurobasal Medium + 10 mL Neural Induction Supplement. Complete PSC Neural 
Induction Medium can be stored at 2–8oC in the dark for up to 2 weeks. Warm the 
medium in a 37°C water bath for 5–10 min before using (no longer than 10 min). N.B. 
Neural Induction Supplement can be thawed at 2–8°C overnight or quickly in a 37°C 
water bath for ~5 min and then aliquoted and frozen at –5°C to –20°C to allow for 
preparation of smaller volumes of complete medium. Avoid repeated thawing and 
freezing of Neural Induction Supplement. 
 Cell culture procedures 
Remove primary tooth pulp cells and GENEA002 cryo-vials from the liquid nitrogen 
storage according to thawing protocols (Section 7.4.7 and 7.5.5) and following the 
scheme in Table 42. 
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Table 42: Neural induction experimental design in 24-well plate 




























On day 1 of splitting (15–25% confluence), aspirate the spent medium to remove non-
attached cells, and add pre-warmed complete PSC Neural Induction Medium (0.5 
mL/well in 24-well plate). Return the plate to the incubator. 
On day 2 of neural induction (~48 h after switching to PSC Neural Induction Medium), 
confirm that the morphology of cell colonies is uniform. Change the medium by 
aspirating spent medium from each well and adding 0.5 mL of pre-warmed complete 
medium per well. 
On day 4 of neural induction, cells will be reaching confluence. Aspirate the spent 
medium from each well. Add 0.5 mL of pre-warmed complete medium per well. 
On day 6 of neural induction, cells should be near maximum confluence. Repeat 
medium change. N.B. Because of high cell-density in the culture from day 4 onwards, 
doubling the volume of PSC Neural Induction Medium is highly critical for cell nutrition. 
On day 7, stain cells for nestin, Pax6, Sox1 and Sox2 markers. 
7.10.1 Neuronal differentiation (immunofluorescence) methods 
Human Neural Stem Cell Immunocytochemistry Kit 
The Molecular Probes Human Neural Stem Cell Immunocytochemistry Kit (Cat# A24354) 
contents are listed in Table 43. 
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Table 43: Molecular Probes Human Neural Stem Cell Immunocytochemistry Kit 
Label or dye: Alexa Fluor 488 
Alexa Fluor 594 
Alexa Fluor 555 
Contents  • 20 µL of goat anti-human Sox1 (50X) 
• 20 µL of rabbit anti-human Sox2 (50X) 
• 20 µL of mouse anti-human nestin (50X) 
• 20 µL of rabbit anti-human Pax6 (50X) 
• 20 µL of Alexa Fluor 488 anti-mouse (250X) 
• 20 µL of Alexa Fluor 488 anti-goat (250X) 
• 40 µL of Alexa Fluor 555 anti-rabbit (250X) 
• 40 µL of Alexa Fluor 594 anti-rabbit (250X) 
• 1 vial of NucBlue Fixed Cell Stain ReadyProbes Reagent (1X) 
• 10 mL of Fixative Solution (1X) 
• 10 mL of Permeabilisation Solution (1X) 
• 20 mL of Blocking Solution (1X) 
• 20 mL of Wash Buffer (10X) 
 
Neuronal differentiation experimental design 
Experimental designs are described in Tables 44–46. 

























































































































































































































































Neural induction immunofluorescence procedures 
The step by step scheme (Error! Reference source not found.) for neuronal induction 
used in the current study  
 





7.11 Methods for cardiomyocyte differentiation 
PSC Cardiomyocyte Differentiation Kit 
The Gibco PSC Cardiomyocyte Differentiation Kit (Cat# A25042-SA) consists of a set 
of serum-free and xeno-free media that enable efficient differentiation of human PSCs 
to contracting cardiomyocytes in 8 days. The kit contains three 1X media that require no 
thawing or mixing and each is used consecutively over a total of 14 days, resulting in 
functional cardiomyocytes that express relevant physiological markers, contract in 
culture and can be subsequently maintained in culture for >15 days. 
Guidelines for cardiomyocyte differentiation are as follows: 
 The PSC Cardiomyocyte Differentiation Kit is usually used with human PSCs (with 
minimal or no differentiated colonies) that have normal karyotype, are confirmed 
to exhibit pluripotency markers and are routinely passaged every 3 days for at 
least three passages before beginning cardiomyocyte differentiation. 
 Cells should be cultured under feeder-free conditions using E8 medium (Cat# 
A1517001). 
 PSCs must be expanded to 30–70% confluence (the ideal target is 35–60%) 
before starting cardiomyocyte differentiation. If confluence of the cultures is 
outside this range, then cardiomyocyte differentiation will be less efficient. Once 
differentiation has begun, the cultures require feeding every other day. 
 For best results, PSCs should be singularised when passaging. Singularising PSCs 
for differentiation to cardiomyocytes allows better seeding and confluence 
estimates, resulting in more consistent results and overall better differentiation 
of difficult to differentiate lines. 
7.11.1 Cardio-myocyte differentiation procedure 
Cardiomyocyte differentiation (day 0) 
On the day of splitting (70–85% confluent PSC culture), prepare VTN-N-coated 12-well 
plates and equilibrate to RT as in Section 7.4.1: 
1. Rinse each well of the 6-well PSC culture plate with 1 mL PBS (without Ca2+ and 
Mg2+), aspirate and then add 1 mL 0.5 mM EDTA per well and incubate for 4–8 min. 
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2. Aspirate the EDTA solution and suspend the cells in an appropriate amount of E8 
medium to obtain a split ratio (typically 1:8–1:12) that will achieve 30–70% 
confluence within 4 days. 
3. Aspirate the VTN-N solution from the newly coated 12-well plate and add E8 
medium to the wells. 
4. Add the appropriate amount of cell suspension into each well of the 12-well plate 
containing E8. Move the plate in several quick back-and-forth and side-to-side 
motions to disperse the cells across the surface and place them gently in a 37°C 
incubator with a humidified atmosphere of 5% CO2. 
Cardiomyocyte differentiation (day 1) 
24 h after splitting, cells should be at 10–30% confluence. Aspirate the spent medium 
and add 1 mL of pre-warmed complete E8 into each well of the 12-well plate. Return 
the plate to incubator. 
Cardiomyocyte differentiation (days 3, 4 and 6) 
On day 3, replace E8. Return the plate to the incubator. 
On day 4, the culture should exhibit 30–70% confluence (ideal target is 35–60%). 
Aspirate the spent medium and add 1 mL of pre-warmed cardiomyocyte differentiation 
(Medium A) into each well of the 12-well plate. Return the plate to the incubator. 
On day 6, the cells will start to become opaque. Some shedding of dead cells is normal. 
Aspirate the spent medium from each well and replace it with 1 mL of pre-warmed 
cardiomyocyte differentiation (Medium B). Return the plate to the incubator. 
Cardiomyocyte differentiation (days 8, 10, 12 and 14) 
On day 8, the cells will have become more opaque again. Some shedding of dead cells is 
normal. Aspirate the spent medium from each well and replace it with 1 mL of pre-
warmed Cardiomyocyte Maintenance Medium per well. Return the plate to the 
incubator. 
On days 10 and 12, feed the cells with Cardiomyocyte Maintenance Medium. Return the 
plate to the incubator. Contracting cardiomyocytes may appear as early as day 10. 
On day 14, spontaneously contracting syncytium of troponin T cardiac type 2 (TNNT2–
cTnT)-positive cardiomyocytes will be present. 
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7.11.2 Cardiomyocyte immunocytochemistry 
The Human Cardiomyocyte Immunocytochemistry Kit (Molecular Probes Cat# 
A25973) includes antibodies that are validated for ICC analysis and characterisation of 
cardiomyocytes. The kit contents are as follows: 
Store at –20°C to 4°C 
 10 µL of mouse anti-human TNNT2 (1000X) 
 10 µL rabbit anti-human Nkx2.5 (1000X) 
 40 µL of Alexa Fluor 555 donkey anti-rabbit (250X) 
 40 µL of Alexa Fluor 594 donkey anti-rabbit (250X) 
 40 µL of Alexa Fluor 488 donkey anti-mouse (250X) 
 
Store at –20°C to RT: 
 1 vial of NucBlue Fixed Cell ReadyProbes Reagent (1X) 
 10 mL of Fixative Solution (1X) 
 10 mL of Permeabilisation Solution S (1X) 
 20 mL of Blocking Solution (1X) 
 20 mL of Wash Buffer (10X) 
7.11.3 Cardiomyocyte immunofluorescence experimental design 
Experiment 1 in 8-well chamber slides (Table 47) 
Table 47: Optimisation experiment for cell lines A1953, B1963 and C353 
TNNT2 
Alexa Fluor 488 
donkey anti-mouse 
A1953 B1963 C353  Differentiation 
A1953 B1963 C353  BASE MEDIUM 
 
Nkx2.5 
Alexa Fluor 594 
donkey anti-rabbit 
A1953 B1963 C353  Differentiation 
A1953 B1963 C353  BASE MEDIUM 
 
MOUSE IgG Control 
Alexa Fluor 488 
donkey anti-mouse 
A1953 B1963 C353  Differentiation 
A1953 B1963 C353  BASE MEDIUM 
 
RABBIT IgG Control 
Alexa Fluor 594 
donkey anti-rabbit 
A1953 B1963 C353  Differentiation 
A1953 B1963 C353  BASE MEDIUM 
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Experiment 2 in 8-well chamber slides (Table 48) 
Table 48: IF experiment for one cell line from each group and control 
TNNT2 + Alexa Fluor 488 donkey anti-mouse 
Set 1 
A1053 B1153 C2153 GENEA 
A1053 B1153 C2153 GENEA 
 
Set 2 
A663 B2283 C2163  
A663 B2283 C2163  
 
Nkx2.5 + Alexa Fluor 594 donkey anti-rabbit 
Set 1 
A1053 B1153 C2153 GENEA 
A1053 B1153 C2153 GENEA 
 
Set 2 
A663 B2283 C2163  
A663 B2283 C2163  
 
IgG control + Alexa Fluor 488 donkey anti-mouse 
Set 1 
A1053 B1153 C2153 GENEA 
A1053 B1153 C2153 GENEA 
 
Set 2 
A663 B2283 C2163  
A663 B2283 C2163  
 
IgG control + Alexa Fluor 594 Donkey anti-rabbit 
Set 1 
A1053 B1153 C2153 GENEA 
A1053 B1153 C2153 GENEA 
 
set 2 
A663 B2283 C2163  




Experiment 3 in 48-well plates (Table 49) 

























A1053 B1153 C2163 GENEA A1053 B1153 C2163 GENEA 
A663 B2253 C2173 GENEA A663 B2253 C2173 GENEA 
E8 
TNNT2 
A1953 B1963 C353 GENEA A1953 B1963 C353 GENEA 
E8 
Nkx2.5 
A1053 B1153 C2163 GENEA A1053 B1153 C2163 GENEA 
A663 B2253 C2173 GENEA A663 B2253 C2173 GENEA 
 
Experiment 4 in 24-well plates: (Table 50) 
Table 50: Visual auto-contractility experiment design 
A1953 B1963 C353 A1953 B1963 C353 
A1053 B1153 C2163 A1053 B1153 C2163 
A663 B2253 C2173 A663 B2253 C2173 
GENEA GENEA GENEA GENEA GENEA GENEA 




7.11.4 Cardiomyocyte immunofluorescence experimental procedure 
Preparation 
Cells: Differentiated cardiomyocyte primary tooth pulp cells (formalin fixed) 
Mouse anti-human TNNT2 preparation 
 10 µL mouse anti-human TNNT2 (1000X) stock concentration 
 1X antibody dilution is recommended to be diluted with blocking buffer (3% BSA 
in PBS) To dilute the antibody to the recommended dilution, the following 
formula can be applied: 
 V1C1 = V2C2 
 V1 = V2C2/C1 = 1000 x 1:1000 = 1 µL of stock TNNT2 
 1 µL of stock TNNT2 + 999 µL blocking buffer 
 Chamber slides: 100 µL working volume/well = 0.1 µL diluted TNNT2/ well 
Rabbit anti-human Nkx2.5 preparation 
 10 µL of mouse anti-human Nkx2.5 (1000X) stock concentration 
 1X antibody dilution is recommended to be diluted with blocking buffer (3% BSA 
in PBS) To dilute the antibody to the recommended dilution, the same formula 
can be applied as above (V1C1 = V2C2) 
Negative control rabbit IgG antibody (Santa Cruz, SC2027) 
Recommended antibody dilution 1:320 
1:320 dilution = 1 µL IgG + 319 µL antibody dilution buffer (1% BSA–PBS) 
0.5 µL IgG + 155.5 µL antibody dilution buffer (1% BSA–PBS) 
Negative control—mouse IgG1 antibody (Dako, Code X0931) 
Stock concentration: 100 mg/L = 100 µg/mL. Use at 5 µg/mL 
Fluorochrome-conjugated secondary antibody preparation 
 Alexa Fluor 555 donkey anti-rabbit (250X) diluted to 1X in blocking solution 
 Alexa Fluor 488 donkey anti-mouse (250X) diluted to 1X in blocking solution 
Dilution of volumes can achieved using the formula V1C1 = V2C2 
N.B. Washing buffer should be diluted from 10X to be used at (1X) dilution. 
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Immunofluorescence protocol for TNNT2 and Nkx2.5 (Error! Reference source not 
found.) 
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Abstract 
Background: When the dental pulp of an immature permanent tooth is 
compromised, it presents a challenge to the clinician because of its incomplete root 
development. The ability to trigger progenitor cells in the dental pulp, to initiate the 
regenerative process aimed at root maturation, would be of significant benefit. The 
current study isolates and characterises progenitor cells from the pulps of primary 
teeth, using techniques that could ultimately aid the regeneration of pulpal tissues in 
permanent teeth. Immunocytochemistry was used to detect the presence of specific 
progenitor markers in the pulp cells in vitro and multi-lineage differentiation 
experiments assessed the ability of these cells to form different specialised cell types. 
Objectives: To isolate and phenotypically characterise pluripotent progenitor cells 
from primary teeth pulp and culture them in vitro retaining their ‘stem cell’ potential. 
Differentiation potential of primary pulp cells to into ectoderm, mesoderm and 
endoderm progenitors was also assessed. 
Methods: Caries-free primary canine teeth from healthy participants who had 
extractions as part of their orthodontic treatment plans were included (n = 9). Stem cell 
medium (Essential 8–Invitrogen) was used with vitronectin as an attachment matrix for 
the cell culture. Phenotyping and differentiation assays where conducted. Human 
embryonic stem cell line GENEA002 was used as a positive control. 
Results and Conclusions: Pulp cells from primary teeth at three stages of root 
resorption were established in stem cell media. These cells showed positive 
identification of specific proteins that highly suggests the presence of “Stem Cell” 
potential. Three groups of markers were used. The embryonic stem cell markers 
NANOG & SOX2 (but not Oct 4), Neural crest progenitor cell markers Nestin & Dlx2, and 
the Mesenchymal stem cell surface markers CD90, CD73 and CD105 were expressed. 
The primary teeth pulp cells were differentiated into progenitor cells of the three germ 
layers, and cardiomyocyte progenitors. This verified their potential to multi-lineage 
differentiation and potentially transform into dental tissues. There was no difference in 
immunostaining among primary teeth pulp cells from the different stages of root 
resorption in relation to the phenotyping or differentiation experiments. 
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